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During the erythrocytic stage, the malaria parasite digests host cell haemoglobin into amino 
acids. Toxic haeme is released and is incorporated into an insoluble non-toxic crystal called 
haemozoin. Haemozoin is released into the blood stream along with the merozoites when 
the erythrocyte bursts and is phagocytosed by circulating monocytes and macrophages 
resident in tissues. Phagocytosed haemozoin impairs many functions of the monocytes, 
including antigen presentation and adhesion to T cells, differentiation and maturation to 
dendritic cells, erythropoiesis and thrombopoiesis, but stimulates the release of pro-
inflammatory cytokines and activation of metalloproteinase 9 expression.  
 
In response to interferon-γ secretion by T-helper cells subtype 1, monocytes secrete 
neopterin, which is used as a marker of a cell mediated immune response. Neopterin is an 
oxidation product of 7,8-dihydroneopterin, produced by the dephosphorylation of 7,8-
dihydroneopterin triphosphate which results from the conversion of guanosine triphosphate 
that is catalysed by GTP-cyclohydrolase 1. Elevated plasma and urine neopterin levels have 
been detected in malaria infections and are associated with severe anaemia, respiratory 
distress, peak temperatures as well as fever- and parasite-clearance times. It has also been 
reported that monocytic U937 cells treated with P. falciparum-infected red blood cell lysate 
secrete elevated levels of neopterin.  
 
Antimalarial drugs are known to modulate the functions of monocytes, including inhibition of 
cytokine release, changes in phospholipid metabolism, decrease in expression of 
cytoadherance receptors as well as TNF receptors and MHC Class I and II molecules, 
changes in the production of reactive oxygen and nitrogen intermediates, and decreased 
phagocytosis. However, the effects of antimalarial drugs on haemozoin phagocytosis and 
GTP-cyclohydrolase 1 mRNA expression by monocytes are unknown.  
 
This study aimed to determine the effects of seven antimalarial drugs, amodiaquine, 
artemisinin, chloroquine, doxycycline, primaquine, pyrimethamine and quinine, on the 
phagocytosis of latex beads and β-haematin, a synthetic equivalent of haemozoin. 
Phagocytosis of β-haematin and latex beads by two monocytic cell lines, J774A.1 and U937, 
as well as peripheral blood mononuclear cells were monitored by enumeration and a novel 
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spectrophotometric method. Patterns of inhibition and activation differed with each cell type 
investigated, due to the differing stages of cell differentiation. In general, artemisinin, 
primaquine, pyrimethamine and quinine activated the phagocytosis of β-haematin, whereas 
amodiaquine and chloroquine inhibited β-haematin phagocytosis. Doxycycline had different 
effects on each cell type investigated. Artemisinin, chloroquine, primaquine and quinine 
inhibited latex bead phagocytosis. The remaining drugs had minimal effects on latex bead 
phagocytosis. Thus, the effects of antimalarial drugs on monocyte phagocytosis appear to 
be dependent on the substance being phagocytosed. 
 
The effects of antimalarial drugs, β-haematin, latex beads, non-infected- and P. falciparum-
infected cell lysates on interferon-γ-induced neopterin secretion by U937 cells was 
monitored by GTP-cyclohydrolase 1 mRNA expression using quantitative PCR. Artemisinin, 
primaquine and quinine down-regulated the interferon-γ-induced expression of GTP-
cyclohydrolase 1 mRNA, but by no greater than 1.7-fold. β-haematin up-regulated mRNA 
expression by 1.2-fold whereas P. falciparum-infected red blood cell lysate down-regulated 
the mRNA expression of GTP-cyclohydrolase 1 by 1.6-fold.  
 
Quinine and artemisinin, currently used to treat malaria, increased β-haematin phagocytosis 
suggesting that quinine and artemisinin might promote increased phagocytosis of infected 
red blood cells and enhance clearance of the parasite from circulation. Increased β-
haematin phagocytosis also reduces ICAM-1 expression on the monocyte surface, thereby 
leading to reduced cytoadherance and sequestration, thus increasing the number of 
circulating monocytes to phagocytose infected red blood cells. Down regulation of GTP-
cyclohydrolase 1 mRNA expression by quinine and artemisinin suggested that the drugs 
reduce the responsiveness of the monocyte to interferon-γ. Thus, quinine and artemisinin 
might also decrease the production of interferon-γ-induced proinflammatory cytokines by 
monocytes, and potentially play a role in maintaining the balance between the pro- and anti-
inflammatory cytokines that determines the progression from acute to severe malaria. 
Therefore, in addition to the drug’s ability to kill the malaria parasite, the immunomodulatory 
effects of the antimalarial drugs may play a role in controlling the pathophysiology 
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An estimated 3.3 billion people were at risk of contracting malaria in 2006. Of this total, 1.2 
billion living in African tropical/subtropical regions and south-east Asia were at high risk (WHO, 
2008). Refer to Figure 1.1. In 2008, 109 countries were endemic for malaria, 45 of which are in 
Africa. There were an estimated 247 million clinical cases of malaria in 2006, 86% of which 
were in Africa, and an estimated 881 000 malaria deaths in 2006, of which 91% were in Africa 




Figure 1.1. World Map of Plasmodium falciparum malaria risk in 2007 . Dark grey areas 
represent areas of stable risk, where the P. falciparum annual parasite incidence (PfAPI) ≥ 0.1 
per 1000 per annum, medium grey areas represent areas of unstable risk (PfAPI < 0.1 per 1000 
people per annum) and light grey areas represent areas of no risk (PfAPI = 0 per 1000 per 
annum). Community surveys of P. falciparum prevalence were conducted between 1st January 
1985 and 31st July 2008 and are illustrated as the P. falciparum parasite rate (PfPR) in the 2- 
up to 10-year age group (PfPR (2-10 years)) as a continuum of yellow to red from 0% to 100% 
(Hay et al., 2009).        
 
 
In South Africa, approximately 4.3 million people living in the border areas of Limpopo Province, 
Mpumalanga, and the north east of KwaZulu-Natal are at risk of contracting malaria (Blumberg 
and Frean, 2007). In 2006, there were 12 098 reported malaria cases and 87 reported malaria 
deaths in South Africa (WHO, 2008). There has been a decrease in the number of reported 
 2 
cases of malaria from 64 622 in 1999 to 12 098 in 2006 due to indoor residual spraying of 
dichlorodiphenyltrichloroethane (DDT), introduction of artemisinin-based combination therapy 
and changes in weather patterns (Blumberg and Frean, 2007; Mabaso et al., 2004). Following 
several years of drought, heavy rainfalls were experienced in 2000 that increased the number of 
breeding habitats for Anopheles funestus [(http://www.doh.gov.za/facts/stats-
notes/2004/malaria.htm) (last accessed: 16-04-2009)]. Reported malaria deaths in South Africa 
decreased from 406 in 1999 to 87 in 2006 (WHO, 2008).  
 
Malaria is caused by an apicomplexan protozoan parasite, Plasmodium, of which there are 4 
species which affect humans, namely, Plasmodium vivax, P. ovale, P. malariae and P. 
falciparum (Garnham, 1988). Most of the infections (91%) were due to P. falciparum (WHO, 
2008). Recently cases of P. knowlesi infections, a malaria disease infecting monkeys, have 
been reported in humans (Cox-Singh et al., 2008; Galinski and Barnwell, 2009; Jongwutiwes et 
al., 2004; Luchavez et al., 2008; Ng et al., 2008). P. falciparum causes the most lethal human 
malaria as it results in cerebral malaria and anaemia if it goes untreated and is responsible for 
most of the malaria deaths in children under the age of 5 and pregnant women (WHO, 2008). In 
2004, P. falciparum was among the leading causes of death world wide from a single infectious 
agent [(www.who.int/healthinfo/bodestimates/en/index.html) (last accessed: 10-05-09)]. The 
clinical manifestations of malaria vary from acute to chronic: from a simple fever to life-
threatening multiple organ failure depending on the species of parasite involved, and the 
immune status of the patient (Van den Ende and Van Gompel, 1997). The host’s immune 
system has considerable difficulties in controlling malarial infection and hence results in 
immunological inappropriate responses that have no effect on the parasite but may have 
immunopathological consequences of varying degrees of severity. The major 
immunopathological syndromes encountered are severe malaria, which includes cerebral 
malaria, severe anaemia, metabolic acidosis or a combination of these, hyperreactive malarial 
splenomegaly, quartan malarial nephropathy and Burkitt’s lymphoma in areas endemic with 
Epstein Barr Virus (Hommel, 1997). 
 
The efficacy of antimalarial drugs and insecticides in controlling malaria outbreaks is decreasing 
with increasing resistance of the malaria parasites and their vectors (Barnes and White, 2005; 
Casimiro et al., 2006; Greenwood and Mutabingwa, 2002; Pearce et al., 2009; Pongtavornpinyo 
et al., 2008; Santolamazza et al., 2008; Wellems and Plowe, 2001; Wondji et al., 2009). 
Although there are many potential antigen candidates for vaccines, the parasite’s ability to 
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evade and disable the immune system has confounded the development of vaccines (Pierce 
and Miller, 2009). For this reason, it is essential to study the biochemical and 
immunomodulatory interactions between the parasite and host in order to design new 
antimalarial drugs and discover means whereby the immune system can be modulated to 
control malaria infection. 
 
1.1.1 Life-Cycle of the human malaria parasite 
All the human Plasmodium species have the same stages in their life cycles. They have two 
hosts: the sexual phase occurs in the Anopheles female mosquito, and the asexual phase 
occurs in man. During the bite and feeding of an anopheline mosquito, the haploid sporozoites 
enter the bloodstream of the human (Figure 1.2). The sporozoites invade the liver cells and 
undergo a period of growth (G1 phase of the cell cycle), followed by several replications of the 
genome and mitotic divisions (S/M phase) resulting in the production of >20 000 merozoites 
(hepatic schizogony) which are released from the liver cell into the bloodstream where they 
invade erythrocytes. In the erythrocytes, the parasites develop from rings to trophozoites and 
undergo several mitotic divisions during the schizont stage (erythrocytic schizogony) to produce 
16-32 new merozoites. The number of merozoites produced and the duration of the erythrocytic 
cycle is species specific. The merozoites are released from the burst erythrocyte into the 
bloodstream to infect naïve erythrocytes and continue the infection (Garnham, 1988). This 
asexual development of the parasites in the erythrocytes causes the pathology of the disease. 
 
During the blood stage, a small percentage of trophozoites develop into male or female 
gametocytes which are arrested in the G0 phase. The gametocytes remain in the human 
bloodstream until they are ingested as part of a blood meal of the female anopheline mosquito. 
In the midgut of the mosquito, the gametocytes are activated to produce gametes, and, after 
fertilization, form a diploid zygote. Following one round of meiotic division, the zygote develops 
into a motile ookinete that attaches to the gut wall. It penetrates and traverses the gut wall and 
becomes an oocyst in the basolateral lamina. After growth and several mitotic divisions, > 10 
000 sporozoites develop in a single oocyst (sporogony). When the oocyst has matured, it bursts 
and releases the motile sporozoites that migrate through the haemolymph to the salivary gland. 
Then when the female anopheline mosquito takes its next blood meal, the sporozoites are 
injected into the human bloodstream with an anticoagulant and the cycle is 
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continued.(Garnham, 1988; Kooij et al., 2006). This study is concerned with the pathogenic 





Figure 1.2. Life cycle of the human malaria parasit e. When the Anopheles female 
mosquito bites a human, sporozoites enter the bloodstream (1) and invade the liver where they 
mature into schizonts, replicate asexually, (Exo-erythrocytic cycle - A) and form merozoites. The 
merozoites are released into the bloodstream (4) were they invade erythrocytes (5) and develop 
from rings to trophozoites to schizonts, which undergo mitotic division to form merozoites 
(Erythrocytic cycle - B). The merozoites are released into the blood steam (6) where they invade 
naïve erythrocytes. A small percentage of the trophozoites develop into male and female 
gametocytes (7) which are ingested by the mosquito during a blood meal (8). In the mosquito 
midgut, the parasite undergoes a sexual phase where the gametes fuse to form a zygote (9) 
which develops into mature ookinetes (10) that traverse the midgut epithelium and become 
oocysts (11). The oocyst ruptures (12) and a fraction of the released sporozoites end up in the 
salivary glands. Innoculation of the sporozoites into the human’s blood stream perpetuates the 
cycle. This study is concerned with the erythrocytic (asexual) cycle. 




1.2 The immune response of monocytes to malaria 
The first encounter of the host with the parasite is represented by the sporozoite/liver stage, 
while the rupture of the infected erythrocytes during the erythrocyctic cycle produces the clinical 
symptoms of malaria. Sporozoites are rapidly processed by the host hepatocytes and antigens 
are presented on the surface of the infected hepatocyte in combination with major 
histocompatibility complex (MHC) 1 (Weiss et al., 1990). The antigens are recognised by 
cytotoxic T lymphocytes (CTLs) which can kill the infected hepatocyte or the antigens can 
stimulate natural killer (NK) and CD4+ T-cells to produce interferon-γ (IFN-γ). Upon antigen 
recognition, the CD4+ T-cell develops into a T-helper cell subtype 1 (Th 1) which produces IFN-
γ. IFN-γ promotes the microbiocidal activity of the macrophage by stimulating the production of 
reactive nitrogen (RNI) and reactive oxygen (ROI) intermediates and it promotes production of 
tumour necrosis factor-α (TNF-α), interleukin (IL)-12, and IL-18 by the macrophage (Wang et 
al., 1996). These immune reactions do not always occur because the small number of 
sporozoites and infected liver cells are not readily detected by the immune system (Pierce and 
Miller, 2009), and the helper T-cell epitopes on the circumsporozoite protein of the liver stage 
are known to be polymorphic (Good et al., 1988). 
 
The merozoite invades the erythrocyte by a parasite-driven active invasion process. The 
parasites modify the infected erythrocytes by expressing parasite proteins on the cell surface, 
such as P. falciparum erythrocyte membrane protein-1 (PfEMP1) (Baruch et al., 1995; Flick and 
Chen, 2004). At the time of erythrocyte rupture, parasite antigens, including merozoites, are 
released into the blood stream (Snounou et al., 2000). Antigenic variation of merozoite surface 
proteins, such as PfMSP 1, 2, 3, and proteins on the red blood cell surface, like PfEMP1, 
enables merozoites and parasitized erythrocytes to avoid antibodies, continue the infection and 
stimulate the immune system (Hisaeda et al., 2005). The immune response to the plasmodium 
parasite results in clinical and pathogenic manifestations that are due to the proinflammatory 
cytokines, including TNF-α, released by T-cells and macrophages in response to the malaria 
parasites and their products, such as glycosylphosphatidylinositol (GPI) moieties (Krishnegowda 
et al., 2005; Schofield and Hackett, 1993; Zhu et al., 2005), malaria pigment (Pichyangkul et al., 
1994), and plasmodium-derived nitric oxide synthase (NOS)-inducing factor (Ghigo et al., 1995).  
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1.2.1 Haemozoin formation by malaria parasites 
During the erythrocytic stage, Plasmodium falciparum ingests between 60 and 80% of the 
haemoglobin in the red blood cell by pinocytosis via a cytostome (Francis et al., 1997). The 
haemoglobin is transported in a transport vesicle to the parasite’s digestive vacuole where it is 
digested by proteolytic enzymes, including plasmepsins I, II and IV (Banerjee et al., 2002), 
histoaspartic protease (HAP), falcipains 2 and 3 (Rosenthal et al., 2002) and falsilysin 
(Eggleson et al., 1999). The short peptides generated are most probably broken down to amino 
acids in the parasite cytoplasm by aminopeptidases (Gavigan et al., 2001). Refer to Figure 1.4. 
About 15% of the amino acids generated are used as a food source for the parasite (Krugliak et 
al., 2002). Digestion of haemoglobin might also be required to reduce the colloid-osmotic 
pressure within the erythrocyte to prevent its premature lysis (Esposito et al., 2008).  
 
During haemoglobin digestion, the haeme in haemoglobin is released into the digestive vacuole. 
The iron is oxidised from iron(II) to iron(III) by auto-oxidation, but the resulting 
ferriprotoporphyrin IX causes lipid peroxidation (Vincent, 1989) and destabilizes membranes 
though a colloid osmotic mechanism (Chou and Fitch, 1981).  The parasite has developed an 
autocatalytic detoxification process whereby it assembles the ferriprotoporphyrin IX into a 
compact highly insoluble haemozoin crystal (Dorn et al., 1995) and thus decreases the pro-
oxidant capacity of the ferriprotoporphyrin IX (Oliveira et al., 2002). The parasite does not 
contain haeme oxygenase (Eckman et al., 1977), which is found in mammals to degrade 
ferriprotoporphyrin IX. If the parasite did have this enzyme, it would have to sequester vast 
quantities of free iron(III) which is also highly toxic. In higher organisms, these large quantities of 
iron(III) are managed by specialized transport and binding proteins (Baker et al., 2003).           
 
1.2.2 The structure of haemozoin 
Through the use of infrared and X-ray absorption spectroscopy, the intermolecular bond 
between the ferriprotoporphyrin IX molecules in haemozoin was found to be an iron(III)-
carboxylate coordinate bond between the central ferric iron of one molecule and the propionic 
carboxylate side chain of a second molecule (Slater et al., 1991). It was initially hypothesized 
that haemozoin was comprised of long chains of polymerized ferriprotoporphyrin IX polymers 
that were joined by hydrogen bonding (Slater and Cerami, 1992; Slater et al., 1991). In 2000, 
Pagola and Bohle demonstrated using X-ray powder diffraction analysis that haemozoin is 
made up of unit head-to-tail ferriprotoporphyrin IX dimers where each dimer consists of two 
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ferriprotoporphyrin IX molecules linked covalently through reciprocal iron-carboxylate coordinate 
bonding (Pagola et al., 2000). These dimers are integrated into the crystal lattice of haemozoin 
by hydrogen bonding between the second protonated propionic acid groups of each 
ferriprotoporphyrin IX moiety to a dimer in the neighbouring unit cell (Bohle et al., 2002a; Egan, 
2008b), see Figure 1.3. The unit cell of the ferriprotoporphyrin IX dimer is approximately 1 nm3 





Figure 1.3. Structure of haemozoin/ β-haematin.  The dimers are formed by an iron 
carboxylate bond between the central iron of one ferriprotoporphyrin IX molecule and the 
propionic carboxylate side chain of the second ferriprotoporphyrin IX molecule. The dimers are 
then assembled into the crystal lattice by hydrogen bonding between the second protonated 




The morphology of the haemozoin crystals isolated from human malaria parasites is brick-like 
with dimensions of approximately 100 nm x 100 nm x 500 nm. Haemozoin crystals isolated from 
murine Plasmodium are slightly smaller (Noland et al., 2003). β-haematin, the synthetic 
equivalent of haemozoin, can be prepared in several ways, but these can be divided into two 
alternative procedures: (1) the acid-catalyzed method, which proceeds in aqueous media under 
acidic conditions, often at elevated temperatures (Bohle et al., 2002b; Egan et al., 1994; Slater 
et al., 1991); (2) the anhydrous method, which is performed under strictly anhydrous conditions 
in methanol at room temperature (Bohle and Helms, 1993). β-haematin crystals have a tapered 
needle like morphology that has been attributed to rapid growth at the faces (Solomonov et al., 
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2007). Refer to Figure 2.5A and 2.6A which are scanning electron micrographs of β-haematin 
crystals.  
 
1.2.3 The mechanism of haemozoin formation 
The formation of the haemozoin crystal from aqueous ferriprotoporphyrin IX in the acidic 
vacuolar mileu has been the subject of much debate (Arese and Schwarzer, 1997; Egan, 2002; 
O'Neill et al., 1998; Slater, 1993; Snounou et al., 2000). The catalyst in the biologic protein/lipid 
aqueous solution has not been fully resolved. The role of parasite histidine rich protein (HRP) 
(Choi et al., 1999; Schneider and Marletta, 2005; Sullivan et al., 1996b) in haemozoin formation 
is being replaced by lipid initiation (Correa Soares et al., 2007; Egan et al., 2006; Fitch et al., 
1999; Tripathi et al., 2002). It should be noted that P. falciparum clones lacking both HRPII and 
III, along with P. vivax and the murine Plasmodium species which lack orthologues to HRPII and 
III, all produce haemozoin (Sullivan, 2002).  
 
Polar lipid initiation for the formation of haemozoin was initially proposed by Bendrat et al. 
(1995) and this was supported by Dorn et al. (1995, 1998a). A role for neutral lipids in the 
initiation of crystal formation was proposed by Fitch et al. (1999). In the Fitch study, the lysate of 
P. falciparum-infected erythrocytes, which supported the formation of β-haematin, was extracted 
with chloroform and this extract induced the formation of β-haematin whereas the residue 
remaining after the chloroform extraction was shown to be completely inactive. Analysis 
indicated that only lipids characteristic of biological membranes and trace amounts of fatty acids 
were present in the chloroform extract (Fitch et al., 1999). Tripathi et al., (2002) and Pandey et 
al., (2003) suggested that a combination of lipids and proteins were involved in the initiation of 
haemozoin formation. Jackson et al., (2004) demonstrated the presence of neutral lipid bodies 
closely associated with the digestive vacuole of P. falciparum using Nile Red labelling and 
spectral imaging on a confocal microscope. These lipid bodies were found to contain 
predominantly mono- and di-acylglycerols and the authors showed that a series of mono-, di- 
and tri-acylglycerols promoted β-haematin formation much more efficiently than HRPII (Jackson 
et al., 2004). Vielemeyer et al., (2004) also demonstrated that neutral lipids synthesized by the 
parasite were stored as lipid bodies in the parasite cytoplasm. The presence of triacylglycerol 
containing lipid bodies in P. falciparum was demonstrated by Palacpac et al., (2004a) and the 
enzyme catalyzing the synthesis of triacylglycerols was shown to be essential for 
intraerythrocytic proliferation of the parasite (Palacpac et al., 2004b).  
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When malaria parasites were stained with malachite green, which is used to fix neutral lipids, 
the resulting transmission electron micrographs showed the haemozoin embedded within a lipid 
body (Coppens and Vielemeyer, 2005) or lipid nanosphere as referred to by Pisciotta et al., 
(2007). This indicated that haemozoin formed within lipid bodies in the parasite’s digestive 
vacuole. Haemozoin together with these lipid bodies were isolated by sucrose density gradient 
centrifugation. Sodium dodecyl sulphate polyacrylamide gel electrophoresis of the lipid bodies 
followed by staining with Coomassie Blue, indicated that there were no proteins and Western 
blots did not detect the presence of HRP II, PfCRT (a protein present in the food vacuole 
membrane) or P. falciparum aldolase (Pisciotta et al., 2007). Analysis by thin layer 
chromatography and hydrolysis followed by gas-liquid chromatography-mass spectroscopy 
indicated that neutral lipids, such as monoacylglycerols, were predominantly present, in 
particular, monopalmitoyl- and monostearoyl-glycerol, together with significant quantities of a 
polar lipid called phosphatidyl ethanolamine (Pisciotta et al., 2007). It was proposed that this 
phospholipid might be involved in the stabilization of the lipid bodies as the neutral lipids in the 
interior are usually surrounded by a monolayer of polar lipids such as phospholipid, glycolipid or 
sterol (Coppens and Vielemeyer, 2005). Monopalmitoyl-glycerol was found to be extremely 
efficient at promoting the formation of β-haematin, while a blend of monopalmitoyl- and 
monostearoyl-glycerol had similar activity to the lipids isolated with haemozoin from the parasite 
lysates. β-haematin product formed within 10 minutes and the reaction was not affected by 
globin which is essential as high concentrations of globin are present in the digestive vacuole. 
The lipids also protected the ferriprotoporphyrin IX from degradation by peroxide (H2O2) 
(Pisciotta et al., 2007). 
 
As in P. falciparum, there is a close association between haemozoin formation and lipids in the 
unrelated organism Schistosoma mansoni. Oliveira et al., (2005) showed that haemozoin 
formation occurs within lipid bodies in the worm’s gut. These bodies were roughly spherical with 
no evidence of a bilayer at their surface. The bodies were either completely filled with 
haemozoin crystals or contained small quantities of the crystals located near the inner surface 
of the lipid body where they made contact with the aqueous interface. This suggested that 
haemozoin grows from the lipid-water interface into the lipid body. Lipids isolated from these 
bodies supported β-haematin formation (Correa Soares et al., 2007).  
The observation that haemozoin formation in S. mansoni occurs at the interface between the 
lipid and aqueous phases strongly suggests that the interface plays an important role in the 
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process. This was confirmed in a biomimetic study in which the organic solvents, octanol and 
pentanol, as well as the lipid, monomyristoylglycerol (MMG), were used to mimic the lipid 
environment (Egan et al., 2006). Ferriprotoporphyrin IX dissolved in 0.1 M NaOH was 
introduced to the interface (via a syringe) of two phase systems of pentanol-, octanol- or MMG-
water where the aqueous phase was buffered at pH 4.8, a recent estimate of the digestive 
vacuole pH (Hayward et al., 2006). β-haematin was produced within 30 minutes at 37ºC as 
confirmed by infra-red spectroscopy, X-ray diffraction and scanning electron microscopy. Using 
an immersion probe, Raman-resonance spectroscopy indicated that β-haematin was formed 




Figure 1.4. Proposed schematic representation of ha emozoin formation in Plasmodium 
falciparum. Cytoplasm from the red blood cell (RBC) is taken up into the parasite by means of a 
cytosome (C) and (a) transported to the digestive vacuole (DV) in a double membrane transport vesicle 
(TV). (b) Once inside the digestive vacuole, the haemoglobin (Hb) is digested by plasmepsins, falcipains 
and falsilysin to short peptides (c). The peptides are transported out the digestive vacuole into the 
cytoplasm (d) where they are broken down by aminopeptidases into amino acids. The haeme, 
(Fe(II)PPIX), is oxidized (f), possibly by molecular oxygen, to ferriprotoporphyrin IX (Fe(III)PPIX) and a 
superoxide anion is released in the process. In the aqueous solution, Fe(III)PPIX forms a π-π complex (g) 
that is delivered to the lipid body (nanosphere) (h). The lipid body has a low dielectric constant, which 
enables the formation of a “haemozoin precursor dimer” (i) in which the axial water ligands of H2O-
Fe(III)PPIX are displaced with the formation of the iron-propionate bonds in the haemozoin dimer (j). In 
the lipid body, there is no solvent available with which to form hydrogen bonds and so the haemozoin 
dimers form hydrogen bonds with each other (k) and result in haemozoin nuclei that finally assemble into 
the crystal (l) (Egan, 2008a).          
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The behaviour of ferriprotoporphyrin IX (Fe(III)PPIX) in aqueous solution was studied to 
understand the molecular mechanism behind β-haematin formation. For 35 years, it has been 
believed that dimerisation involves the formation of µ-oxo dimers (Brown et al., 1969). Although 
this species is present at high pH in the presence of high salt concentrations or organic bases, it 
does not appear to be present in abundance under the conditions prevailing in haemozoin-
forming organisms. 
 
It has been shown that H2O-Fe(III)PPIX and HO-Fe(III)PPIX form π-π complexes in aqueous 
solution (de Villiers et al., 2007). Under conditions resembling the digestive vacuole, the most 
likely dimer to form is a neutral (H2O-Fe(III)PPIX)2 species in which one propionic acid group on 
each porphyrin is ionised and one is not. At higher pH, the likely dimers to form are anionic 
(H2O-Fe(III)PPIX)2, H2O-Fe(III)PPIX•HO-Fe(III)PPIX and (HO-Fe(III)PPIX)2 in which both 
propionic acid groups on each porphyrin are ionised (de Villiers et al., 2007). The charges on 
the propionic acid groups are relatively distant from each other and the interacting iron centres 
are positively charged in the H2O-Fe(III)PPIX species and neutral in the HO-Fe(III)PPIX species. 
Molecular dynamic simulations of two H2O-Fe(III)PPIX molecules in a vacuum showed the rapid 
formation of a “haemozoin precursor dimer” (Egan et al., 2006) in which the positively charged 
iron(III) centre of one Fe(III)PPIX molecule interacts with the negatively charged propionate 
group of the other molecule. A haemozoin dimer is formed with the formation of the iron(III)-
propionate bond and the concomitant displacement of the axial water molecule from the 
opposite face of the porphyrin molecule (Figure 1.4). This precursor dimer was found to be 
unstable in the presence of water molecules as the propionate groups move rapidly away from 
the iron centres and interact with the water molecules (Egan et al., 2006). This observation is 
supported by the rapid formation of β-haematin in the low dielectric medium of the interface 
systems and the slow difficult formation of β-haematin in the aqueous systems which require 
high concentrations of acetate and high temperatures. Formation of β-haematin in the aqueous 
systems exhibits sigmoidal kinetics with long induction periods and large activation energies 
(Egan et al., 2001; Egan and Tshivhase, 2006). Hydrogen bonding between the dimers to form 
the haemozoin crystal will also be inhibited in the presence of competing hydrogen bonding 
from water molecules. Two important questions remain: (1) how are the ferriprotoporphyrin IX 
molecules delivered to the lipid bodies and (2) how is the crystal formation initiated?    
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1.2.4 Biology of the mononuclear phagocyte system 
The mononuclear phagocyte system is made up of bone marrow monoblasts and 
promonocytes, peripheral blood monocytes and tissue macrophages (Auger and Ross, 1992). 
The least mature cell is the monoblast which divides to give rise to two promonocytes, which are 
the precursors of monocytes. Monocytes leave the bone marrow after less than 24 hours and 
enter the peripheral blood (Meuret and Hoffmann, 1973). From the peripheral blood, the 
monocytes migrate into tissues to become macrophages. During an acute inflammatory 
reaction, there is an increase in bone marrow production and circulating monocytes (Van Furth 
et al., 1973). 
 
1.2.4.1. Morphology of the mononuclear phagocyte 
Macrophages are irregularly shaped, large cells with a diameter of 25-50 µm. They have a 
round or kidney-shaped nucleus and granules in the cytoplasm. Vacuoles are often found in the 
cytoplasm near the cell periphery indicating pinocytosis activity. Monocytes have a smaller size 
(12-15 µm) and a round, kidney-shaped or irregularly shaped nucleus that occupies about 50% 
of the cell area. The cytoplasm contents of monocytes are similar to that of macrophages. Both 
monocytes and macrophages have a ruffled appearance on the surface (Auger and Ross, 
1992). 
 
1.2.4.2. Composition and metabolism of the mononucl ear phagocyte   
The composition and metabolism of mononuclear phagocytes changes during differentiation. 
When monocytes differentiate into macrophages, there is an increase in the number of 
mitochondria, an increase in the activity of the mitochondrial enzymes and the rate of cellular 
respiration (Cohn, 1968). The number of lysosomes and lysosomal enzymes is also increased. 
Lysosomal enzymes are synthesized in the endoplasmic reticulum and packaged into primary 
lysosomes by the Golgi apparatus  (Nichols et al., 1971). These primary lysosomes fuse with 
phagosomes which contain ingested material to form secondary lysosomes or phagolysosomes. 
 
Receptor-ligand interactions affect the basal metabolism of the macrophages and result in a 
respiratory burst in which oxygen consumption is increased, and large quantities of glucose are 
metabolised by the hexose monophosphate shunt. The membrane-bound oxidase complex is 
altered and molecular oxygen is reduced to superoxide (Babior, 1984). The superoxide is 
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rapidly converted to hydrogen peroxide and hydroxyl radicals, which provide most of the 
microbiocidal activity within the lysosomes and in the extracellular environment. The respiratory 
burst is markedly decreased as the monocytes mature into macrophages, but it is increased 
several fold when the macrophages are activated by exposure to IFN-γ (Nathan et al., 1983) 
and migration inhibitory factor (Nathan et al., 1984). Activation of the macrophages results in an 
enhanced cellular metabolism, mobility, lysosomal enzyme activity, including neutral proteases, 
cytocidal capacity and an increase in acid hydrolases, complement components, enzyme 
inhibitors, binding proteins, IL-1, TNF-α, and factors promoting haematopoiesis (production of 
blood cells and platelets) (North, 1978).   
 
1.2.4.3. Functions of the mononuclear phagocyte 
Macrophages provide a defence against invasion of the host by a wide variety of micro-
organisms, such as bacteria, viruses, fungi and protozoa (Cohn, 1968). The macrophages are 
guided towards the micro-organism by a trail of chemotactic molecules emanating from them. 
The micro-organism is then engulfed by the macrophage. Phagocytosis can be enhanced by 
opsonins, which consist of immunoglobulin G (IgG), or fragments of the third component of 
complement which bind to specific sites on the micro-organism, and Fc receptors (that bind to 
Fc domain of various subclasses of IgG) or C3 receptors (that bind to several isotypes of 
complement) on the macrophage (Adams and Hamilton, 1984). Phagocytosis can also occur 
without opsonisation, for example, when the macrophage mannose-fucose receptor interacts 
with the carbohydrate residues on the micro-organism (Sung et al., 1983). The microbiocidal 
effects of the monocyte/macrophage are catalyzed by a set of interrelated enzyme pathways. 
The most important of these are nitric oxide (inducible nitric oxide synthase), hydrogen peroxide 
and superoxide anion (phagocyte NADPH oxidase) and hypochlorous acid (myeloperoxidase), 
which are toxic to micro-organisms (Albrich et al., 1981; Rosen et al., 1995; Wang et al., 2001).     
 
A second major function of the macrophages is to assist in initiating and facilitating cell-
mediated immune responses against pathogens by acting as antigen presenting cells. The 
macrophage takes up the antigens, processes them by denaturation or partial degradation and 
in the case of protein antigens, generates peptides that are recycled to the cell surface in 
association with glycoproteins encoded by the Class I or II genes of the major histocompatibility 
complex (MHC). The peptides in association with Class I or II molecules on the cell surface are 
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recognised by MHC Class I- (CD8-expressing T-cell) or Class II- (CD4-expressing T-cell) 
restricted specific T-cells (Auger and Ross, 1992). 
 
Mononuclear phagocytes have an extensive secretory capability, in that they not only secrete 
enzymes, but many other substances that have functions ranging from induction of cell growth 
to cell death (Nathan, 1987). Enzymes include lysozyme, acid hydrolases, neutral proteases, 
lipase and arginase. Other substances which are secreted include enzyme inhibitors, 
complement components, reactive oxygen intermediates, arachidonic acid intermediates, 
coagulation factors and cytokines such as interferon-α, TNF-α, colony stimulating factors, IL-6, 
IL-1, transforming growth factor-β, platelet derived growth factor and epidermal growth factor.  
 
1.2.5 The role of monocytes/macrophages in the immu ne response to malaria  
A large portion of resident macrophages, circulating monocytes and neutrophils of malaria-
infected patients contain haemozoin crystals (Amodu et al., 1998; Lyke et al., 2003; Metzger et 
al., 1995b; Nguyen et al., 1995). Unpurified haemozoin contains ferriprotoporphyrin IX, proteins, 
lipids and nucleic acids of both host and parasitic origin (Goldie et al., 1990). Macrophages are 
involved in the control of the malaria infection by antibody-dependent (Fc receptors) and 
independent (CD36) phagocytosis of haemozoin and parasite-infected erythrocytes (Ayi et al., 
2005; Celada et al., 1983b; Patel et al., 2004), and the release of soluble factors which are toxic 
either directly or indirectly to the parasite. These factors include IL-1, TNF-α (Pichyangkul et al., 
1994), granulocyte-macrophage colony stimulating factor (GM-CSF) (Yamada-Tanaka et al., 
1995), reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) (Prada et 
al., 1996a). 
 
Confocal microscopy studies indicate that haemozoin remains unharmed inside the 
macrophage for up to 72  hours (Schwarzer et al., 2001). The percentage of pigment- containing 
neutrophils and monocytes appears to roughly correlate with the severity of the disease (Amodu 
et al., 1998; Hanscheid et al., 2008; Lyke et al., 2003; Metzger et al., 1995b; Nguyen et al., 
1995). The accumulation of haemozoin inside the macrophage impairs the functions and 
activation of the macrophage. The haemozoin-laden macrophage is unable to repeat 
phagocytosis (Schwarzer et al., 1992), generate a respiratory burst upon stimulation with 
phorbol-12-myristate-13-acetate (Schwarzer et al., 1992) or produce nitric oxide (Taramelli et 
al., 1995), and hence, cannot kill ingested bacteria, fungi or tumour cells (Fiori et al., 1993). 
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Phagocytosed haemozoin also inhibits the membrane translocation and activity of protein 
kinase C (Schwarzer et al., 1993), in addition to the activity of NADPH oxidase (Schwarzer and 
Arese, 1996). Moreover, monocytes containing haemozoin cannot express MHC Class II in 
response to IFN-γ (Schwarzer et al., 1998), thus suggesting a link between haemozoin 
phagocytosis by monocytes, suppression of IFN-γ responsiveness, failure to up-regulate MHC 
Class II, impairment in antigen presentation and immunosuppression in malaria (Scorza et al., 
1999). Haemozoin also impairs the spontaneous up regulation of intercellular adhesion 
molecule (ICAM-1) and integrin-CD11c on the surface of the monocyte (Schwarzer et al., 1998). 
ICAM-1 is an adhesion molecule that contributes to the capacity of the monocytes to adhere 
and stimulate T-cell proliferation. These observations might explain the defective T-cell 
response in malaria. Another contributing factor to the immunosuppression observed in malaria 
is that haemozoin inhibits the differentiation and maturation of monocytes into functional 
antigen-presenting dendritic cells (Skorokhod et al., 2004). As dendritic cells play an important 
role in linking the innate immune response with the adaptive immune response through antigen 
presentation, this may also explain the deficient response of B and T cells and the reduced 
antibody response in malaria. A recent study confirmed that haemozoin induced failed dendritic 
cell function in vivo and in vitro in a P. chabaudi murine model (Millington et al., 2006).  
 
Haemozoin-laden monocytes have an enhanced metalloproteinase 9 activity (Prato et al., 2008; 
Prato et al., 2005) which functions by proteolytically shedding pro-forms of cytokines, such as 
TNF-α and IL-1β, thereby activating them and releasing them into the blood. Metalloproteinase 
9 is also involved in disrupting basal lamina and may be responsible for symptoms of cerebral 
malaria, notably dysfunction of the blood-brain barrier, local haemorrhages and extravasation of 
phagocytic cells and blood cells into the brain tissues (Prato et al., 2008). Most of these effects 
are as a result of the accumulation of lipoperoxidation products, such as the monohydroxy 
derivatives of arachidonic acid and linoleic acid, and large amounts of the potent aldehyde, 4-
hydroxynonenal, in the macrophage. These lipoperoxidation products are ferried into the 
monocyte with phagocytosed haemozoin, while ingested haemozoin produces more by haeme-
catalysis of lipoperoxidation of unsaturated fatty acids (Schwarzer et al., 2003).  
 
Nitric oxide produced by monocytes plays a two-fold role in malaria, both in the protection and 
pathology of malaria. In the protection of the host, nitric oxide (NO) is responsible for the killing 
of the liver stage of the parasites in response to TNF-α and IL-1β secretion (Clark et al., 1997). 
However, when NO is produced in excess, it is toxic to both the invading parasites as well as 
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the host cells. During cerebral malaria, parasite-infected erythrocytes adhere to the 
microvasculature in the brain, block the vessels and induce proinflammatory cytokine secretion 
that results in inducible nitric oxide synthase (iNOS) generated NO both by leucocytes and 
endothelial cells in a localized area (Ghigo et al., 1995; Tachado et al., 1996). NO may act as a 
local neuroactive mediator, thus induction of iNOS expression may contribute to coma, seizures 
and death associated with cerebral malaria (Maneerat et al., 2000).           
 
Macrophages contribute to the pathogenesis of malaria through their expression and response 
to cytokines and chemokines. In human malaria, the immune reactivity is altered late in the 
acute phase and it often lasts for a long time after the parasite has been cleared from the 
circulation (Hviid et al., 1991). One of the reasons why malaria immunity is poorly acquired in 
naturally exposed populations is that the parasites modulate the immune system of the host and 
prevent specific immune responses (Plebanski and Hill, 2000). The inflammatory response 
required to kill the parasites often causes tissue damage, and activation of phagocytes to kill 
intracellular or extracellular parasites requires the production of inflammatory cytokines, which 
can cause systemic effects like anaemia and cerebral malaria (Luty et al., 2000; McGuire et al., 
1994). Thus, there needs to be a delicate balance in the induction and inhibition of these 
mediators. Refer to Figure 1.5.     
 
1.2.5.1 Pro-inflammatory cytokines in malaria infec tion 
Tumour necrosis factor-α (TNF-α) is induced in macrophages by P. falciparum-infected   
erythrocytes, haemozoin (Pichyangkul et al., 1994) and certain glycolipids, for example, 
glycosylphosphatidylinositols (GPI) (Schofield and Hackett, 1993). GPI also induces iNOS in 
macrophages (Tachado et al., 1996) and activates endothelial cells for enhanced cytoadhesion 
to leucocytes and parasite-infected red blood cells (Schofield et al., 1996). Antibodies raised 
against GPI prevented lysates of plasmodium-infected erythrocytes from inducing TNF-α 
secretion from mononuclear cells (Bate and Kwiatkowski, 1994). The levels of TNF-α can be 
modulated by IFN-γ, which stimulates TNF-α production by monocytes, and IL-4 and IL-10, 
which both decrease the secretion of TNF-α (Essner et al., 1989; Fiorentino et al., 1991). TNF-α 
increased the phagocytic capacity of monocytes by increasing the number of Fc receptors on 
the monocyte or by modulating Fc receptor-mediated signalling pathways by binding to the Fc 
receptors. TNF-α also inhibits P. falciparum growth by a pleiotropic antimalarial effect that is not 
related to phagocytosis (Muniz-Junqueira et al., 2001) . TNF-α plays a role in regulating IL-12 
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production in macrophages and it is a co-factor in the IL-12-induced production of IFN-γ by 
natural killer cells (Tripp et al., 1993). Although high plasma NO and TNF-α levels are 
associated with parasite clearance, TNF-α also has detrimental properties such as fever, aches 
and pains and correlates to acute disease, hypoglycaemia, shock, bleeding and reversible coma 
(Beutler and Grau, 1993). A close association between high TNF-α levels, severe anaemia and 
large numbers of circulating haemozoin-containing monocytes has been demonstrated 
suggesting that haemozoin-induced TNF-α production plays a role in either the initiation or the 
exacerbation of anaemia as a result of chronic uncontrolled parasitaemia (Luty et al., 2000). 
 
Interferon-γ (IFN-γ) is a macrophage-activating factor involved in the protective innate immune 
response to the blood stage of malaria. It is produced by natural killer cells in a non-specific 
response and by CD4+ and CD8+ T cells in a specific immune response (Arase et al., 1996; 
Rincon et al., 1998). In Gabonese children, IFN-γ released by CD4+ T cells to specific parasitic 
erythrocytic antigens was associated with protection against malaria reinfection (Luty et al., 
1999). INF-γ secreted by T cells induces the production of specific IgG against blood stage 
malaria parasites and assists with the monocyte-mediated antibody-dependent cellular inhibitory 
mechanisms (Bouharoun-Tayoun et al., 1995). During P. falciparum infection, the target cells of 
IFN-γ are monocytes/ macrophages (Bate et al., 1988), neutrophils (Kumaratilake et al., 1991), 
T-helper cells subtype 2 (Th 2) (Taverne, 1993) and parasite-infected hepatocytes (Klotz et al., 
1995). Macrophages that are activated by IFN-γ release TNF-α, transforming growth factor-beta 
(TGF-β), IL-1, IL-6, ROI and RNI (Clark et al., 1997). IFN-γ signalling affects transducers 
associated with transcription, activates iNOS and initiates L-arginine-dependent NO pathway, 
produces NO and subsequently eradicates the P. falciparum infected hepatocytes (Snounou et 
al., 2000).  
 
Children with P. falciparum hyperparasitaemia had fewer IFN-γ-secreting CD4+ T cells than 
children with uncomplicated malaria (Winkler et al., 1999). Thus, it appears that IFN-γ is 
essential for resolving the primary infection by limiting the initial phase of parasite replication. 
However, IFN-γ also contributes to the acute symptoms of malaria infection such as fever, 
headache and nausea through the induction of TNF-α and IL-1. Over production of TNF-α or 
IFN-γ can result in severe pathology. IL-12 and IL-18 control the IFN-γ secretion by T cells 
(Riley, 1999). 
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Interleukin (IL)-12 is a potent immunomodulatory cytokine that links the early innate non-specific 
immune response to later adaptive specific immune responses (Trinchieri, 1995).  IL-12 is 
produced by macrophages in response to infectious agents and it is likely that the process of 
phagocytosis stimulates IL-12 production. IL-12 acts on antigen-stimulated CD4+ T cells and 
activates ‘signal transducers and activating transcription 4’ (STAT 4), thus promoting the 
differentiation of the T cells into T helper cell subtype 1 (Th 1) (O'Garra and Arai, 2000). The Th 
1 cells produce INF-γ, which in turn acts on macrophages by stimulating their microbiocidal 
properties and increasing their production of IL-12. The increased concentrations of IL-12 
moderates the activity of the macrophage and results in increased erythrocyte destruction and 
bone marrow diserythropoiesis (Crutcher et al., 1995). IL-12 also induces IFN-γ production by 
natural killer (NK) cells early in the infection, it acts as a growth factor for NK cells and it 
enhances the cytotoxic activity of NK cells (Trinchieri, 1995). IL-12 has also been demonstrated 
to be involved in the adaptive immune response in that it stimulates the production of antibodies 
by B cells and it has been associated with protective immunity against the blood stage infection 
in the murine model (Crutcher et al., 1995). IL-12 also favours cytotoxic T lymphocyte (CD8+) 
generation (Trinchieri, 1995). In patients with hyperparasitaemia and severe malaria, the lower 
IL-12 concentrations were related to reduced T-cell mediated IFN-γ activity (Malaguarnera et al., 
2002). In acute malaria, the constitutive production of IL-12 by monocytes was inhibited when 
the monocytes phagocytosed haemozoin. Β-cell or Th 2 production of IL-10 also antagonized 
the activity of IL-12 (O'Garra and Arai, 2000).   
 
Interleukin 18, which is produced by monocytes/macrophages, has a wide range of 
immunoregulatory functions including gene expression and synthesis of TNF-α and IL-1 by 
macrophages, increased Th 1 cell differentiation and induction of NK cell cytotoxicity (Dinarello, 
1999). Certain structural motifs and amino acid sequences indicate that IL-18 is in the IL-1 
family of cytokines (Okamura et al., 1995). In a similar manner to IL-1, IL-18 is also processed 
by the IL-1 converting enzyme and the activity of mature IL-18 is closely related to that of IL-1β 
(Bazan et al., 1996; Dinarello, 1999). IL-18 acts synergistically with IL-12. IL-18 by itself induces 
low concentrations of IFN-γ production by B and T cells. However, when IL-12 and IL-18 
synergistically act on Th 1 cells and B cells, high concentrations of IFN-γ are produced. Thus it 
has been postulated that IL-18 induces IFN-γ production only when IL-12 up-regulates the IL-18 




Figure 1.5. The immune response of macrophages duri ng malaria infection.  P. 
falciparum-infected red blood cells induce macrophages to produce TNF-α, IL-12 and IL-18. IL-12 and IL-
18 synergistically induce Th 1 differentiation and the production of IFN-γ by Th 1 cells, NK cells and B 
cells. The IFN-γ stimulates further production of TNF-α from macrophages resulting in clearing of 
parasites or pathophysiology depending on the stage of disease. IL-12 also stimulates the production of 
antibodies from B cells and favours cytotoxic (CD8+) T cell generation. IL-4 induces Th 2 differentiation 
and the production of IL-10 and TGF-β which together suppress the secretion of TNF-α and IFN-γ from 
monocytes and antagonize the activity of IL-12. IL-4 also stimulates B cells to produce antibodies and 
development of cytotoxic CD8+ T cells against the parasite-infected hepatocytes. Pro-inflammatory 
cytokines are in bold and anti-inflammatory cytokines are in italics. Pf-RBC: Plasmodium falciparum-
infected red blood cell. 
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During acute malaria and the recovery phases of uncomplicated P. falciparum infections, there 
are high plasma concentrations of IL-18, suggesting a proinflammatory role in these patients 
(Torre et al., 2001). Chaiyaroj et al. (2004) found that IL-18 levels were higher in uncomplicated 
malaria in Thai adults than in healthy controls and that the IL-18 response rate declined as the 
symptoms of the disease became more severe suggesting that the IL-18 response was 
impaired with increasing disease severity. In contrast, Kojima et al. (2004) found that Thai 
patients with severe malaria had higher IL-18 levels than those with uncomplicated malaria, and 
with treatment, the IL-18 levels decreased in cerebral malaria but remained high in severe 
malaria (Nagamine et al., 2003).    
 
1.2.5.2 Anti-inflammatory cytokines in the malaria infection  
Pro-inflammatory cytokines produced early in malaria infection mediate protective immunity, 
whereas when they are produced later in the infection, they contribute to the pathology of the 
malaria infection. Thus, if the inflammatory response is not controlled, it will lead to severe 
disease. During mild malaria, the inflammatory response can be down-regulated by anti-
inflammatory cytokines such as IL-4, IL-10 and transforming growth factor-β (TGF-β). 
 
Interleukin-4 is produced by Th 2 cells and mast/basophil cells and it is a growth factor for B 
cells and promotes IgE and IgG synthesis (Howard et al., 1982; Vitetta et al., 1985). IL-4 
enhances the tumouricidal activity of macrophages and the expression of MHC Class II on the 
macrophage surface (Crawford et al., 1987; te Velde et al., 1988). It stimulates the 
differentiation of CD4+ T cells into Th 2 cells and inhibits the Th 1 cell response (Fernandez-
Botran et al., 1986). Th 2 cells and IL-4 have been shown to be important in the antibody 
response against the malaria parasite (Troye-Blomberg et al., 1990). IL-4 secreted by CD4+ Th 
2 cells is essential for the development of the CD8+ T cells (cytotoxic T cells) against 
hepatocytes infected with the malaria parasite (Carvalho et al., 2002). The phagocytosis of P. 
falciparum-infected red blood cells by non-activated macrophages and monocytes was found to 
be inhibited by IL-4 (Kumaratilake and Ferrante, 1992). 
 
Transforming growth factor-β (TGF-β) is produced by a variety of cells, including NK cells, 
macrophages, T cells and B cells and it has pro-inflammatory properties at low concentrations 
and anti-inflammatory properties at high concentrations (Wahl, 1994). Pro-inflammatory 
properties of TGF-β include its ability to recruit monocytes, T cells and neutrophils to the site of 
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inflammation early in an infection, by modulating endothelial cell adhesion molecule expression 
(Wahl, 1994). However, high concentrations of TGF-β suppress production of TNF-α and NO 
from macrophages (Espevik et al., 1987), inhibit production of TNF-α and IFN-γ from NK cells 
(Bellone et al., 1995) and antagonize IFN-γ-stimulated up regulation of major histocompatibility 
complex II antigens (Nandan and Reiner, 1997). TGF-β antagonizes the effects of IL-4, IL-2 
(Ruegemer et al., 1990) and IL-12 (Pardoux et al., 1997). These effects may be enhanced by 
IL-10 produced by macrophages, which may cause a shift from a Th 1 immune response to a 
Th 2 immune response (Maeda and Shiraishi, 1996).  
 
In the murine malaria model, levels of TGF-β were inversely associated with the severity of 
malaria infection in mice and TGF-β appears to have a protective effect by down regulating the 
production of potentially pathogenic pro-inflammatory cytokines, TNF-α and IFN-γ (Omer and 
Riley, 1998). Evidence suggests that TGF-β has a dual function in malaria: early in the 
infection, TGF-β up-regulates Th 1-mediated immune responses and promotes antibody-
independent cell mediated mechanisms that control acute parasitaemia. Later in the malaria 
infection, TGF-β down-regulates the Th 1 immune response to reduce the inflammatory-
associated pathology (Omer et al., 2000; Omer and Riley, 1998). TGF-β might also play a role 
in the outcome of malaria via its effects on B cells. Low concentrations of TGF-β stimulate B 
cells to secrete immunoglobulin G subclasses (Snapper et al., 1993) but high concentrations of 
TGF-β inhibit the formation of antibodies (Stavnezer, 1995).  
 
Not many studies have measured the levels of TGF-β in children with acute malaria. Lower 
plasma levels of TGF-β in comparison to healthy controls were measured in Thai patients with 
acute malaria (Wenisch et al., 1995a).  In another study, TGF-β levels were measured in Thai 
adults with uncomplicated, severe and cerebral malaria, Tanzanian children with cerebral 
malaria and pregnant women. The lowest levels of TGF-β were detected in peripheral blood of 
adult patients with cerebral malaria and placental blood of pregnant women infected with P. 
falciparum, but the levels observed in severe malaria were also significantly lower than those in 
uncomplicated malaria. Overall, the TGF-β levels were inversely correlated with the severity of 
disease (Chaiyaroj et al., 2004). Other studies have demonstrated the accumulation of TGF-β 
in the brain and the involvement of TGF-β in the reorganisation process of the brain 
parenchyma, immunological dysfunction and endothelial cell activation in patients with cerebral 
malaria (Deininger et al., 2000).        
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Interleukin-10 is produced by monocytes, Th 2 cells and B Cells. It inhibits cytokine production 
from Th 1 cells and CD8+ T cells. IL-10 induces B cell proliferation and immunoglobulin 
production, but it down-regulates the MHC Class II expression on the surface of the 
macrophages and thus reduces antigen presentation and T-cell priming. IL-10 also inhibits 
production of ROI and RNI. IL-10 was shown to reduce generation of TNF-α, granulocyte-
macrophage colony-stimulating factor, and IL-6 from mouse bone marrow and rat peritoneal 
mast cells in response to specific IgE cross-linking (Akdis and Blaser, 1999). Elevated levels of 
IL-10 were found in acute P. falciparum malaria in Thai patients (Wenisch et al., 1995b) which 
declined with treatment (Wenisch et al., 1995b). IL-10 was found to inhibit IFN-γ secretion and 
protect against experimental cerebral malaria in mice (Kossodo et al., 1997). Severe malaria 
anaemia is associated with significantly decreased circulating levels of IL-10 (Kurtzhals et al., 
1998). Furthermore, the mean ratio of IL-10 to TNF-α was found to be significantly lower in 
children with malaria anaemia (1.77) than in children with mild and high-density parasitaemia 
(4.64). Hence, the development of malaria anaemia may be prevented by higher levels of IL-10 
which can control the excessive inflammatory activities of TNF-α (Othoro et al., 1999). It is still 
not clear if increased levels of IL-10 have a beneficial role in decreasing the parasite-induced 
inflammatory response or a detrimental role in inhibiting the cell mediated immune response. 
 
In summary, during the erythrocytic stage of malaria infection, early strong pro-inflammatory, 
cytokine-mediated, effector mechanisms control parasite replication and promote clearance of 
the infected erythrocytes. However, this pro-inflammatory response must be tightly regulated 
and suppressed equally rapidly by anti-inflammatory effectors (such as IL-10 and TGF-β) to 
prevent the immune-mediated pathology which results in the development of severe 
complications of the malaria infection (Artavanis-Tsakonas et al., 2003; Omer et al., 2000). 
Refer to Figure 1.5. The malaria parasite can also suppress the generation of immune 
responses (Luty et al., 2000; Riley et al., 1989; Wipasa et al., 2001) by apoptosis, parasite 
inhibition of macrophage activation and antigen presentation, and by inhibition of dendritic cell 
maturation, or alteration of dendritic cell function (Urban et al., 1999; Urban and Roberts, 2003).  
 
1.2.6 The role of dendritic cells in the immune res ponse to malaria  
Dendritic cells provide a crucial link between the innate and adaptive immune responses (Reis 
e Sousa, 2004). They are specialized in the uptake, processing and presentation of antigens on 
the surface of the dendritic cell with MHC class II and co-stimulants CD80/86 to T cells. 
 23 
Dendritic cells are the only antigen presenting cells that can activate naïve T cells (Banchereau 
and Steinman, 1998). The activated T cells produce cytokines that stimulate B cells to produce 
antibodies, and promote maturation of the cellular responses to launch an effective adaptive 
immune response.  
 
Dendritic cell function in Plasmodium infections have been extensively studied in vitro and in 
vivo, but the findings are controversial (Wykes et al., 2007a). Several investigations have 
reported that dendritic cells are activated and matured during Plasmodium infection and induce 
a powerful T response (Coban et al., 2002; Ing et al., 2006; Leisewitz et al., 2004; Newman et 
al., 2006; Perry et al., 2004; Sponaas et al., 2006; Wilson et al., 2006). Plasmodium-infected 
red blood cells have activated human plasmacytoid-derived dendritic cells (Pichyangkul et al., 
2004), possibly through haemozoin (Coban et al., 2005), which appears to bind to Toll-like 
receptor 9 (Parroche et al., 2007), a pattern-recognition molecule expressed on dendritic cells, 
that interacts with DNA, lipoprotein and lipopolysaccharides of infectious micro-organisms. 
Other reports have demonstrated that dendritic cells are impaired during malaria infection and 
this suppression might be mediated by haemozoin (Millington et al., 2006; Skorokhod et al., 
2004; Urban et al., 1999; Wykes et al., 2007b). Haemozoin-loaded dendritic cells: failed to form 
stable clusters and interactions with T cells (Millington et al., 2007); reduced T-cell activation; 
failed to migrate to lymphoid-organ follicles and stimulate B cells to respond to heterologous 
antigens (Millington et al., 2006); and had reduced expression of MHC Class II and co-
stimulatory molecules, CD80 and CD40, on their surface (Skorokhod et al., 2005).  
 
The contradictory results could be due to the differences in Plasmodium species studied, 
dendritic cell subsets used or experimental protocols (Langhorne et al., 2004; Sponaas et al., 
2006). Thus, it is difficult to ascertain the conclusive effect of the malaria infection on the 
biology of the dendritic cells.    
 
1.2.7 Neopterin, a marker of inflammation 
The role of IFN-γ in communications between T cells and macrophages with the subsequent 
release of neopterin, make plasma measurements of neopterin an ideal method for measuring 
immune activation within a patient (Wachter et al., 1989). IFN-γ results in a rapid and sustained 
increase in neopterin levels in plasma (Muller et al., 1991).  Neopterin can be easily measured 
in plasma, urine and cerebrospinal fluid by high performance liquid chromatography because of 
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its high fluorescence (Rippin, 1992; Werner et al., 1987a; Werner et al., 1987b), although many 
clinical laboratories also use immuno-based methods such as enzyme-linked immunosorbent 
assay to measure neopterin (Westermann et al., 2000). 
 
Neopterin levels rise rapidly in parallel with C-reactive protein levels in response to an infection 
well before a patient becomes sero-positive. Monitoring neopterin levels in plasma can be used 
to assess the efficacy of treatment used in a range of infections such as malaria (Awandare et 
al., 2006a; Reibnegger et al., 1984), human immunodeficiency virus (Baier-Bitterlich et al., 
1996a; Fuchs et al., 1988) and tuberculosis (Fuchs et al., 1984b; Yuksekol et al., 2003). As 
elevated neopterin levels are indicative of inflammatory conditions, plasma neopterin 
concentrations can serve as a primary screen for blood donations (Zangerle et al., 1992). The 
measurement of plasma neopterin levels has also been used in the study and management of 
cancer (Fuchs et al., 1984a; Reibnegger et al., 1991), autoimmune disease (Leohirun et al., 
1991; Reibnegger et al., 1986; Schroecksnadel et al., 2003) and transplant patients (Margreiter 
et al., 1983; Reibnegger et al., 1991) where an increase in plasma or urine levels gives 
clinicians adequate warning of allograft rejections enabling them to alter immunosuppressant 
treatment. Serum neopterin has also been found elevated in patients with unstable angina and 
acute myocardial infarction (Schumacher et al., 1992; Schumacher et al., 1997; Tatzber et al., 
1991). 
 
1.2.7.1 Biosynthesis of neopterin and 7,8-dihydrone opterin 
The biosynthesis of neopterin is similar to the pathway leading to tetrahydrobiopterin, an 
essential cofactor of several mono-oxygenases and inducible nitric oxide synthases (Gorren 
and Mayer, 2002). Refer to Figure 1.6. GTP-cyclohydrolase I (EC 3.5.4.16), an enzyme up-
regulated by IFN-γ, catalyses the breakdown of guanosine triphosphate to 7,8-dihydroneopterin 
triphosphate. In non-primate macrophages, for example, mouse macrophages, 7,8-
dihydroneopterin triphosphate is converted by 6-pyruvoyltetrahydropterin synthase (PTPS) in 
an Mg2+-dependent step to form 6-pyrovoyltetrahydropterin. In the final step, yielding 
tetrahydrobiopterin, sepiapterinreductase catalyzes the NADPH-dependent reduction of 6-
pyruvoyltetrahydropterin. Human and primate monocytes and macrophages have lower levels 
of 6-pyruvoyltetrahydropterin synthase activity (Schoedon et al., 1987; Werner et al., 1990), 

































































































Figure 1.6. Synthesis of 5,6,7,8-tetrahydrobiopteri n and neopterin.  The synthesis of 
neopterin has similarity to the pathway leading to 5,6,7,8-tetrahydrobiopterin. GTP-
cyclohydrolase 1, a key enzyme in the process, catalyses the conversion of guanosine 
triphosphate to 7,8-dihydroneopterin triphosphate, which in the 5,6,7,8-tetrahydrobiopterin 
synthetic pathway, is converted to 6-pyrovoyltetrahydropterin in a step catalysed by 6-
pyrovoyltetrahydropterinsynthase. The transformation of 6-Pyrovoyltetrahydropterin to 5,6,7,8-
tetrahydrobiopterin is catalysed by sepiapterinreductase. In human and primate monocytes and 
macrophages, there are very low activities of 6-pyrovoyltetrahydropterinsynthase, resulting in 
an accumulation of 7,8-dihydroneopterin triphosphate that is cleaved by non-specific 
phosphatases to 7,8-dihydroneopterin which is then oxidized in a non-enzymatic step to 
neopterin (Gieseg et al., 2008; Murr et al., 2002).             
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triphosphate which is released as 7,8-dihydroneopterin due to the action of intracellular 
phosphatases. 7,8-Dihydroneopterin diffuses out of the activated macrophage into the 
intercellular spaces and finally into the plasma. Some of the 7,8-dihyroneopterin is oxidized to 
7,8-dihydroxanthopterin by reactive oxygen species. The main reaction generating neopterin 
from 7,8-dihydroneopterin is oxidation by hypohalous acids such as hypochlorous acid (HOCl) 
(Widner et al., 2000). Neutrophils, and possibly macrophages release large amounts of HOCl 
during inflammation (Chisolm et al., 1999; Schraufstatter et al., 1990) suggesting that neopterin 
measured in plasma comes from sites of inflammation where HOCl is released.       
 
1.2.7.2 Functions of 7,8-dihydroneopterin and neopt erin 
A clear biological function for neopterin and its derivatives is not completely understood at this 
stage, but they do appear to play a role in oxidative stress. Neopterin was found to enhance 
chloramine-T and H2O2-mediated chemiluminescence in vitro (Weiss et al., 1993). This 
suggested neopterin had pro-oxidant properties which was further substantiated by neopterin 
enhancing tyrosine nitration (Widner et al., 1998) and low density lipoprotein-(LDL)-oxidation 
(Herpfer et al., 2002) by peroxynitrite. Moreover, neopterin was also found to augment H2O2-, 
hypochlorite-, or chloramine-T-mediated toxicity against bacteria (Horejsi et al., 1996; Weiss et 
al., 1993) and induce apoptosis in vascular smooth muscle cells and the alveolar type II-like 
epithelial cell line L2 (Hoffmann et al., 1998; Schobersberger et al., 1996). However, neopterin 
also displayed anti-oxidant effects: in the absence of iron, neopterin was a potent scavenger of 
H2O2-induced chemiluminescence (Murr et al., 1994); and neopterin also suppressed NADPH-
oxidase in macrophages stimulated with phorbol-12-myristate-13-acetate, and thus decreased 
the generation of superoxide anions (Kojima et al., 1992).  
 
7,8-Dihydroneopterin displays anti-oxidant properties at low concentrations. It inhibited: the 
luminescence signal from superoxide and hydrogen peroxide (Shen, 1994); tyrosine nitration by 
peroxynitrite (Widner et al., 1998); and metal ion and aqueous peroxyl radical (2,2’-
azobis(amidinopropane)dihydrochloride)-mediated LDL oxidation (Gieseg et al., 1995). 7,8-
Dihydroneopteirn also suppressed the toxicity of H2O2, hypochlorite, or chloramine-T against 
bacteria (Horejsi et al., 1996; Weiss et al., 1993). Furthermore, micromolar concentrations of 
7,8-dihydroneopterin inhibited cellular damage to red blood cells and human monocytic U937 
cells from a range of oxidants such as hydrogen peroxide, hypochlorite, aqueous peroxyl 
radicals, nitric oxide and direct plasma membrane oxidation by ferrous ions (Gieseg et al., 
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2000; Gieseg et al., 2001a; Gieseg et al., 2001b). These findings have led to the hypothesis 
that 7,8-dihydroneopterin secreted by IFN-γ-stimulated macrophages protects these antigen-
presenting cells from oxidants encountered in the inflammatory site (Duggan et al., 2002; 
Gieseg et al., 1995; Kojima et al., 1992; Schroder et al., 1987).      
 
However, at high concentrations, 7,8-dihydroneopterin acts as a pro-oxidant and induces 
apoptosis in the presence of TNF-α in the human neuronal cell line (NT2) (Spottl et al., 2000), 
astrocytic and microglial cell lines (Speth et al., 2000) and the rat pheochromocytoma cells 
(PC12) (Enzinger et al., 2002b) by the formation of ROI.  At concentrations below 300 µM, 7,8-
dihydroneopterin diminished TNF-α-induced programmed cell death in U937 cells, whereas 5 
mM 7,8-dihydroneopterin enhanced the effect of TNF-α on apoptosis (Baier-Bitterlich et al., 
1995). Likewise with Jurkat T cells, 7,8-dihydroneopterin only induces apoptosis above 1 mM 
(Baier-Bitterlich et al., 1996a; Wirleitner et al., 1998; Wirleitner et al., 2001) via the redox-
sensitive Bcl-2 pathway (Enzinger et al., 2002a). 
 
Neopterin and its derivatives have also been shown to play a role in cell signalling. Micromolar 
levels of both neopterin and 7,8-dihydroneopterin increased intracellular calcium levels in 
human-derived monocyte-like THP-1 cells (Woll et al., 1993) and nanomolar levels of neopterin 
effectively inhibited ATP-induced calcium release from alveolar epithelial cells (Hoffmann et al., 
2002). Micromolar concentrations of neopterin were also reported to cause cardiac contractile 
dysfunction in isolated perfused rat hearts (Balogh et al., 2005; Margreiter et al., 2000).  
 
Neopterin and 7,8-dihydroneopterin were found to interfere with intracellular signalling 
pathways that are influenced by oxidative stress. Neopterin and 7,8-dihydroneopterin activated 
the redox-sensitive transcription factor nuclear factor-κB (NF-κB) in Jurkat cells (Baier-Bitterlich 
et al., 1997) and murine vascular smooth muscle cells (Hoffmann et al., 1996). In vitro, 
neopterin inhibited hypoxia-induced erythropoietin gene expression and formation in HepG2 
cell cultures (Schobersberger et al., 1995b) and hypoxically perfused isolated rat kidneys 
(Pagel et al., 1999). Neopterin also stimulated cytokine-inducible nitric oxide synthase gene 
expression in rat vascular smooth muscle cells (Schobersberger et al., 1995a). Both neopterin 
and 7,8-dihydroneopterin together with cyclic-GMP induced the redox-sensitive proto-oncogene 
c-fos in NIH 3T3 fibroblasts (Uberall et al., 1994) and neopterin also enhanced the cell damage 
caused by UV-A irradiation of Β-16 melanoma cells (Kojima et al., 1995).        
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1.2.8 Neopterin during malaria infections  
Elevated levels of neopterin have been detected in urine (Reibnegger et al., 1984) and plasma 
(Kremsner et al., 1989; Ringwald et al., 1991) of patients infected with Plasmodium falciparum. 
Children with malaria infections showed extremely high neopterin excretion levels when 
compared to adult malaria infections (Reibnegger et al., 1987). When 71 Thai patients with 
acute, uncomplicated falciparum malaria were treated with quinine and tetracycline for 7 days, 
the neopterin levels in urine peaked on days 3-5 following the start of treatment before 
decreasing towards the normal range on days 6-8 (Brown et al., 1990). In patients with a history 
of previous malaria infections, an inverse relationship was found between the frequency of prior 
malaria episodes and neopterin concentration during infection (Brown et al., 1990). Increasing 
neopterin levels were found to correlate with peak temperature, fever clearance time and 
parasite clearance time. High concentrations of IFN-γ were found more frequently in malaria 
naïve than experienced patients (Brown et al., 1990; Ringwald et al., 1991). These data 
suggested that with repeated malaria infection and antigen exposure, there is a progressive 
suppression of the T-cell-macrophage interaction mediated by IFN-γ.  
 
Neopterin levels were also elevated in Thai adults infected with Plasmodium vivax and found to 
be positively correlated with magnitude of fever. Neopterin excretion also increased during the 
first two days of chemotherapy and decreased to within the normal range by the sixth day post-
treatment (Brown et al., 1991). In an area endemic for malaria, patients subjected to repeated 
infestations have chronic parasitaemia and neopterin proved to be a good indicator of slowly 
acquired immunity but poorly reflected acute immune responses (Picot et al., 1993).  
 
Severe malarial anaemia was found to be directly associated with elevated serum neopterin 
concentrations and inversely correlated with serum IL-4 levels (Biemba et al., 2000). Neopterin 
is secreted by IFN-γ-activated macrophages and thus reflects the Th 1 immune response, but 
IL-4 is a major cytokine that is inhibited by Th 1 activity. During seven days of quinine 
antimalarial therapy, serum neopterin levels remained elevated in children who were still found 
to have persisting anaemia one month after completing treatment, but the neopterin levels 
declined significantly in the children who had normal haemoglobin levels a month after 
completing treatment (Biemba et al., 1998). The elevated neopterin levels suggested that the 
persistence of the Th 1 mediated immune response and associated macrophage activation may 
be involved in the pathogenesis of the lingering anaemia after the treatment of malaria. 
Children with severe P. falciparum malaria with respiratory distress, which is a symptom of 
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underlying acidosis, had significantly higher levels of neopterin than those malaria-infected 
children without respiratory distress (Awandare et al., 2006a). 
 
1.3 Antimalarial drugs 
Drugs interfering with the erythrocytic schizogony, known as blood schizontocides, are the most 
important antimalarial drugs therapeutically as they interfere with the stage of the Plasmodium 
life cycle that is responsible for the clinical manifestations of malaria.  (Wernsdorfer, 1997).  
 
1.3.1 Quinoline containing drugs 
In 1820, Pelletier and Caventou isolated quinine (6-methoxy-α-(5-vinyl-2-quinuclidyl)-4-
quinolinemethanol) from the bark of the Cinchona tree and it was used for the treatment of 
malaria until the 1930’s (Foley and Tilley, 1998). Since then other synthetic quinoline 
antimalarials, amodiaquine (7-chloro-4-(3’-diethylaminomethyl-4’-hydroxyanilino)-quinoline), 
chloroquine (7-chloro-4-(4’-diethylamino-1’-methylbutylamino)quinoline) and mefloquine (α-(2-
piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol) were mainstays for much of the next 50 
years (Foley and Tilley, 1998; O'Neill et al., 1998).  Quinine, mefloquine, chloroquine and 
amodiaquine all have blood schizontocidal activity against all four species of human-pathogenic 
plasmodia (P. falciparum, P. vivax, P. ovale and P. malariae) and incidental human infections 
with simian plasmodia (P. knowlesi and P. cynomolgi) (Wernsdorfer, 1997).  
 
Chloroquine has been the most important synthetic quinoline due to its excellent clinical 
efficacy, limited host toxicity, ease of use and simple cost-effective synthesis. However, the 
value of synthetic quinolines has been reduced due to the development and spread of parasite 
resistance (Warhurst, 2001; Winstanley et al., 2002). The exact mode of action and mechanism 
of resistance to the 4-aminoquinolines (chloroquine and amodiaquine) and the quinoline 
methanols (quinine and mefloquine) is still not fully understood. However, a crucial step in the 
mode of action appears to be the binding of the drug to ferriprotoporphyrin IX which is released 
during the digestion of the haemoglobin (Egan et al., 1994). The antimalarial activity of 
chloroquine is directly related to its highly selective uptake and concentration in the malaria-
infected erythrocytes (Diribe and Warhurst, 1985; Hawley et al., 1998; Verdier et al., 1985). 
Chloroquine is a weak uncharged base that diffuses freely into acidic compartments where it 
binds to protons and becomes trapped. Chloroquine accumulates in parasite infected 
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erythrocytes to concentrations about 20-fold higher than that accumulated in mammalian cells 
with large acidic lysosomes (Hawley et al., 1996) and the extent of chloroquine accumulation 
appears to be determined by the amount of free ferriprotoporphyrin IX in the parasite (Bray et 
al., 1999; Bray et al., 1998). The steps following the initial binding of chloroquine to 
ferriprotoporphyrin IX leading to the death of the parasite are less certain. It has been proposed 
that the chloroquine-ferriprotoporphyrin IX complexes accumulate in the parasite membranes 
and destroy the membranes by lipid peroxidation resulting in the lysis of the parasite (Fitch et 
al., 1982). Other investigators suggested that chloroquine inhibits the formation of haemozoin 
crystals, thus leading to the build up of toxic concentrations of free ferriprotoporphyrin IX within 
the parasite (Goldberg and Slater, 1992; Slater and Cerami, 1992; Sullivan, 2002). Free 
ferriprotoporphyrin IX may exert its toxic effects by inhibiting crucial parasite enzymes such as 
proteases of the digestive vacuole (Vander Jagt et al., 1987). Inhibition of haemozoin formation 
can occur by either chloroquine binding to the substrate and depleting the substrate for 
haemozoin formation (Dorn et al., 1998a; Dorn et al., 1998b) or by chloroquine binding to the 
haemozoin crystal, capping it and preventing further growth of the crystal (Chong and Sullivan, 
2003; Sullivan, 2002). However, it is not known which, if any of these mechanisms operate in 
the parasite.               
 
Other quinoline-containing drugs are thought to act in a similar manner to chloroquine in that 
they all bind to ferriprotoporphyrin IX (Foley and Tilley, 1998; Mungthin et al., 1998; Sullivan, 
2002), but the effects on the feeding processes may be subtly different. The 4-aminoquinolines, 
chloroquine and amodiaquine have been associated with an accumulation of undigested 
haemoglobin in the digestive vacuole (Yayon et al., 1984), whereas the quinoline methanols, 
quinine and mefloquine, have not been associated with a build up of haemoglobin in the 
parasite (Famin and Ginsburg, 2002). It was suggested that the 4-aminoquinolines inhibit the 
digestion of the haemoglobin, whereas the quinoline methanols possibly interfere with the 
ingestion of haemoglobin, that is, the endocytic process. 
 
The 4-aminoquinolines, chloroquine and amodiaquine, have also been shown to inhibit the 
glutathione-dependent destruction of ferriprotoporphyrin IX (Ginsburg et al., 1998), resulting in 
an accumulation of ferriprotoporphyrin IX in the membrane fraction of infected cells that 
correlated with parasite killing (Zhang et al., 1999). Although the quinoline methanols, quinine 
and mefloquine, were able to inhibit the glutathione-mediated destruction of ferriprotoporphyrin 
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IX in solution, they were unable to inhibit the degradation of membrane associated 
ferriprotoporphyrin IX (Famin et al., 1999).     
 
Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites revealed that 
chloroquine treatment did not appear to affect the progress through the cell cycle and 
suggested that chloroquine toxicity may be manifested post-schizogony as “delayed death” 
(Gligorijevic et al., 2006). Using these methods, it was also found that Pfcrt conferred 
resistance to chloroquine when it was added at the very early ring stage of development when 
the digestive vacuole has not yet formed, as well as when the chloroquine is added at the 
schizont stage when haemozoin development is completed (Gligorijevic et al., 2008). This 
prompts further questions about the action of chloroquine and chloroquine resistance. 
  
Primaquine is an 8-aminoquinoline that is effective against hypnozoites, the intrahepatic forms 
responsible for the relapsing infections of P. vivax and P. ovale and P. cynomolgi (Robert et al., 
2001). It also has marked activity against the gametocytes of all the plasmodia affecting 
humans. Primaquine has a very short half life as it undergoes extensive and rapid metabolism 
in the liver by cytochrome P450 enzymes to form carboxyprimaquine (Bangchang et al., 1992). 
Primaquine and some of its metabolites inhibit the mitochondrial respiration of the parasite by 
mimicking ubiquinone and reduced ubiquinone found in the mitochondrial electron transport 
chain (Desjardins et al., 1988; Lopez-Antunano, 1999) and they also interfere with the synthesis 
of pyrimidines (Wernsdorfer, 1997). Primaquine is also known to stimulate the oxidative 
pathway of glucose metabolism in non-infected erythrocytes and thus may cause haemolysis in 
patients with a glucose-6-phosphate dehydrogenase deficiency (Carson et al., 1981). 
Primaquine has minimal activity against the asexual blood stages of the parasite and hence is 
always used in conjunction with a blood schizontocide.          
 
1.3.2 Antifolates 
Plasmodium in humans can capture and utilize the host’s purines but not the host’s pyrimidines, 
thus the parasite synthesizes its own pyrimidines (Le Bras and Durand, 2003). Pyrimidine 
biosynthesis includes the folate pathway and antifolates refer to drugs which interfere with 
enzymes involved in folate biosynthesis and thus inhibit the synthesis of parasitic pyrimidines 
and consequently parasitic DNA (Wernsdorfer, 1997). There are two groups of antifolates: (a) 
the dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (2,4-diamino-5-p-
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chlorophenyl-6-ethylpyrimidine) and proguanil (1-(4-chlorophenyl)-5-isopropylbiguanide 
hydrochloride), and (b) the dihydropteroate synthase (DHPS) inhibitors, which are sulfones and 
sulphonamides such as sulfadoxine (N-1-(5,6-dimethoxy-4-pyrimidinyl) sulphanilamide) and 
dapsone (4,4’-diaminodiphenylsulfone), respectively. A member of the first group is usually 
used in combination with a member of the second group because of their marked synergistic 
effects (Chulay et al., 1984). Fansidar®, which is the most widely used combination, contains 
pyrimethamine and sulfadoxine. Pyrimethamine is structurally similar to dihydrofolate and is 
thus a competitive inhibitor of dihydrofolate reductase, whereas sulfadoxine is an analogue of 
p-amino-benzoic acid and is a competitive inhibitor of dihydropteroate synthase (Hayton and 
Su, 2008) . Unfortunately, Fansidar® is particularly prone to rapid emergence of resistance, 
which is widely spread in Asia, South America, India and now Africa (Cowman, 2001; Plowe et 
al., 1998) .       
 
1.3.3 Antibiotics 
Doxycycline (4-dimethylamino-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 5, 10, 12, 12a 
pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide) belongs to the tetracycline 
group and it has blood schizontocidal activity (Wernsdorfer, 1997) and tissue schizontocidal 
activity against the pre-erythrocytic forms in the hepatocytes (Marussig et al., 1993). Its blood 
schizontocidal activity is too slow to be used as monotherapy in the treatment of acute malaria 
and hence it is often used in combination with a fast acting drug, such as quinine, which results 
in complete eradication of the infection in the blood (Metzger et al., 1995a). The antimalarial 
action of doxycycline is due to the inhibition of ribosomal protein synthesis and chelation of 
calcium ions (Ca2+) (Wernsdorfer, 1997). Doxycycline has also been shown to reduce the levels 
of nucleoside 5’-triphosphates and deoxynucleoside 5’-triphosphates (Pradines et al., 2000).  
 
1.3.4 Artemisinin 
Artemisinin, also known as Qinghaosu, is a sesquiterpene lactone that was isolated from a 
Chinese herb, Artemisia annua L. in 1972. Its structure and pharmacological properties were 
first published by Chinese scientists in 1978 (Hayton and Su, 2008). Definitive antimalarial 
activities of artemisinin were reported in an English Chinese journal in 1979 (Qinghaosu 
Antimalarial Co-ordinating Research Group, 1979). Due to its low solubility in both water and 
oil, several derivatives of artemisinin were produced of which artemether, sodium artesunate 
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and dihydroartemisinin are available commercially (Wernsdorfer, 1997). Artemisinin is toxic to 
the malaria parasites at nanomolar concentrations (White, 1994) and it kills the parasites more 
rapidly than any other antimalarial drugs: artemisinins clear fever within 32 hours in contrast to 
the 2-3 days of other anti-malarial agents (Wiesner et al., 2003).  Artemisinin and its derivatives 
are effective against all the asexual stages and gametocytes, especially when administered in 
combination with other drugs, and thus may be able to decrease disease transmission (Nosten 
and White, 2007).  
 
The exact mechanism of action for artemisinin is yet to be elucidated. Both parasite-specific 
and parasite non-specific mechanisms have been proposed (Golenser et al., 2006). The 
pharmacophore in artemisinin is the 1,2,4-trioxane unit, and in particular, the endoperoxide 
bond is crucial for its antiparasitic activity. Studies have indicated that interactions between the 
endoperoxide bridge and iron in the haeme molecule released during digestion of haemoglobin 
inside the digestive vacuole might be responsible for the cytotoxic effects of artemisinin 
(Kannan et al., 2005). The build up of redox active alkylated porphyrins has been proposed to 
generate free radicals that alkylate and oxidize proteins and lipids within infected red blood 
cells. This hypothesis is supported by the finding that the activity of artemisinin is potentiated by 
oxidising agents and oxygen and attenuated by reducing agents (Krungkrai and Yuthavong, 
1987). However, evidence against the haeme hypothesis is that artemisinins are effective 
against ring stage parasites which do not have high concentrations of haeme (Olliaro et al., 
2001).  
 
Another study proposed that intracellular iron-sulphur redox centres found in Plasmodium 
enzymes activated the artemisinins via reductive cleavage of the peroxide bond and the 
resulting alkylation of these enzymes could lead to parasite death (Wu, 2002). When 
radiolabelled artemisinin was incubated with parasite lysates, several interacting proteins, such 
as translationally controlled tumour proteins (TCTP), were identified suggesting that parasite 
death might result from alkylation and inactivation of parasite proteins (Bhisutthibhan and 
Meshnick, 2001; Bhisutthibhan et al., 1998). Other proteins which have been proposed to be 
the target of artemisinin include cysteine proteases (Pandey et al., 1999), which are involved in 
the catabolism of haemoglobin; proteins of the electron transport chain (Li et al., 2005), which 
can provide the electron source required to activate the artemisinins and generate oxidative 
species, and membrane-associated proteins, which may form covalent adducts with 
artemisinins, such as PfATPase6, a sarco-endoplasmic reticulum calcium adenosine 
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triphosphatase (ATPase), [SERCA] (Eckstein-Ludwig et al., 2003). Artemisinin has been shown 
to inhibit the activity of PfATPase6 in transfected Xenopus laevis oocytes, whereas other 
antimalarials have no effect on the ATPase activity (Eckstein-Ludwig et al., 2003). Additional 
studies in the X. laevis oocyte expression system reported that an L263E point mutation 
abolished the inhibition caused by artemisinin (Uhlemann et al., 2005). Furthermore, evidence 
from field studies and heterologous expression systems support a role for PfATPase6 
mutations in the emerging resistance against artemisinins (Krishna et al., 2006). However, 
recent studies provide evidence that the artemisinin derivatives cause early disruption of the 
parasite digestive vacuole membrane and with longer incubation times, extensive loss of 
organellar structures (del Pilar Crespo et al., 2008). In addition, they also demonstrated that the 
artemisinin did not alter the morphology of the endoplasmic reticulum, where SERCA is located.  
 
1.3.5 Resistance to antimalarial drugs  
Drug resistant Plasmodium falciparum is wide spread in the Amazon region, tropical Africa and 
south-east Asia (Wellems and Plowe, 2001; Wootton et al., 2002). Chloroquine resistance has 
been associated with an increase in mortality rates in endemic regions (Trape et al., 1998).   
 
A) Chloroquine resistance is due to impaired uptake of the drug into the parasite digestive 
vacuole, leading to a reduced accumulation of chloroquine within the digestive vacuole when 
compared to chloroquine sensitive parasites (Fitch, 1969; Fitch, 1970; Verdier et al., 1985). 
This phenotype is commonly correlated with mutations in the P. falciparum chloroquine 
resistance transporter gene (Pfcrt), encoding a putative regulator of protein transport or a 
chloride channel localized to the parasite’s food vacuole (Djimde et al., 2001; Durand et al., 
2001); the P. falciparum multi-drug resistance gene 1 (Pfmdr1), encoding a P-glycoprotein 
homologue (PfPgh1) which belongs to the family of ABC transporters (Duraisingh et al., 2000; 
Foote et al., 1990b; von Seidlein et al., 1997); and the Pfcg2 genes (Cooper et al., 2005). 
Mutations and copy number changes in the Pfmdr1 are often associated with chloroquine 
resistance and Pfcrt mutations (Djimde et al., 2001; Mita et al., 2006; Mu et al., 2003), but the 
contribution of Pfmdr1 in modulating chloroquine resistance is still unknown (Hayton and Su, 
2004). Some parasite isolates have the same Pfcrt and Pfmdr1 alleles, but have different 
chloroquine phenotypes as measured by their IC50 values, suggesting that additional genes 
modulate the parasite response to chloroquine (Mu et al., 2003).    
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(B) Point mutations in dihydrofolate reductase and dihydropteroate synthase of the folate 
pathway produces moderate to high resistance to the antifolates, pyrimethamine and 
cycloguanil (the active metabolite of proguanil) (Basco et al., 1995; Cowman et al., 1988; 
Sirawaraporn, 1998); and sulphonamides and sulfones (Brooks et al., 1994; Triglia and 
Cowman, 1994; Triglia et al., 1997). There is a clear association between the number of point 
mutations in the dhfr and dhfs gene and the extent of resistance in vitro to the antifolates (Foote 
et al., 1990a; Gesase et al., 2009; Nzila-Mounda et al., 1998; Peterson et al., 1988). A 
quadruple mutant observed along the Thai-Myanmar border shows the highest IC50 to 
pyrimethamine so far (Hyde, 2008; Nair et al., 2003). Triple mutants have conferred a 24-fold 
increase in sulfadoxine resistance over the wild type (Triglia et al., 1997). Gene expression 
changes or mutations in other genes expressing enzymes of the folate metabolism pathway 
may also contribute to sulfadoxine-pyrimethamine (Fansidar®) resistance (Kidgell et al., 2006; 
Volkman et al., 2007; Wang et al., 1997). 
 
(C) The mechanisms of resistance for amino-alcohols, mefloquine, quinine and halofantrine, 
are still unclear. An increase in the copy number of Pfmdr1 has been associated with an 
increase in the mefloquine IC50 (Cowman et al., 1994; Peel et al., 1994; Price et al., 2004; 
Wilson et al., 1989). Furthermore, disruption of one of two copies of the Pfmdr1 gene resulted 
in a decrease in the IC50 of mefloquine, artemisinin, halofantrine, lumefantrine and quinine 
(Sidhu et al., 2006). However, mefloquine resistance in field isolates do not always correlate 
with an increase in the copy number of Pfmdr1 (Chaiyaroj et al., 1999). Moreover, increased 
mefloquine IC50 values are often found in parasites with increased IC50 values for quinine and 
halofantrine, thus higher copy numbers of Pfmdr1 could be due selection of quinine and/or 
other drugs (Cowman et al., 1994). Amplification of Pfmdr1 may be a compensatory response 
of the parasite to the changes in the food vacuole due to mutations in Pfcrt and other genes 
(Jiang et al., 2008). 
 
High quinine IC50 values have been associated with Pfcrt encoding a putative Na
+/H+ exchanger 
(PfNHE), Pfmdr1 encoding a P-glycoprotein homologue (PfPgh1), and a locus on chromosome 
9 (Ferdig et al., 2004). This has been substantiated by the N1042D amino acid substitution in 
PfPgh1 contributing to quinine resistance (Sidhu et al., 2006), and elevated activities of PfNHE 
found in parasites with high quinine IC50 values (Bennett et al., 2007).  Both PfNHE and PfPgh1 
may play a role in regulating the pH of the cytoplasm and/or digestive vacuole of the parasite, 
and thus mutations in these proteins may cause changes in drug accumulation (Bennett et al., 
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2007; Rohrbach et al., 2006). Mutations in other transporters, especially ABC transporters, 
might also contribute to quinine resistance as the parasite’s response to quinine is most 
probably a multi-gene trait which would explain why quinine is still effective in eradicating 
malaria parasites after ~350 years of use (Ferdig et al., 2004; Mu et al., 2003). 
 
(D) Resistance to artemisinin has yet to be confirmed, but recent reports of high failure rates 
with artemisinin-based combination therapies (Carrara et al., 2009; Denis et al., 2006a; Denis 
et al., 2006b; Rogers et al., 2009; Vijaykadga et al., 2006; Wongsrichanalai and Meshnick, 
2008) in addition to decreased in vitro susceptibility to artemisinin (Jambou et al., 2005) have 
been reported in Thailand and Cambodia. Parasites with significantly reduced in vitro 
susceptibility to lumefantrine, artesunate and mefloquine had increased copy numbers of 
Pfmdr1 (Lim et al., 2009). The presence of three or more copies of the Pfmdr1 gene was 
associated with recrudescence in patients treated with artesunate-mefloquine but not with 
recrudescence in patients treated with artesunate-lumefantrine (Lim et al., 2009). Another 
candidate gene associated with increased IC50 values to artemisinin derivatives is SERCA-
PfATPase6  (Jambou et al., 2005). However, Noedl et al. (2008) found prolonged parasite 
clearance times in Cambodian patients treated with artesunate alone and this was not mediated 
by a change in the copy number of Pfmdr1 gene or selected polymorphisms in the PfATPase6 
gene.  
 
1.3.6 Immunomodulatory effects of antimalarial drug s  
1.3.6.1 Effect of antimalarial drugs on cytokine pr oduction 
Chloroquine was found to inhibit phytohaemoagglutinin or lipopolysaccharide induced 
production of the proinflammatory cytokines TNF-α, IFN-γ, IL-6 and IL-1β by peripheral blood 
mononuclear cells without causing cell cytotoxicity (Karres et al., 1998; Picot et al., 1991; van 
den Borne et al., 1997). Chloroquine exerts its inhibitory action by blocking the conversion of 
the TNF-α precursor to mature soluble protein and reduced the levels of IL-1β and IL-6 mRNA 
by decreasing the stability of the mRNA by a pH-dependent mechanism (Jang et al., 2006). At 
concentrations that blocked calcium-activated potassium channels in alveolar macrophages, 
quinine, a potassium channel blocker, dose-dependently inhibited the secretion of TNF-α 
without affecting the phagocytosis of latex beads. This was as a result of quinine inhibition of 
TNF-α mRNA expression (Maruyama et al., 1994).   
 37 
        
 Doxycycline inhibited staphylococcal exotoxin-stimulated T-cell proliferation in a dose-
dependent manner. In addition, doxycycline dose-dependently down-regulated the secretion of 
the cytokines IL-1β, IL-6, TNF-α and IFN-γ and chemokines monocyte chemotactic protein 1 
(MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β by human peripheral 
blood mononuclear cells incubated with staphylococcal exotoxins (Krakauer and Buckley, 
2003). The suppression of proinflammatory cytokines may involve the down regulation of 
protein kinase C (Webster et al., 1994).     
 
Chloroquine decreases the MHC I and MHC II expression on antigen-presenting macrophages 
(Nowell and Quaranta, 1985; Schultz et al., 1995) and hence results in decreased stimulation of 
CD4+ T cells and decreased cytokine production which would usually be secreted after 
interaction between the antigen presenting cell and the T cells. This is substantiated by the 
finding that chloroquine and pyrimethamine both inhibited T cell IL-2 production and IL-2-driven 
T cell proliferation, and decreased responsiveness of T cells clones to IL-2 (Landewe et al., 
1995; Viora et al., 1996). Chloroquine, mefloquine and quinine have all been found to decrease 
the activity of natural killer cells with mefloquine and quinine being the most potent (Pedersen 
et al., 1986).   
 
In the clinical setting, antimalarial drugs were also found to modulate cytokine production in 
malaria patients: Korean patients with P. vivax malaria were treated with 
chloroquine/primaquine combined chemotherapy which resulted in a decrease in serum levels 
of interferon gamma inducible protein-10 that was strongly reactive prior to treatment (Kim et 
al., 2006). Treatment of P. falciparum-infected patients with quinine or artesunate, resulted in a 
dramatic increase in plasma TNF-α after quinine administration followed by a rapid clearance, 
but no effect on plasma TNF-α concentration after artesunate administration as artesunate 
clears the parasite more rapidly than quinine (Ittarat et al., 1999). When Sudanese patients with 
acute P. falciparum malaria and control subjects were treated with chloroquine, concentrations 
of erythropoietin (a hormone which increases the rate of red blood cell production, namely 
erythropoiesis) was decreased in the control subjects but increased in the malaria subjects. 
This was attributed to the anti-inflammatory action of chloroquine as the concentrations of 
proinflammatory cytokines, IFN-γ, IL-1 and IL-6 decreased with chloroquine treatment. Hence, it 
was proposed that the impaired erythropoietin production associated with the prolonged 
elevation in proinflammatory cytokines characteristic of malaria infection can contribute to the 
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anaemia observed in malaria patients (Ballal et al., 2009). When Balb/c mice infected with 
Plasmodium yoelli 17XL were treated with chloroquine, TNF-α mRNA expression was up-
regulated and expression of anti-inflammatory cytokines, IL-10 and TGF-β, was down-
regulated. Treatment of the same mice with pyrimethamine increased IFN-γ mRNA expression, 
but up-regulated TGF-β (Ramos-Avila et al., 2007). However, the effects of drugs on cytokine 
levels in malaria-infected patients could also be as a result of the eradication of the malaria 
parasite.     
 
1.3.6.2 Effect of antimalarial drugs on monocyte me tabolism  
Antimalarial drugs have also been shown to affect metabolic processes in cells. Quinine 
resulted in a significant increase in phosphatidylserine and phosphatidylinositol synthesis and a 
pronounced decrease in phosphatidylcholine and phosphatidylethanolamine synthesis in the 
human monocytic cell line, THP1 (Pelassy et al., 1992). Quinine has also been shown to 
increase phosphatidylserine synthesis in the Jurkat T-cell line (Aussel et al., 1990). Quinidine 
dose-dependently inhibited naphthol AS-D chloroacetate esterase in polymorphonuclear 
neutrophils and α-naphthyl acetate esterase and α-naphthyl butyrate esterase in monocytes. 
Other quinoline drugs, such as chloroquine, primaquine and quinine also affected the esterases 
but to a lesser extent (Markovic et al., 1988). Artemisinin was found to increase the protein 
levels of protein kinase Cβ1 isoform and enhance protein kinase C activity in the human 
promyelocytic leukaemia HL-60 cell line (a promonocytic cell line) treated with 1α,25,-
dihydroxyvitamin D3 and thus potentiated cell differentiation predominantly into monocytes (Kim 
et al., 2003). 
  
Chloroquine is a weak diprotic base that can pass through lipid membranes and accumulate in 
acidic cytoplasmic vesicles. Inside the vesicle, chloroquine is protonated and trapped within the 
vesicle (Homewood et al., 1972). An adenosine triphosphate pump pumps more hydrogen ions 
into the cell, which attracts more unprotonated chloroquine into the vesicle, resulting in high 
chloroquine concentrations in intracellular vesicles. This effect is more pronounced in cells with 
an increased number of acidic vesicles such as phagocytosing cells and macrophages 
(Ferrante et al., 1986). This increased chloroquine concentration in lysosomes results in the 
accumulation of inclusion bodies containing phospholipids from the plasma membrane which 
leads to decreased phagocytosis, chemotaxis and overall cell functioning. Consequently, 
chloroquine will also delay the recycling of enzymes and surface receptors from lysosomes to 
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the cell surface. The depletion of cell surface receptors decreases the cell’s responsiveness to 
mitogenic stimuli (Homewood et al., 1972). 
 
1.3.6.3 Effect of antimalarial drugs on monocyte su rface receptors 
Therapeutic concentrations of quinine, chloroquine, primaquine, pyrimethamine, artemisinin, 
mefloquine and proguanil reduced the cytoadherance of P. falciparum-infected red blood cells 
to monocytes by 40% or more, indicating a down regulation in the expression of monocyte 
cytoadherance receptors. Quinine, proguanil and pyrimethamine were the most effective in 
down regulating the cytoadherance receptor expression with artemisinin being the least 
effective (Goldring and Nemaorani, 1999).   
 
Treatment of human monocytic U937 cells and peripheral blood monocytes with chloroquine 
significantly down-regulated the expression of TNF receptors on the cell surface by retarding 
the transport of the receptors to the cell surface (Jeong et al., 2002). Chloroquine also 
suppressed β1-integrin mediated U937 cell-cell adhesion and this suppression appears to be 
mediated by the lysosomotropic character of chloroquine (Cho, 2008).       
 
1.3.6.4 Effect of antimalarial drugs on the product ion of monocyte reactive oxygen and 
nitrogen intermediates  
Reactive oxygen intermediates (ROI), such as singlet oxygen, superoxides, peroxides, hydroxyl 
radical and hypochlorous acid, and reactive nitrogen intermediates (RNI), such as nitric oxide, 
nitrite and nitrate, are produced by activated macrophages as part of the host’s first line of 
defence against malaria (Clark and Hunt, 1983; Kremsner et al., 1993b; Rockett et al., 1991). 
Therapeutic concentrations of quinine and halofantrine caused a significant decrease in IFN-γ-
induced RNI production in mouse peritoneal macrophages, whereas chloroquine, quinine, and 
halofantrine had no effects on ROI (Kremsner et al., 1993a). Furthermore, quinine was found to 
inhibit RNI and ROI production in lipopolysaccharide-activated goldfish macrophages (Stafford 
et al., 2002), which was associated with transcriptional changes in the inducible nitric oxide 
synthase gene. In human neutrophil granulocytes, therapeutic serum levels of 
dihydroartemisinin, artemisinin and artesunate enhanced the generation of ROI (Wenisch et al., 
1997), whereas therapeutic concentrations of quinine inhibited the oxidative burst in human 
peripheral neutrophils (el Benna and Labro, 1990). Neutrophil oxidative burst induced by 
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phorbol-12-myristate-13-acetate was also found to be reduced by doxycycline in a dose 
dependent manner (Sinico-Durieux et al., 1986). C57B1/6 mice infected with Plasmodium 
berghei ANKA were treated with artemether or chloroquine, which significantly increased the 
capacity of the mice to produce ROI and RNI. This was further corroborated by high levels of 
inducible nitric oxide synthase gene expression (Prada et al., 1996b).  
 
1.3.6.5 Effect of antimalarial drugs on monocyte ph agocytosis 
Therapeutic concentrations of chloroquine, quinine, mefloquine, amodiaquine and artemether 
reduced the binding of immunoglobulin G (IgG) to P. falciparum-infected red blood cells and the 
subsequent phagocytosis of the infected red blood cells by a human monocytic J-111 cell line 
(Shalmiev et al., 1996). Peripheral blood mononuclear cells isolated from healthy subjects 
receiving prophylactic doses of chloroquine exhibited reduced phagocytosis of opsonised 
sheep red blood cells and non-opsonised zymosan particles (Osorio et al., 1992). Furthermore, 
chloroquine and quinine sulphate were shown to suppress the phagocytic activity of Fc-coated 
sheep red blood cells, latex beads and Staphylococcus aureus by monocytes isolated from 
normal rhesus monkeys (Macaca mulatta) treated with chloroquine or quinine sulphate (Prasad 
et al., 1986; Prasad et al., 1984).  
 
1.4 Aim of study 
Both antimalarial drugs and haemozoin (β-haematin) have immunomodulatory effects on 
monocytes. Antimalarial drugs have been shown to reduce the phagocytosis of P. falciparum 
infected red blood cells (Shalmiev et al., 1996) and although haemozoin (β-haematin) is avidly 
phagocytosed by the monocytes (Schwarzer et al., 2001), it  modifies a number of monocyte 
functions that contribute towards the immunodepression associated with malaria (Schwarzer et 
al., 2008). Haemozoin loading of monocytes leads to suppression of IFN-γ responsiveness, 
failure of MHC II up regulation, disturbances in antigen presentation to T cells and a reduced 
up-regulation of ICAM-1, an adhesion molecule that enables monocytes to adhere and 
stimulate T-cell proliferation (Schwarzer et al., 1998; Scorza et al., 1999). Neopterin, a marker 
of T helper cell subtype 1 activated cellular immune response, is secreted by IFN-γ-stimulated 
monocytes/macrophages (Murr et al., 2002). Neopterin is elevated in malaria infection but 
decreases with antimalarial drug treatment in acute malaria (Brown et al., 1990). The effects of 
antimalarial drugs on the phagocytosis of β-haematin by monocytes as well as the IFN-γ-
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stimulation of monocytes are unknown. Measuring neopterin secretion should give an indication 
of the activation or inhibitory effects of the antimalarial drugs on the IFN-γ-stimulation of the 
monocytes. Thus the aim of this investigation was to determine the immunomodulatory effects 
of antimalarial drugs on the phagocytosis of β-haematin and the secretion of neopterin by 
monocytes.      
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Chapter 2  
Effect of antimalarial drugs on the phagocytosis of  haemozoin ( β-
haematin) by monocytes. 
 
B.M. Cumming  
Abstract 
Malaria is the cause of approximately one million deaths a year especially amongst children. 
During the blood stage of infection, the malaria parasite digests the haemoglobin of the 
erythrocyte into amino acids and releases toxic free haeme that is sequestered into an 
insoluble non-toxic crystalline pigment called haemozoin. Following erythrocyte rupture, 
haemozoin is released into the blood stream and phagocytosed by circulating monocytes. 
Phagocytosed haemozoin has been reported to have deleterious effects on monocyte 
functions, such as inhibition of re-phagocytosis of bacteria and viruses, release of cytokines 
and inhibition of oxidative burst. This study aimed to determine the effects of seven antimalarial 
drugs, amodiaquine, artemisinin, chloroquine, doxycycline, primaquine, pyrimethamine and 
quinine, on the monocyte phagocytosis of β-haematin, a synthetic equivalent of haemozoin, 
and latex beads. Mouse J774A.1 cells, human peripheral blood mononuclear cells and phorbol-
12-myristate-13-acetate-differentiated human U937 cells were treated with therapeutic 
concentrations of the drugs prior to exposure to β-haematin or latex beads. The effect on 
phagocytosis was determined by both counting and a novel spectrophotometric method. 
Artemisinin, doxycycline and pyrimethamine resulted in more than 10% activation of β-haematin 
phagocytosis by mouse J774A.1 cells, whilst artemisinin, primaquine, pyrimethamine, and 
quinine activated β-haematin phagocytosis in peripheral blood mononuclear cells by more than 
10%. Only pyrimethamine induced more than 10% activation of β-haematin phagocytosis in the 
U937 cells. Both chloroquine and amodiaquine resulted in more than 10% inhibition of β-
haematin phagocytosis in the peripheral blood mononuclear cells. In contrast, only quinine 
resulted in more than 10% inhibition of latex beads in the J774A.1 cells. Thus, the latex beads 
and β-haematin appear to be phagocytosed by different mechanisms. The small but significant 
effects on phagocytosis appear to be dependent on the antimalarial drug used to treat the cells 
as well as the substance being phagocytosed.   
 43 
2.1 Introduction 
An estimated 250 million cases of malaria, which is endemic in 109 countries, occur annually, 
leading to approximately 1 million deaths, mostly of children under 5 years (WHO, 2008). 
Malaria is caused by intracellular parasitic protozoa of the genus Plasmodium. The host’s 
immunological response to the parasite could contribute to the pathophysiology of the disease 
in humans (Malaguarnera and Musumeci, 2002; Miller et al., 2002). Phagocytic cells provide 
the first line of defence against the malaria parasite by recognizing the parasitized erythrocytes 
as foreign cells. This leads to the extracellular generation of aggressive oxidative compounds, 
and phagocytosis. (Abdalla, 1990; Perrin et al., 1982).  In vitro and in vivo studies have shown 
that human monocytes and resident macrophages avidly phagocytose erythrocytes that are 
parasitized by trophozoites and schizonts of Plasmodium falciparum, and the malaria pigment 
called haemozoin (Celada et al., 1983a; Turrini et al., 1992).   
 
Haemozoin is produced in the parasite during the intraerythrocytic stage in the human host. As 
the parasite develops from the early ring stage to the trophozoite stage, it ingests haemoglobin 
from the red blood cell cytoplasm by pinocytosis via a plasma membrane invagination known as 
a cytostome. Haemoglobin transport vesicles transport the haemoglobin to the acidic food 
vacuole (also known as a digestive vacuole) where the haemoglobin is digested by four 
plasmepsins (aspartic proteases, Banerjee et al., 2002), three falcipains (cysteine proteases, 
Rosenthal et al., 2002) and a zinc metalloprotease (falsilysin, Eggleson et al., 1999) into 
peptides of about 20 amino acids long. These are exported from the food vacuole and finally 
degraded into amino acids, probably by aminopeptidases in the parasite cytoplasm (Gavigan et 
al., 2001). About 15% of these amino acids are then utilised in parasite protein synthesis 
(Krugliak et al., 2002). During the catabolism of haemoglobin in the food vacuole, free haeme 
(iron (II) protoporphyrin IX) is released and oxidised to generate iron (III) protoporphyrin IX, 
which is toxic to both the parasite and the host cell as it can generate reactive oxygen species. 
The parasite does not contain haeme oxygenase, an enzyme that can cleave the porphyrin ring 
into an open chain tetrapyrrole, which is necessary for cellular excretion (Eckman et al., 1977). 
To protect itself, the parasite detoxifies free haeme by neutralisation with histidine rich protein II 
(Huy et al., 2003; Sullivan et al., 1996b), degradation with reduced glutathione (Atamna and 
Ginsburg, 1995; Huy et al., 2002a; Huy et al., 2002b) or crystallisation into insoluble 
haemozoin, produced in the food vacuole (Francis et al., 1997; Sullivan et al., 1996b). Recent 
studies have indicated that haemozoin formation is the major route whereby haeme is 
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detoxified in the parasite since the quantity of haemozoin formed corresponds to about 88% of 
the haeme in the erythrocyte (Egan et al., 2002; Gligorijevic et al., 2006).  
 
Haemozoin is a cyclic dimer of ferriprotoporphyrin IX in which the propionate group of each 
ferriprotoporphyrin IX molecule coordinates to the iron(III) centre of its partner, while the dimers 
are linked through hydrogen bonding of the propionic acid groups (Pagola et al., 2000). The 
mechanism of formation of haemozoin is poorly understood. Several theories have been 
proposed, but it appears that a biomineralisation process is favoured, requiring a nucleation site 
for crystal growth. Initiation could involve lipids (various unsaturated fatty acids and mono- and 
dioleoylglycerol) or proteins (histidine rich protein (HRP) or the haeme detoxification protein 
(HDP) (Jani et al., 2008)) or both (Egan, 2008b). Pigment is released along with the merozoites 
into the blood stream when the erythrocyte bursts and is phagocytosed (along with associated 
proteins and lipids of parasite and erythrocyte origin, Goldie et al., 1990) by circulating 
monocytes, neutrophils and resident macrophages. 
 
Ingested haemozoin persists unmodified for long periods within the phagocyte and modifies a 
number of monocyte functions (Schwarzer et al., 2008). Haemozoin causes inhibition of the 
following monocyte functions: PMA-elicited respiratory burst (Schwarzer et al., 1992), ability to 
repeat phagocytosis (Schwarzer et al., 1992), membrane translocation and activity of protein 
kinase C (Schwarzer et al., 1993), activity of NADPH oxidase (Schwarzer and Arese, 1996), 
ability to kill ingested bacteria, fungi, or tumour cells (Fiori et al., 1993), expression of ICAM-1, 
integrin-CD11c, MHC-class II (Interferon-γ-mediated) (Schwarzer et al., 1998) and 
differentiation of monocytes into functional, antigen-presenting dendritic cells (Skorokhod et al., 
2004). Phagocytosed haemozoin stimulates the accumulation of lipoperoxidation products in 
monocytes (Schwarzer et al., 2003), activates metalloproteinase-9 in monocytes (Prato et al., 
2005), and stimulates the production of pro-inflammatory chemokines, such as macrophage 
inflammatory protein (MIP)-1α and -1β, MIP-2, and monocyte chemoattractant protein (MCP)-1, 
and the production of pro-inflammatory cytokines, such as interleukin (IL)-1β and IL-6 (Jaramillo 
et al., 2004). Most of these effects are a result of the large amounts of lipoperoxidation 
products, such as monohydroxy derivatives of arachidonic acid and linoleic acid, and 4-
hydroxynonenal (HNE) generated by non-enzymatic catalysis of haemozoin (Schwarzer et al., 
2003; Skorokhod et al., 2005).  
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Antimalarial drugs appear to perturb the functions of monocytes in a number of ways. Many 
antimalarial drugs inhibit cytokine production by the monocytes. Chloroquine and quinine inhibit 
the production of monocyte tumour necrosis factor (Kwiatkowski and Bate, 1995; Maruyama et 
al., 1994; Picot et al., 1991). Chloroquine inhibits the production of IL-1β and IL-6 from 
lipopolysaccharide-stimulated monocytes (PBMC, THP-1 and U937 monocytic cells) by 
reducing the level of IL-1β and IL-6 mRNA (Jang et al., 2006; Salmeron and Lipsky, 1983). 
Doxycycline dose dependently inhibited the production of cytokines IL-1β, IL-6, tumour necrosis 
factor alpha (TNF-α) and interferon gamma (IFN-γ) and the chemokines MCP-1, MIP-1α, and 
MIP-1β by PBMC incubated with staphylococcal endotoxins (Krakauer and Buckley, 2003). 
Chloroquine and pyrimethamine both interfere with IL-2 production and hence inhibit T-cell 
proliferation (Landewe et al., 1995; Viora et al., 1996).   
 
Other effects of the antimalarial drugs include alterations in phospholipid metabolism in 
monocytes: quinine markedly increased phosphatidylserine and phosphatidylinositol synthesis 
and strongly decreased phosphatidylcholine and phosphatidylethanolamine synthesis (Pelassy 
et al., 1992). Quinidine inhibits α-naphthyl acetate esterase and α-naphthyl butyrate esterase in 
monocytes. Quinine, chloroquine and primaquine also inhibit the monocyte esterases but to a 
lesser extent (Markovic et al., 1988). Artemisinin increased protein kinase C activity and the  
level of protein kinase Cβ1 isoforms in human promyelocytic leukaemia cells (human 
promonocytes), and enhanced cell differentiation predominantly into monocytes (Kim et al., 
2003). Quinine, chloroquine, primaquine, pyrimethamine, artemisinin, mefloquine and proguanil  
all decreased the cytoadherance of P. falciparum to monocytes by 40% or more due to down 
regulation of the expression of monocyte receptors (Goldring and Nemaorani, 1999). Treatment 
of U937 cells with chloroquine significantly down-regulated the expression of cell surface TNF 
receptors and a similar effect was observed with human peripheral blood monocytes (Jeong et 
al., 2002). Chloroquine also suppressed β1-integrin mediated U937 cell-cell adhesion (Cho, 
2008).     
  
Antimalarial drugs have been shown to inhibit monocyte phagocytosis. Chloroquine at doses 
recommended for malaria prophylaxis inhibited the Fc-receptor mediated phagocytosis of 
sheep red blood cells and non-immunologic receptor-mediated phagocytosis of zymosan 
particles by PBMC (Osorio et al., 1992). Chloroquine, quinine, mefloquine, amodiaquine and 
artemether were all found to reduce the binding of immunoglobulin G (IgG) to P. falciparum 
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infected red blood cells, and thus reduced their subsequent phagocytosis by a human 
monocytic J-111 cell line (Shalmiev et al., 1996). Mefloquine, proguanil and cycloguanil, at 
concentrations higher than 0.5 µg/ml, reduced the phagocytosis of opsonised Staphylococcus 
aureus by leucocytes. Quinine, chloroquine and pyrimethamine had no inhibitory effect on the 
phagocytosis of S. aureus  (Kharazmi and Eriksen, 1986).   
 
Thus, phagocytosed haemozoin as well as antimalarial drugs perturb monocyte functions. 
Haemozoin plays a key role in the induction of immunosuppression associated with malaria 
(Scorza et al., 1999) and antimalarial drugs have been shown to inhibit phagocytosis (Shalmiev 
et al., 1996). Phagocytosis still occurs in malaria patients that are being treated with 
antimalarial drugs but the effect of the antimalarial drugs on the phagocytosis of haemozoin is 
unknown. Synthetic haemozoin, also called β-haematin, is chemically and structurally identical 
to the native pigment (Egan, 2002). Thus, in this study, two monocytic cell lines, J774A.1 and 
U937, and peripheral blood mononuclear cells (PBMC) were characterised for their 
monocyte/macrophage properties, β-haematin was synthesized and the effects of seven 
antimalarial drugs (amodiaquine, artemisinin, chloroquine, doxycycline, primaquine, 
pyrimethamine and quinine) on the phagocytosis of β-haematin by J774A.1 cells were 
compared to that of latex beads using a counting assay. A spectrophotometric assay was 
developed to determine the effect of the drugs on the phagocytosis of β-haematin by the U937 
cell line and PBMC. Knowledge of the effects of the drugs on phagocytosis of β-haematin might 
give an indication of whether the antimalarial drugs enhance or suppress the 
immunosuppression caused by malaria in addition to eradicating the parasite.    
 
2.2 Materials and Methods 
2.2.1 Materials 
Common chemicals and buffer salts were purchased from Saarchem (South Africa) and Sigma-
Aldrich (Germany). DMEM, RPMI-1640, Hank’s Balanced Salt Solution (HBSS), penicillin-
streptomycin, L-glutamine, phorbol-12-myristate-13-acetate, chloroquine diphosphate, quinine 
hydrochloride, pyrimethamine, primaquine diphosphate, artemisinin, doxycycline hydrochloride, 
amodiaquine dihydrochloride dihydrate, porcine haematin, latex beads (10% w/v, 0.8 µm), 
Histopaque®-1077, 3,3’-diaminobenzidine, sodium cacodylate, methyl green, trypan blue, 
dimethyl sulphoxide (DMSO, tissue culture grade) and sodium acetate trihydrate were 
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purchased from Sigma-Aldrich (Germany). 4-Nitro blue tetrazolium chloride and 5-bromo-4-
chloro-3-indolyl phosphate were obtained from Roche Diagnostics (Germany). 50% (v/v) 
Glutaraldehyde (E.M. Grade), haemin chloride and Giemsa stain were purchased from Fluka 
Biochemika (Germany).  Foetal calf serum (FCS) was obtained from Gibco, Invitrogen (U.S.A.). 
Hydrochloric acid, acetic acid, hydrogen peroxide (30%, v/v), acetone and sodium hydroxide 
were purchased from Merck (Germany). Lead nitrate and sodium citrate were obtained from 
BDH (England). Osmium tetroxide was purchased from Electron Microscopy Services (U.S.A.). 
Agar 100 Resin (Epon 812), Araldite, dodecenyl succinic anhydride (DDSA), 2,4,6-
tri(dimethylaminoethyl)phenol (DMP) and Copper grids (200 Mesh) were purchased from Agar 
Scientific (England). Uranyl acetate was purchased from TED Pella, Inc. (Canada). Nunc 
(Denmark) T-flasks (75 cm2 and 25 cm2), Delta (Spain) 15 ml, 50 ml tubes and Falcon (U.S.A.) 
35 x 10 mm Petri-dishes were used. VacuCap PF Bottle-top Filter devices were obtained from 
PALL Life Sciences (U.S.A.). Distilled water (dH2O) was produced by a Milli-Q Plus ultra pure 
water system (Millipore, U.S.A.).  
 
2.2.2 Culturing of J774A.1 and U937 cell lines 
Both the mouse monocyte-macrophage cell line, J774A.1 (Ralph and Nakoinz, 1975; Ralph and 
Nakoinz, 1977a; Ralph and Nakoinz, 1977b; Ralph et al., 1975) and the human monocyte-like 
U937 cell line (Fischer et al., 1980; Koren et al., 1979; Ralph et al., 1976; Sundstrom and 
Nilsson, 1976) were obtained from the European Collection of Cell Cultures (ECACC, 
Salisbury, U.K.). The J774A.1 cell line was cultured in complete DMEM with 10% heat-
inactivated FCS and 4 mM L-glutamine. Subcultures were prepared by lifting the cells with 
0.02% (w/v) EDTA in HBSS and transferring the cells to fresh medium every 2 to 3 days. The 
U937 cell line was cultured in complete RPMI-1640 medium supplemented with 10% FCS 
(NOT heat-inactivated), 4 mM L-glutamine, 100 units/ml of penicillin and 100 µg/ml of 
streptomycin. This cell line was subcultured every 2-3 days. Both cell lines were grown at 37ºC 
under a humidified atmosphere of 5% CO2. 
 
2.2.3 Isolation of peripheral blood mononuclear cel ls (PBMC) 
Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats obtained from the 
South African National Blood Service on the second day after collection. The buffy coats were 
initially diluted with half the volume of complete medium (RPMI-1640, 10% FCS, 4 mM L-
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Glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin). Buffy coat (25 ml) was layered 
on top of 15 ml Histopaque®-1077 and centrifuged at 400 g for 30 min at RT (Boyum, 1968). 
The first layer (plasma) was aspirated off and the opaque layer of mononuclear cells was 
transferred to a sterile tube. Aliquots (5ml) of the mononuclear cells were washed with 10 ml of 
complete media and the suspension was spun at 150 g for 10 min. The slow centrifugation 
speed ensured that most of the platelets stayed in suspension. After aspirating the supernatant 
and removing the platelets, the pellet was washed twice in complete media (Roos and de Boer, 
1986). The cells were resuspended in complete media to a concentration of 8 x 106 cells/ml 
(Prato et al., 2008). The viability and the concentration of the cells were determined by trypan-
blue exclusion (98%) and the cells were counted using a haemocytometer at 400x 
magnification (Strober, 2001). 
 
2.2.4 Adhesion of J774A.1, U937 and PBMC (monocytes ) onto coverslips 
J774A.1 cells (2 x 105 cells/ml) and PBMC (8 x 106 cells/ml) were seeded onto coverslips (22 x 
22  mm2) in 35 x 10 mm Petri-dishes and incubated for 2 h at 37ºC under humidified 5% CO2 to 
allow the monocytes to adhere to the coverslips (Cline and Lehrer, 1968; Ralph et al., 1975). 
The coverslips were washed with complete media to remove non-adherent cells. U937 cells (2 
x 105 cells/ml) were differentiated by incubation with 10 ng/ml phorbol-12-myristate-13-acetate 
(PMA) for 48 h (Goldring et al., 1992) at 37ºC with the resultant adhesion of the cells to the 
coverslips in Petri-dishes. 
 
2.2.5 Characterisation of the cell lines  
Monocytes were stained to ascertain their adherence to plastic and phagocytosis properties. 
Monocytes were fixed with methanol, and stained with 2% (w/v) methyl green or Giemsa at RT 
(Cline and Lehrer, 1968; Gurr, 1965). The coverslips were then washed three times in dH2O, 
allowed to air dry and mounted onto slides using DPX mountant. 
 
Alkaline phosphatase activity was detected with 0.377 mM 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) and 0.367 mM 4-nitro blue tetrazolium chloride (NBT) in 50 mM Tris-HCl, 5 
mM MgCl2 (pH 9.5). Peroxidase activity was detected with 1.5 mM 3,3’-diaminobenzidine (DAB) 
in 50 mM Tris-HCl (pH 8) with 0.03% H2O2. Adherent cells were incubated with the substrates 
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for 20 min in the dark at RT. The coverslips were air dried, mounted and viewed at 1000x 
magnification under oil immersion. (Van Noorden and Frederiks, 1992) 
 
2.2.6 Synthesis and analysis of β-haematin 
β-haematin was prepared according to Egan et al. (1994). Briefly, haemin chloride (30 mg) was 
dissolved in 6.0 ml of 0.1 M NaOH and equilibrated at 60ºC. To this solution, 0.6 ml of 1.0 M 
HCl and 3.7 ml of 12.9 M sodium acetate (pH 5) pre-incubated at 60ºC were added and the 
mixture was stirred at 60ºC for 1 h. The crystals were filtered (8 µm cellulose acetate/nitrate 
Millipore filter Type SC), washed extensively with dH2O and dried at 37 ºC over silica gel for 48 
h.  
 
β-haematin was also prepared according to the method of Slater et al. (1991) as follows: 
porcine haematin (30 mg) was dissolved in 8 ml of 0.1 M NaOH. The porphyrin was precipitated 
by the addition of 2.86 ml of acetic acid and the suspension was heated at 70ºC overnight. The 
following day, the suspension was spun at 20 000 g for 10 min at RT to pellet the β-haematin. 
The supernatant was discarded and the pellet was washed three times with dH2O. The 
unreacted haematin was removed by extracting the pellet twice for 3 h with 20 ml of 0.1 M 
sodium bicarbonate buffer, pH 9.1. The β-haematin was recovered by centrifugation at 20 000 g 
for 10 min at RT and washed three times with dH2O (20 ml). The final washed pellet was dried 
at 37ºC over silica for 48 h. 
 
The β-haematin crystals from both synthetic methods were mounted onto stubs covered with 
carbon tape and viewed under a Philips environmental scanning electron microscope (ESEM) 
with a large field detector and a gaseous secondary electron detector. X-Ray microanalysis of 
the crystals was performed on the ESEM at 2000x magnification, an accelerating voltage of 15 
kV and a spot size of 4.5 for 150 s under low vacuum. In addition, β-haematin crystals were 
embedded in Epon-Araldite (Section 2.2.7) and viewed using transmission electron microscopy.  
 
2.2.7 Preparation of samples for transmission elect ron microscopy (TEM) 
Adherent J774A.1 cells were incubated with β-haematin or latex beads for 30 min or 2 h. The 
cells were scraped off the bottom of the T-flasks and washed in HBSS. A small aliquot of the 
cell suspension was allowed to adhere to coverslips, followed by staining with 2% (w/v) methyl 
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green (Section 2.2.5) for viewing with bright field microscopy. The rest of the cells were fixed 
overnight at 4ºC in 3% (v/v) glutaraldehyde in 0.05 M sodium cacodylate buffer, pH 7.1. The 
fixed cells were rinsed twice for 30 min each in 0.05 M sodium cacodylate buffer, pH 7.1 and 
postfixed in 2% (w/v) osmium tetroxide in 0.05 M sodium cacodylate buffer, pH 7.1 for 30 min. 
After washing twice for 30 min each in the same buffer, the samples were dehydrated in a 
series of acetone concentrations (10, 40, 60, 80, 90, 100%) for 10 min each. The samples were 
then embedded in a series of  Epon-Araldite (1 part Epon 812, 1 part Araldite CY212, 3 parts 
DDSA) concentrations in acetone (25, 50, 75, 100%) with equivalent drops of 2,4,6-
tri(dimethylaminoethyl)phenol per ml of Epon-Araldite used for 2 h each. The embedding in 
100% Epon-Araldite was repeated for 24 h at RT and again at 70ºC for 48 h to cure the 
samples. The polymerized resin was trimmed and ultra thin sections (100 nm) were cut on a 
LKB Ultratome III using a glass knife and collected on copper grids with 200 Mesh. The 
samples were stained in 2% (w/v) uranyl acetate for 10 min and, after washing with dH2O, in 
0.08 M lead citrate for 5 min followed by washing with dH2O. The ultrathin sections were 
observed in a Philips CM120 transmission electron microscope. Images were acquired using a 
Megaview III Soft Imaging System. 
        
2.2.8 Treatment of monocytes with antimalarial drug s 
Complete culture media (2 ml) containing physiological therapeutic concentrations of one of 
seven antimalarial drugs, were added to each Petri-dish containing adherent cells (J774A.1, 
U937 or PBMC) and incubated for 18 h at 37ºC under humidified 5% CO2. The cells were 
treated with antimalarial drugs for 18 h as this time period was compatible to other assays in 
which the effect of antimalarial drugs on the expression of monocyte receptors and TNF 
secretion was investigated (Goldring and Nemaorani, 1999; Kwiatkowski and Bate, 1995).  The 
antimalarial drugs included amodiaquine, 75.6 ng/ml (White et al., 1987; Winstanley et al., 
1987; Winstanley et al., 1990); artemisinin, 400 ng/ml (Wernsdorfer, 1997); chloroquine, 200 
ng/ml (Desjardins et al., 1988); doxycycline, 3 µg/ml (Wernsdorfer, 1997); primaquine, 153 
ng/ml (Desjardins et al., 1988); pyrimethamine, 234 ng/ml; and quinine, 15 µg/ml (Wernsdorfer, 
1997). Controls were also set up containing the concentrations of solvents used to solubilise 
the antimalarial drugs.  
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2.2.9 Measuring phagocytosis of β-haematin and latex beads by monocytes    
β-haematin and latex beads were added to the 2 ml of culture medium with or without the 
antimalarial drugs to a final concentration of 25 µg/ml β-haematin or 0.1% (w/v) latex beads. 
The cells were incubated for 30 min at 37ºC under humidified 5% CO2. The concentration of β-
haematin added to the monocytes (25 µg/ml) was chosen based on reported estimates of the 
haemozoin concentrations encountered during malaria infections (Jaramillo et al., 2005; Sherry 
et al., 1995; Sullivan et al., 1996a). Cells were incubated with β-haematin for 30 min as Olliaro 
et al. (2000) detected aggregates of β-haematin crystals inside phagolysosomes in monocytes 
within 25 minutes of treatment (Olliaro et al., 2000). Following the incubation with latex beads or 
β-haematin, the supernatant was aspirated and the cells were washed three times in pre-
warmed HBSS. The effects of the antimalarial drugs on the phagocytosis of latex beads were 
determined by the counting assay, whereas the effects of antimalarial drugs on the 
phagocytosis of β-haematin were analysed by either the counting assay or the OD 400 assay. 
 
Counting assay: The J774A.1 cells were stained with 2% (w/v) methyl green (Section 2.2.5) 
and viewed (400x). AnalySIS® 3.0 (Soft Imaging System) was used to capture images of 
various fields of the coverslips and modify the images by separating the image into its red, 
green and blue components. The software was also used to maximise the contrast of the red 
image and ‘touch count’ the total number of cells and the cells containing latex beads observed 
in each field. The maximised-contrasted blue image was used to ‘touch count’ the total cells 
and cells containing β-haematin in each field. Between a total of 500 to 1000 cells were 
counted per coverslip and each experiment was performed in duplicate. Results were 
expressed as per cent inhibition or activation of phagocytosis of latex beads or β-haematin 
relative to the control for each antimalarial drug. 
 
OD 400 Assay: The amount of β-haematin phagocytosed by the cells (U937 and PBMC) was 
determined by measuring the total haeme content in the cells after the phagocytosis assay 
using an adaptation of the procedure developed by Sullivan et al. (1996c). The cells were lysed 
and the β-haematin was solubilised to haeme by exposing the coverslips to 500 µl of 20 mM 
NaOH and 2% SDS for 2 h at RT, followed by measuring the optical density (OD) of the lysate 
at 400 nm. The haeme content of the lysate was determined by extrapolation from a standard 
curve of OD at 400 nm plotted against haeme concentration. The results were expressed as the 
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per cent inhibition or activation of phagocytosis of β-haematin relative to the control of each 
antimalarial drug.  
 
2.2.10 Statistical analysis 
Statistically significant differences were determined by the Mann-Whitney U (Wilcoxon Rank-
Sum) test using the GenStat program, 9th Edition. Values of p<0.05 were considered 
statistically significant. All data are presented as the mean ± SEM.     
 
2.3 Results 
Prior to investigating the effects of antimalarial drugs on the phagocytosis of latex beads and β-
haematin, the mouse J774A.1 and human U937 cell lines and human peripheral blood 
mononuclear cells (PBMC) were first characterised to verify their monocytic/macrophagic 
properties by evaluating their adherence to glass, the presence of hydrolytic enzymes and their 
ability to phagocytose. β-haematin, which is structurally and chemically equivalent to 
haemozoin (Egan, 2002), was synthesized and the morphology validated by scanning electron 
microscopy. The effect of the antimalarial drugs on the phagocytosis of latex beads and β-
haematin was first ascertained using a counting method with the J774A.1 cell line. As the 
counting assay was time consuming and labour intensive, a spectrophotometric assay was 
developed to measure the effect of the drugs on the phagocytosis of β-haematin. This method 
was compared to the counting assay using variables such as the amount of β-haematin added 
to the cells, the number of cells treated with β-haematin, the time of exposure to β-haematin 
and temperature of phagocytosis.  The OD 400 assay was then adopted to determine the 
effects of the antimalarial drugs on the phagocytosis of β-haematin by the U937 cell line and 
PBMC. 
 
2.3.1 Characterisation of the monocytes 
The J774A.1 and U937 cell lines and the PBMC were characterised by histochemical, 
morphological and functional assays to determine if they had characteristic 
monocyte/macrophage properties. Histochemical techniques were used to determine the 
presence of alkaline phosphatase and peroxidase in vesicles within the monocyte’s cytoplasm. 
Staining with Giemsa and methyl green as well as transmission electron microscopic analysis 
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confirmed the morphology as well as the functional ability of monocytes to phagocytose latex 
beads and β-haematin. 
 
Monocytes were characterized by their ability to adhere to glass and plastic. The presence of 
adherent cells on glass coverslips was characterized by staining with methyl green or Giemsa. 
The J774A.1 cell line is an adherent cell line, and the cells adhered to the coverslips after 2 
hours incubation at 37ºC (Figure 2.1A). The U937 cell line is a non-adherent cell line, which 
adheres to the coverslips after differentiation with phorbol-12-myristate-13-acetate (PMA), 
(Figure 2.1B). 
 
A                                                                          B 
      
 
Figure 2.1. Adherence of J774A.1 cells and PMA-trea ted U937 cells to glass 
coverslips.  Adherent cells were fixed with methanol and the (A) J774A.1 cells were stained 
with methyl green and the (B) U937 cells were stained with Giemsa. The stained cells were 
viewed at 1000x magnification under oil immersion. 
 
 
2.3.1.1 Detection of peroxidase and alkaline phosph atase activity in monocytes 
Peroxidase activity in cytoplasmic granules was observed in J774A.1 cells and PBMC as brown 
punctate spots (Figure 2.2).  Peroxidase activity was not observed in the adherent U937 cells 
differentiated with PMA.  Variations in the staining procedure, such as a change in the pH of the 
buffer (from pH 8 to 7.6) as well as varied concentrations of hydrogen peroxide (0.3%, 0.1%, 
and 0.01%) did not produce staining suggesting that these cells lack peroxidase activity. 
However, peroxidase activity was detected in the U937 suspension culture prior to 
differentiation (data not shown). 
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Figure 2.2. Peroxidase activity in J774A.1 cells an d peripheral blood mononuclear 
cells (PBMC). Cells adherent to coverslips were incubated with the peroxidase substrate 




Alkaline phosphatase activity was observed in the J774A.1, U937 and PBMC as punctate blue 
spots throughout the cells illustrating enzyme activity in numerous cytoplasmic granules (Figure 
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Figure 2.3. Alkaline phosphatase activity in J774A. 1 cells, U937 cells and peripheral 
blood mononuclear cells (PBMC).  Adherent cells were incubated with the alkaline 
phosphatase substrate (BCIP/NBT). (A, B) J774A.1 cells, (C, D) U937 cells and (E, F) PBMC 
were viewed at 1000x magnification under oil immersion. 
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2.3.1.2 Synthesis and analysis of β-haematin 
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Figure 2.4. Scanning electron micrograph of haemati n and the corresponding X-ray 
spectrum.  Haematin was mounted onto a stub covered in carbon tape and viewed under a 
Philips environmental scanning electron microscope fitted with a large field detector. (A) The 
crystal structure of haematin at a magnification of 12 000x. (B) The X-ray spectrum obtained at 





























Figure 2.5. Scanning electron micrograph of β-haematin synthesized according to the 
method of Egan et al. (1994) and the corresponding X-ray spectrum . β-haematin was 
mounted onto a stub covered in carbon tape and viewed under a Philips environmental 
scanning electron microscope fitted with a large field detector. (A) The crystal structure of β-




























Figure 2.6. Scanning electron micrograph of β-haematin synthesized according to the 
method of Slater et al. (1991) and the corresponding X-ray spectrum.  β-haematin was 
mounted onto a stub covered in carbon tape and viewed under a Philips environmental 
scanning electron microscope fitted with a large field detector. (A) The crystal structure of β-













The scanning electron micrographs (SEMs) indicate a distinct difference between the crystal 
structures of the starting material, haematin, and the finished product, β-haematin. Haematin is 
made up of large crystals with smooth surfaces (Figure 2.4A). β-haematin is made up of smaller 
thin, needle-like crystals that are tapered towards the ends (Figure 2.5A and Figure 2.6A). The 
β-haematin crystals radiate in all directions. These crystals have a similar appearance to those 
in SEMs of crystals synthesized by Egan et al. (2001). The longest needle-like crystals 
produced by both methods appear to be roughly the same length (0.9-1.4 µm) and width (0.15-
0.2 µm). The transmission electron micrographs (TEMs) of β-haematin (Figure 2.7) show 
needle-like crystals that taper towards the ends and have a similar appearance to those 
published by Egan et al. (2001) and Olliaro et al. (2000).  
 
X-ray microanalysis showed that both haematin and β-haematin contain the common elements 
iron, oxygen and carbon (Figures 2.4B, 2.5B and 2.6B). Quantification of the X-ray spectrum of 
haematin showed that the crystals contained 80.59% carbon, 10.85% oxygen, 6.5% iron, 
1.77% potassium and 0.29% chloride (Figure 2.4B). The trace amounts of potassium and 
chloride could be as a result of the supplier’s extraction procedure to prepare haematin. 
Quantification of the spectrums of β-haematin prepared by (a) the method of Egan et al. (1994) 
indicated that the crystals contained 84.84% carbon, 8.38% oxygen and 6.81% iron, and that 
prepared by (b) the method of Slater et al. (1991) contained 84.2% carbon, 9.23% oxygen and 
6.57% iron. The ratios of the elements in the β-haematin crystals prepared by the two different 
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Figure 2.7. Transmission electron micrographs of β-haematin synthesized by two 
methods. The method of Egan et al. (1994) is shown in (A) and the method of Slater et al. 
(1991) is shown in (B). 
2.3.1.3 Measuring phagocytosis of latex beads and β-haematin by monocytes 
After incubation with latex beads and β-haematin, the bright field images of the monocytes 
(Figure 2.8) and the transmission electron micrographs (TEM) (Figure 2.9 and 2.10) indicate 
that the J774A.1 cells phagocytosed unopsonised latex beads and β-haematin. In Figure 2.8 (A 
and B), the latex beads appear to be localized in distinct areas, possibly the cytoplasm, as the 
methyl green staining does not distinguish the cytoplasm from the nucleus. β-haematin appears 
to be less localized in Figure 2.8 (C and D) as crystals also adhere to the surface of the cell 
membrane. In the TEMs in Figure 2.9 and 2.10, the latex beads and β-haematin are located in 
the cytoplasm of the monocytes. The distinctive kidney-shaped nucleus characteristic of 
monocytes is visible in Figure 2.9B (Auger and Ross, 1992). This kidney-shaped nucleus is not 
always visible in the TEMs of monocytes owing to the angle at which the cells are sectioned. 
 
After 30 minutes, there were fewer β-haematin crystals present in the monocytes than there 
were latex beads (Figure 2.9 and 2.10). This could be due to the slightly larger size of the β-
haematin crystals (approximately 1.4 µm versus 0.8 µm of the latex beads). In addition, 
phagocytic receptors on the monocytes may have lower affinities for the β-haematin crystals 
than for the latex beads, and the numbers of β-haematin crystals and latex beads added to the 
cells may have been unequal. β-haematin was observed as free crystals in the cytoplasm 
surrounded by a discontinuous membrane (Figure 2.10B) as well as in phagocytic vacuoles 
with a clear matrix that are situated very close to the cell membrane (Figure 2.10C, D, E).  
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Figure 2.8. Phagocytosis of latex beads and β-haematin by J774A.1 cells. Adherent 
J774A.1 cells were exposed to (A, B) latex beads (0.1% (w/v)) or (C, D) β-haematin (25 µg/ml) 
for 30 min and the stained cells were examined at 1000x magnification under oil immersion. 
 
 
A                                                                           B  
    
 
Figure 2.9. Transmission electron micrographs of J7 74A.1 cells after phagocytosis of 
latex beads. J774A.1 cells were exposed to latex beads for (A) 30 minutes and (B) 2 hours. 
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Figure 2.10. Transmission electron micrographs (TEM ) of J774A.1 cells after 
phagocytosis of β-haematin. (A) A J774A.1 cell after phagocytosis of β-haematin for 2 hours; 
(B) TEM (A) at a higher magnification to illustrate the two β-haematin crystals surrounded by a 
discontinuous membrane; (C, D, E) β-haematin crystals in phagocytic vacuoles after (C) 30 
minutes, (D, E) 2 hours of phagocytosis. Arrows indicate the β-haematin crystals. 
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2.3.2 Comparison of the counting and OD 400 assay m ethods to determine the 
extent of phagocytosis of β-haematin 
When increasing quantities of β-haematin were added to equivalent numbers of J774A.1 cells, 
there was a corresponding increase in the percentage phagocytosis observed by the counting 
method (Figure 2.11A) as well as an increase in the amount of haeme measured by the OD 
400 assay (Figure 2.11B). Thus, both assays detect an increase in phagocytosis of β-haematin, 
although the counting method measures the number of cells phagocytosing β-haematin, 
whereas the OD 400 assay does not differentiate between the amount of β-haematin 
phagocytosed, and the number of cells phagocytosing β-haematin. When the cells were 
exposed very briefly to β-haematin (3 minutes), there was a minimal amount of haeme 
measured by the OD 400 assay. 
 
Figure 2.12A showed that when using the counting method, a 4- to 5-fold decrease in 
phagocytosis was observed when the time of treatment with β-haematin was decreased from 
30 minutes to 3 minutes. This reduction in phagocytosis with a decreased time of exposure to 
β-haematin occurred regardless of the quantity of β-haematin used to treat the cells. A similar 
trend was observed with the OD 400 assay, where the amount of haeme detected in the cell 
lysate decreased 3.5-fold when the β-haematin treatment was decreased from 30 minutes to 3 
minutes (Figure 2.12B). The amount of haeme present in the lysate also decreased almost 2-
fold when the temperature of the β-haematin treatment was decreased from 37ºC to 4ºC. The 
haeme detected in the lysate of the cells incubated at 4ºC was probably due to the adherence 
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Figure 2.11. J774A.1 phagocytosis of β-haematin determined by the counting and OD 
400 assays, following the addition of increasing qu antities of β-haematin to the cells.  
J774A.1 cells were treated with varying concentrations of β-haematin and (A) the percentage 
phagocytosis was determined by the counting assay, or (B) the amount of haeme in the cell 
lysates was measured by the OD 400 assay. Results were expressed as the mean of 













































Figure 2.12. Effect of temperature and time on the J774A.1 phagocytosis of β-haematin 
determined by the counting and OD 400 assays.  (A) Two concentrations of β-haematin were 
added to J774A.1 cells for 3 and 30 minutes at 37ºC and the percentage phagocytosis was 
determined by counting. (B) β-haematin (25 µg/ml) was added to the J774A.1 cells for 30 
minutes at 37ºC and 4ºC and for 3 min at 37ºC. This was followed by measuring the amount of 
haeme present in the cell lysates using the OD 400 assay. Results are the mean of three 





















Figure 2.13. Effect of the number of J774A.1 cells on the phagocytosis of β-haematin. 
Increasing concentrations of J774A.1 cells were exposed to β-haematin and the OD 400 assay 
was used to determine the amount of haeme present in the cell lysates. Results are expressed 
as the mean of two experiments done in duplicate ± SEM. 
 
 
Figure 2.13 demonstrates that there was a 1.2- to 1.3-fold increase in the amount of haeme 
detected in the cell lysate as the number of cells treated with 25 µg/ml β-haematin was 
doubled. Thus, the OD 400 assay detected an increase in phagocytosis of β-haematin as the 
number of the cells was increased. Figures 2.11 to 2.13 demonstrated that the OD 400 assay 
was sensitive enough to detect changes in the amount of β-haematin phagocytosed by the 
monocytes when the monocytes were subjected to variations in the quantity of β-haematin 
added, the time period of β-haematin treatment, the temperature of phagocytosis and the 




2.3.3 Effect of febrile temperature on phagocytosis  of β-haematin by monocytes 
One of the most characteristic clinical symptoms of malaria infection is fever which typically 
recurs at intervals of 48 hours in infections due to Plasmodium vivax and P. falciparum 
(Karunaweera et al., 1992). J774A.1 cells were pre-conditioned to a febrile temperature of 41ºC 
for 2 hours prior to a β-haematin phagocytosis assay at 41ºC and compared to that of cells 
incubated at 37ºC (Table 2.1). The OD 400 assay demonstrated that the effect of a febrile 
temperature of 41ºC did not significantly affect the phagocytosis of β-haematin by J774A.1 cells 
(p>0.05). 
 
Table 2.1. Effect of febrile temperature on J774A.1  phagocytosis of β-haematin 
Temperature of phagocytosis µg/ml Haemea SEMb 
37ºC 4.56 0.50 
41ºC 5.06 0.66 
a) The phagocytosis of β-haematin was measured by the OD 400 assay, which determines the 
amount of haeme present in the cell lysate. 
b) SEM: Standard error of the mean. 
 
 
2.3.4 Effect of antimalarial drugs on the phagocyto sis of latex beads and β-
haematin by monocytes 
J774A.1 cells were treated with seven antimalarial drugs for 18 h prior to 30 min of 
phagocytosis of β-haematin or latex beads. The effects of the drugs on the phagocytosis of β-
haematin or latex beads by the J774A.1 cells were determined by the counting assay as 
described in section 2.2.9.  Figure 2.14A demonstrates that chloroquine and quinine inhibited 
latex bead phagocytosis by the J774A.1 cells with quinine having the most significant effect, 4-
fold greater than that caused by chloroquine, p<0.05. Amodiaquine, artemisinin, doxycycline, 
primaquine, and pyrimethamine had minimal inhibitory effects on the phagocytosis of latex 
beads (<5%), with amodiaquine having the least effect. In contrast, the phagocytosis of β-
haematin by the J774A.1 cells was activated by five out of seven of the antimalarial drugs 
investigated (Figure 2.14B). Artemisinin, doxycycline and pyrimethamine treatment resulted in 
an activation of 10% or more. The difference between the effects of artemisinin, doxycycline, 
primaquine and pyrimethamine, and the effects of amodiaquine, chloroquine and quinine on β-
haematin phagocytosis, was significant (p<0.05). Amodiaquine and chloroquine inhibited the 



















































































Figure 2.14. Effects of antimalarial drugs on J774A .1 phagocytosis as determined by 
the counting assay. J774A.1 cells were exposed to physiological concentrations of seven 
antimalarial drugs for 18 hours. (A) Latex beads (0.1% (w/v)) or (B) β-haematin (25 µg/ml) were 
added to the cells and they were incubated for a further 30 minutes. The cells were evaluated 
for phagocytosis by the counting assay at 400x magnification. Results are expressed as the 
mean of two experiments done in duplicate ± SEM. 
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To determine if there was a correlation between the counting and OD 400 assays, the effects of 
quinine, pyrimethamine and artemisinin on the phagocytosis of β-haematin by the J774A.1 cells 
were analysed by the OD 400 assay, and the results obtained were compared to those of the 
counting assay (Figure 2.15). Both assays demonstrated that artemisinin, pyrimethamine and 
quinine activated the phagocytosis of β-haematin by the J774A.1 cells. Furthermore, the same 
trends were observed among the three drugs in both assays: Of the three drugs investigated, 
artemisinin had the greatest effect and quinine had the least effect on the increased β-haematin 
phagocytosis. Hence, the OD 400 assay was used to analyse the effect of the antimalarial 
drugs on the phagocytosis of β-haematin by the human U937 cell line and peripheral blood 





































Figure 2.15. Comparison of the counting and OD 400 assays. J774A.1 cells were exposed 
to physiological concentrations of artemisinin, pyrimethamine and quinine for 18 hours. β-
haematin (25 µg/ml) was added to the cells and they were incubated for a further 30 minutes. 
The cells were evaluated for phagocytosis by the counting assay at 400x magnification and the 












































Figure 2.16. Effect of antimalarial drugs on U937 p hagocytosis of β-haematin as 
measured by the OD 400 assay. U937 cells were treated with physiological concentrations of 
seven antimalarial drugs for 18 hours. β-haematin (25 µg/ml) was added, the cells were 
incubated for a further 30 minutes and evaluated for phagocytosis. Results are expressed as 
the mean of three experiments done in duplicate ± SEM. 
 
In the case of the U937 cells, pyrimethamine and quinine activated the phagocytosis of β-
haematin, with pyrimethamine resulting more than 10% activation (Figure 2.16). These 
activation effects were significantly different to the effects of the remaining five drugs (p<0.05). 
Amodiaquine and chloroquine inhibited the phagocytosis of β-haematin by less than 5%, and 
the effects of artemisinin, doxycycline and primaquine on phagocytosis were all below 2%. 
 
When the effects of the antimalarial drugs on the U937 cells were compared to those of the 
J774A.1 cells, pyrimethamine and quinine both activated the phagocytosis of β-haematin, with 
pyrimethamine resulting in more than 10% activation in both cell lines. Both amodiaquine and 
chloroquine resulted in less than 5% inhibition in both cell lines. However, noticeable 
differences were observed in the effects of artemisinin, doxycycline and primaquine on the two 
cell lines. In the J774A.1 cell line, artemisinin, doxycycline and primaquine activated the 
phagocytosis of β-haematin, with artemisinin and doxycycline inducing more than 10% 
activation. In the U937 cells, these three drugs had minimal effects below 2% activation or 
















































Figure 2.17. Effect of antimalarial drugs on PBMC p hagocytosis of β-haematin as 
measured by the OD 400 assay.  PBMC were isolated from buffy coats using Histopaque®-
1.077. The adherent mononuclear cells were treated with antimalarial drugs for 18 hours. β-
haematin (25 µg/ml) was added, the cells were incubated for a further 30 minutes and 
phagocytosis was measured. Results are expressed as the mean of triplicate experiments done 
in duplicate ± SEM. 
 
When PBMC were treated with antimalarial drugs, four out of seven of the antimalarial drugs 
investigated: artemisinin, primaquine, pyrimethamine and quinine resulted in greater than 10% 
activation of β-haematin phagocytosis (Figure 2.17). Pyrimethamine had the most significant 
activation, about 1.5-fold greater than that of primaquine (p<0.05). The other three drugs, 
amodiaquine, chloroquine and doxycycline, all had inhibitory effects of 10% or more on the 
phagocytosis of β-haematin by PBMC, with amodiaquine having the most significant inhibition, 
more than 2-fold greater than that caused by doxycycline (p<0.05). 
 
When the patterns of inhibition and activation of the antimalarial drugs on β-haematin 
phagocytosis for all three cell types were examined, pyrimethamine had the most consistent 
pattern promoting more than 10% increased β-haematin phagocytosis. Quinine also promoted 
phagocytosis in all three cell types but to varying degrees with the activation of β-haematin 
phagocytosis in PBMC cells being 9-fold greater than that observed with the J774A.1 cells 
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(p<0.05) and 2-fold greater than the activation in the U937 cells. Artemisinin and primaquine 
also resulted in increased β-haematin phagocytosis in both the J774A.1 cells and PBMC, with 
artemisinin causing more than 10% increase in both cell types; however, minimal effects were 
observed in the U937 cell line (p<0.05). Amodiaquine and chloroquine both inhibited β-
haematin phagocytosis in all three cell types, but with varying degrees. The inhibitory effect of 
amodiaquine on PBMC was most significant, almost 18-fold greater than the effect on U937 
cells (p<0.05) and 5-fold greater than the inhibition of β-haematin phagocytosis of J774A.1 cells 
(p<0.05). Chloroquine inhibition of β-haematin phagocytosis of the PBMC was almost 9-fold 
greater than the drug’s inhibition of the J774A.1 phagocytosis and 5-fold greater than that of the 
U937 cells. Doxycycline had different effects on each cell type: it caused about 10% activation 
of the β-haematin phagocytosis of the J774A.1 cells, almost 10% inhibition in PBMC and had 
very little effect on the U937 cells. Overall, the antimalarial drugs exhibited similar patterns of 
inhibition and activation, although with varying degrees, of β-haematin phagocytosis of the 
PBMC and J774A.1 cell line, with the exception of doxycycline.  
 
In summary, in the J774A.1 cell line, two of the seven drugs, chloroquine and quinine inhibited 
latex bead phagocytosis. The other drugs had minimal effects on the latex bead phagocytosis. 
In the J774A.1 cells, five out of seven antimalarial drugs, artemisinin, doxycycline, primaquine, 
pyrimethamine and quinine activated β-haematin phagocytosis, while amodiaquine and 
chloroquine inhibited β-haematin phagocytosis. The same drugs that activated β-haematin 
phagocytosis in J774A.1, with the exception of doxycycline, promoted β-haematin phagocytosis 
in PBMC, but to a greater degree. Doxycycline inhibited the β-haematin phagocytosis as did 
chloroquine and amodiaquine, which caused a 5-fold greater inhibition in the PBMC than that 
observed in the J774A.1 cells. In the U937 cells, only two of the four drugs that promoted β-
haematin phagocytosis in the PBMC, pyrimethamine and quinine, activated phagocytosis to 
levels about 1.5-fold lower than that observed in PBMC. Similar to J774A.1 and PBMC, 
chloroquine and amodiaquine inhibited β-haematin phagocytosis in the U937 cells, but to lesser 
extents than that in PBMC. Artemisinin, doxycycline and primaquine had minimal effects on the 
β-haematin phagocytosis in the U937 cells.    
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2.4 Discussion  
2.4.1 Characterisation of the monocytes 
Monocytes and macrophages are often the first cells of the immune system to encounter 
invading pathogens, thus their responsibilities are two-fold: firstly, they must function as 
effective phagocytic killer cells; secondly, they must present parasite-derived antigens to the 
rest of the immune system in the presence of Class II major histocompatibility complex (MHC), 
and secrete immuno-modulating cytokines that will induce a protective immune response 
(Sadick, 1992). The monocyte cell types used in this investigation were characterised by their 
ability to adhere to glass, their production of hydrolytic enzymes and their ability to phagocytose 
β-haematin and latex beads. 
 
Both J774A.1 and PMA-treated U937 cells (Figure 2.1) adhered to glass coverslips, and in the 
case of PBMC, following centrifugation of the buffy coat over a layer of Histopaque®-1.077, 
adherence to glass coverslips was used to isolate the monocytes from the polymorphonuclear 
cells (Roos and de Boer, 1986). The kidney-shaped nucleus observed in the transmission 
electron micrograph of the J774A.1 cell (Figure 2.9B) is also characteristic of monocytes and 
gives further evidence of the monocytic character of the J774A.1 cell line (Auger and Ross, 
1992).   
 
Various hydrolytic enzymes, including peroxidases and phosphatases, have been isolated from 
macrophages and monocytes. These enzymes are necessary for the degradation of 
phagocytosed particles and killing of phagocytosed micro-organisms. The activity of these 
enzymes has often been employed in the detection of promonocytes and monocytes 
(Papadimitriou and Ashman, 1989). Alkaline phosphatase activity was detected in granules in 
the cytoplasm of all three cell types, J774A.1, U937 cell lines and PBMC (Figure 2.3). 
Peroxidase was detected in cytoplasmic granules in the J774A.1 cells and PBMC (Figure 2.2). 
Peroxidase activity was not detected in the PMA-treated U937 cell lines, although it was 
detected in the suspended U937 cells, prior to differentiation with PMA. As monocytes mature 
into macrophages, there is a decrease in the content of granule peroxidases (Nakagawara et 
al., 1981; Papadimitriou and Ashman, 1989), as observed in the U937 cells. The U937 cell line 
in suspension has monoblast-like characteristics (Koren et al., 1979); the monoblast is the least 
mature cell of the mononuclear phagocyte system. After treatment with conditioned medium 
from mixed lymphocyte cultures (Koren et al., 1979) or 12-O-tetradecanoylphorbol-13-acetate 
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(Nilsson et al., 1980), the U937 cells differentiate into morphologically mature macrophage-like 
cells.   
 
2.4.2 Characterisation of β-haematin 
The morphology of the β-haematin crystals produced by the methods of Egan et al. (1994) and 
Slater et al. (1991) (Figures 3.5A, 3.6A and 3.7) resembled those published by Egan et al. 
(2001) and Olliaro et al. (2000). The dimensions of the β-haematin crystals in these figures fall 
within the large range of 0.2 to > 1.6 µm previously observed for β-haematin prepared 
according to Egan’s method (Noland et al., 2003). Based on the scanning electron micrographs 
and transmission electron micrographs, the β-haematin crystals produced by both methods 
(Egan et al., 1994; Slater et al., 1991) have similar morphologies, and X-ray microanalyses 
revealed comparable elemental composition (Figures 3.5B and 3.6B). The method according to 
Egan et al. (1994), due to the shorter preparation time, was adopted in this study.  
 
2.4.3 Phagocytosis of latex beads and β-haematin  
J774A.1 cells phagocytosed latex beads and β-haematin, as demonstrated by methyl green 
staining (Figure 2.8) and transmission electron micrographs (Figure 2.9 and 2.10). Monoblasts, 
promonocytes, monocytes and macrophages comprise the mononuclear phagocyte system. As 
the promonocytes develop into monocytes, which then finally mature into macrophages, there 
is an increase in the phagocytic ability of the cells (Cline et al., 1978).  
 
Thus, the J774A.1 and U937 cell lines and PBMC demonstrate adherence to glass, alkaline 
phosphatase and peroxidase activities, in addition to phagocytosis. These are all characteristic 
properties of monocytes. 
  
2.4.4 Comparison of the counting and OD 400 assays to monitor phagocytosis 
of β-haematin by the monocytes 
A concomitant increase in phagocytosis of β-haematin by J774A.1 cells was observed in both 
the counting and the OD 400 assays when: (a) the cells were treated with increasing quantities 
of β-haematin, (b) the temperature of phagocytosis was increased from 4ºC to 37ºC, (c) the 
time period of treatment with β-haematin was increased from 3 minutes to 30 minutes, and (d) 
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the number of cells treated with a fixed quantity of β-haematin was increased. These findings 
indicate that the counting and OD 400 assays are comparable (Figures 2.11-2.13). However, 
these comparisons were not performed on U937 cells and PBMC. Hence, the conditions 
chosen for J774A.1 cells were not necessarily optimal for U937 cells and PBMC, but for 
comparative purposes, the conditions were kept constant for all three cell types investigated.  
 
Both the counting and OD 400 assays did not distinguish between latex beads or β-haematin 
crystals bound to the cell surface and those that have been phagocytosed and were located 
intracellularly. In the counting assay, only crystals located inside the periphery of the cell were 
assumed to be phagocytosed. Crystals attached to the outside of the periphery of the cell were 
not considered to be phagocytosed. Cells were counted after 3 min or 30 min of β-haematin 
phagocytosis in two different manners. In one instance, only cells containing “internalized” 
crystals were considered phagocytosed and counted, and in the second instance, cells 
containing crystals attached to the outside of the periphery of the cell were included in the 
number that phagocytosed β-haematin. However, there was no difference between the two 
methods of counting in the fold-change observed between 3 and 30 min. To determine the 
amount of β-haematin that was bound to the cell surface, phagocytosis was monitored after 
cells were exposed to β-haematin for 3 min, and after cells were exposed to β-haematin at 4ºC 
for 30 min (Figure 2.12). In both cases, phagocytosis should have been minimal or completely 
blocked (Peterson et al., 1977), and the cells counted or haeme measured were used as an 
indication of the amount of β-haematin bound to the cell surface. (The amount of haeme 
measured after phagocytosis at 4ºC was approximately 50% of the amount of haeme measured 
after 30 min at 37ºC).       
 
2.4.5 Effect of febrile temperature on phagocytosis  of β-haematin 
A common manifestation of malaria is the occurrence of febrile episodes, resulting in body 
temperatures as high as 41ºC (Bruce-Chwatt et al., 1986; Karunaweera et al., 1992). In 
mammalian cells, an increase in temperature can lead to a number of changes within the cell, 
including protein denaturation, transient cell cycle arrest, and changes in the membrane fluidity 
(Beere and Green, 2001; Feder and Hofmann, 1999). Depression of phagocytosis of [3H] 
thymidine-labelled staphylococci by human neutrophils has been observed at 41ºC (Peterson et 
al., 1977). However, Mandell (1975) indicated that 41ºC did not significantly affect the 
phagocytosis of 14C-labeled Staphylococcus aureus by peripheral blood polymorphonuclear 
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neutrophils. Yet Mandell did not preincubate the leucocytes at elevated temperatures prior to 
the phagocytosis assay (Mandell, 1975). In this investigation, J774A.1 cells were preincubated 
at 41ºC and 37ºC for 2 hours prior to the phagocytosis assay. However, incubating monocytes 
under febrile conditions had no significant effects on the phagocytosis of β-haematin (Table 
2.1). 
 
2.4.6 Effects of antimalarial drugs on the phagocyt osis of monocytes 
The effect of antimalarial drugs on the phagocytosis of β-haematin by the J774A.1, U937 cell 
lines and PBMC was investigated. The effects of the antimalarial drugs on the phagocytosis of 
latex beads by the J774A.1 cells were also investigated to determine if the effects observed 
were solely due to the antimalarial drugs or if the effects were influenced by the material being 
phagocytosed. Reported therapeutic physiological concentrations of the antimalarial drugs that 
occur in the plasma of malaria patients were used for the investigation so that the results can 
be related to clinical observations (Desjardins et al., 1988; Wernsdorfer, 1997; White et al., 
1987; Winstanley et al., 1990).  
 
When examining the effects of the antimalarial drugs on the phagocytosis of unopsonised β-
haematin and latex beads by the J774A.1 cells (Figure 3.14), the most striking observation was 
that quinine had an inhibitory effect of greater than 20% on the phagocytosis of latex beads, 
whereas quinine had minimal effects on the phagocytosis of β-haematin (less than 2% 
activation). Besides the small inhibitory effect of chloroquine (6%), the other antimalarial drugs 
investigated had minimal inhibitory effects on the phagocytosis of the latex beads. In contrast, 
artemisinin, doxycycline, primaquine and pyrimethamine activated the phagocytosis of β-
haematin, while amodiaquine and chloroquine inhibited the phagocytosis to a small degree. 
The different patterns of inhibition and activation of phagocytosis obtained with the latex beads 
and β-haematin indicate that different mechanisms are involved in their phagocytosis. This is 
not totally unexpected as the structural characteristics of the two compounds are quite different.    
 
Therapeutically-relevant concentrations of amodiaquine, artemether, chloroquine, mefloquine 
and quinine considerably reduced the binding of immunoglobulin G (IgG) to P. falciparum-
infected red blood cells and the subsequent phagocytosis of the infected red blood cells by a 
human monocytic leukaemia-derived cell line J-111 (Shalmiev et al., 1996). Prasad et al. 
(1984,1986) demonstrated the inhibition of the phagocytosis of latex beads, Fc-coated sheep 
 77 
red blood cells and Staphylococcus aureus by monocytes isolated from rhesus monkeys 
treated with therapeutic concentrations of chloroquine or quinine. Some antimalarial drugs have 
acidotropic properties that could impair phagocytosis by raising the pH of the phagosomes, 
thereby reducing digestion, and the recycling of receptors (Hart and Young, 1978).  
 
Quinine has been described as a potassium channel blocker and potassium channels are 
responsible for the outward flowing currents that occur during phagocytosis (Ince et al., 1988). 
Consequently, quinine has been shown to inhibit phagocytosis of latex beads that was 
enhanced by feeding and sleep regulating peptides (Ichinose and Watanabe, 2004) and this 
may account for the observations with latex beads presented here. Furthermore, quinine has 
previously been reported to inhibit the phagocytosis of staphylococci by leucocytes (Felton and 
Dougherty, 1922) and the phagocytosis of P. falciparum infected red blood cells by the 
monocytic leukaemia-derived J-111 cell line (Shalmiev et al., 1996). Thus, the activation effects 
of quinine on β-haematin phagocytosis by the J774A.1, U937 cells and PBMC suggests that a 
different mechanism is involved in β-haematin phagocytosis.   
     
When the effects of the antimalarial drugs on the phagocytosis of β-haematin by the three cell 
types were compared (Figures 2.14B, 2.16 and 2.17), pyrimethamine promoted phagocytosis in 
all three cell types. Pyrimethamine is a dihydrofolate reductase inhibitor and out of the drugs 
investigated, it is the only diaminopyrimidine (Wernsdorfer, 1997) (Figure 2.18). Amodiaquine 
and chloroquine are both 4-aminoquinolines and both have inhibitory effects on the 
phagocytosis of β-haematin by all three cell types, although to much greater degrees in PBMC. 
Chloroquine has been reported to inhibit both Fc receptor-mediated as well as non-
immunologic receptor mediated phagocytosis at prophylactic concentrations (Osorio et al., 
1992) as well as at therapeutically-relevant concentrations (Shalmiev et al., 1996). Quinine and 
primaquine are related to amodiaquine and chloroquine in that they contain quinoline groups 
but quinine is a 4-quinoline methanol and primaquine is an 8-aminoquinoline (Figure 2.18). 
These differences in their chemical structures are reflected in their different effects on β-
haematin phagocytosis: quinine activates phagocytosis of β-haematin in all three cell types, 
although to varying degrees; and primaquine activates β-haematin phagocytosis in two of the 
three cell types, J774A.1 and PBMC. Artemisinin is a sesquiterpene lactone that activates 
phagocytosis in both J774A.1 cells and PBMC. Doxycycline is a naphthacenecarboxamide that 
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Figure 2.18. Structures of antimalarial drugs (chem ical group) 
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different effects on the phagocytosis of β-haematin in all three monocytic cell types: It activates 
the J774A.1 cells, inhibits PBMC and has no effect on U937 cells. Thus, it is difficult to relate  
the chemical structures of the antimalarial drugs to their effects on the phagocytosis of β-
haematin because three of the drugs are derived from unrelated chemical groups. 
    
Even though the patterns of activation or inhibition of phagocytosis of β-haematin were 
qualitatively but not quantitatively similar between the J774A.1 cells and PBMC, it appears that 
each cell type has its own unique interactions with the antimalarial drugs. Each monocytic cell 
type is inherently different. The two cultured cell lines are isolated from different species: the  
J774A.1 cell line is from Mus musculus and the U937 cell line is from Homo sapiens. 
Furthermore, the stages of differentiation of these two cell lines are different. Initially, the U937  
cells have monoblast-like characteristics and are in suspension (Koren et al., 1979), but upon 
treatment with PMA, they differentiate into morphologically mature adherent macrophage-like 
cells (Nilsson et al., 1980). The J774A.1 cell line has been described as an adherent 
macrophage-like cell line that does not require any differentiation with PMA to adhere and 
phagocytose (Ralph et al., 1975). The presence of peroxidase activity in the J774A.1 cell line 
(section 2.4.1) and not in the PMA-differentiated U937 cell line could indicate that the J774A.1 
cells are not as mature as the PMA-differentiated U937 cells. The PBMC are isolated from 
human buffy coats by centrifugation over a layer of Histopaque®-1077 and adherence to glass 
coverslips (Roos and de Boer, 1986). It has been observed that the purity of the 
monocytes/macrophages prepared in this manner is not very high (Brodersen et al., 1973; 
Koller et al., 1973). Hence, the PBMC are possibly a mixed population of monocytes and 
macrophages at different maturation stages, although the results of the PBMC are not 
intermediate between those of the U937 and J774A.1 cells. It has recently been demonstrated 
that the phagocytosis of β-haematin requires cholesterol-rich lipid domains in surface lipid rafts 
(Tiemi Shio et al., 2009). Each cell type may have different membrane compositions which 
could also contribute to the differences between the cell lines. Furthermore, it is not known how 
the antimalarial drugs affect the lipid raft compositions of the membranes. In addition, β-
haematin has been shown to have different effects on different cell types depending on the cell 
line’s susceptibility to lipid peroxidation induced by β-haematin (Omodeo-Sale et al., 1998; 
Taramelli et al., 2000).         
  
Further investigations could be done to determine which cell line (J774A.1 or U937) most 
closely resembles the PBMC in terms of differentiation status. The number of Fc (FcR1, FcRII), 
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C3b and mannose-fucose receptor sites present on the cell surfaces could be measured using 
flow cytometry as the number of Fc and C3b receptors increases with the maturity of the 
macrophage, while the mannose-fucose receptor sites decrease (Papadimitriou and Ashman, 
1989). Furthermore, secretion of lysosomes and neutral proteases (elastase, collagenase and 
plasminogen activator) into the supernatant could be measured by ELISA (Calbiochem, 
U.S.A.), reverse-phase high performance liquid chromatography or radioimmunoassay as the 
secretion of these enzymes is enhanced with macrophage maturity. In addition, phagocytosis is 
enhanced with increased macrophage differentiation and could be measured by flow cytometry 
using fluorescent-labelled latex beads (Papadimitriou and Ashman, 1989).     
 
It would have been preferable to determine if compounds resulting in more than 15% activation 
or inhibition had dose-dependent effects, if any. On reflection, positive and negative controls for 
the process of phagocytosis should have also been included in the experiments, whereby 
phagocytosis could be induced by treatment with lipopolysaccharide (Bohmer et al., 1992; 
Engels et al., 1985) or interferon-γ (Marodi et al., 1993; Shalaby et al., 1985; Wirth et al., 1985) 
and inhibited by treatment with cytochalasin B (Malawista et al., 1971; Painter et al., 1981). 
Further considerations are the effects of the antimalarial drugs on the cell viability, growth rate 
and cell adhesion of the monocytes after treatment with antimalarial drugs for 18 hours. This is 
especially pertinent to the OD 400 spectrophotometric assay where the number of viable cells 
is unknown (only viable cells were counted under the microscope in the counting assay). Thus 
it would have been preferable to correct the total haeme observed in the lysates to the number 
of viable cells in each group. 
 
Phagocytosis of P. falciparum infected red blood cells by monocytes and macrophages is the 
first line of defence against the malaria parasite (Abdalla, 1990). However, immunosuppression 
caused by the parasite and its products, such as haemozoin, contributes towards the 
pathogenesis of the disease (Miller et al., 2002). In this scenario, malaria patients are treated 
with antimalarial drugs to eradicate the parasite. If the drugs inhibit/depress monocyte 
phagocytosis, this will contribute to the immunosuppression already observed in the disease. 
However, activation of phagocytosis will promote the phagocytosis of parasite-infected red 
blood cells as well as erythrophagocytosis, the phagocytosis of complement activated non-
infected red blood cells (Goka et al., 2001), which would contribute towards anaemia, a 
symptom often associated with malaria. This study showed that only quinine inhibited the 
monocyte phagocytosis of latex beads by more than 10%. However, quinine activated β-
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haematin phagocytosis in monocytes which clearly demonstrates differences between the 
uptake mechanisms of latex beads and β-haematin. Hence, the effects of antimalarial drugs on 
phagocytosis, and thus immunosuppression, would depend to a large degree on what was 
being phagocytosed. Haemozoin, or β-haematin, is known to have inhibitory as well as 
stimulatory effects on the functions of monocytes (Schwarzer et al., 2008). Haemozoin 
phagocytosed by macrophages prevents repeat phagocytosis and respiratory burst upon 
appropriate stimulation (Schwarzer et al., 1992), and thus prevents the killing of  bacteria, fungi 
and tumour cells (Fiori et al., 1993). Moreover, in haemozoin-containing monocytes, the 
expression of MHC Class II and ICAM-1 in response to interferon-γ was impaired, thus linking 
haemozoin to disturbances in antigen presentation and immunosuppression (Schwarzer et al., 
1998). Thus, although the immunomodulatory effects of antimalarial drugs on monocyte 
phagocytosis appear to be mild (10-20%) in a healthy individual, in a malaria patient, these 
immunomodulatory effects could contribute to controlling the malaria infection by increasing 
monocyte phagocytosis of infected red blood cells.        
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Chapter 3 
Effect of antimalarial drugs, haemozoin ( β-haematin), Plasmodium 
falciparum-infected red blood cell lysates on neopterin produ ction 
and GTP-cyclohydrolase 1 mRNA expression in U937 ce lls 
 
B.M. Cumming  
Abstract 
Neopterin, a marker of cell-mediated immune response, is secreted from interferon-γ activated 
human macrophages. In the biosynthesis of neopterin, GTP-cyclohydrolase 1 catalyses the 
conversion of guanosine triphosphate to 7,8-dihydroneopterin triphosphate, which is 
dephosphorylated and oxidised to form neopterin. Elevated levels of neopterin have been 
detected in the urine and serum of malaria-infected patients and were associated with severe 
anaemia, respiratory distress, peak temperatures, fever- and parasite-clearance times. 
Plasmodium falciparum-infected red blood cell lysates have been reported to increase 
neopterin secretion from monocytic U937 cells in vitro. In this study, U937 cells were treated 
with seven antimalarial drugs, amodiaquine, artemisinin, chloroquine, doxycycline, primaquine, 
pyrimethamine and quinine, β-haematin (synthetic equivalent of haemozoin), latex beads, non-
infected- and P. falciparum-infected-red blood cell lysates. Chicken antibodies were raised 
against neopterin-rabbit albumin conjugates to detect neopterin in the U937 supernatants. 
Although anti-neopterin antibodies detected neopterin-ovalbumin conjugates and neopterin 
added to glutaraldehyde-coated wells in indirect ELISAs, it did not bind to free neopterin in the 
competitive ELISA. Thus neopterin levels in the U937 supernatants could not be investigated. 
GTP-cyclohydrolase 1 mRNA expression in U937 cells was therefore monitored using 
quantitative PCR. Artemisinin, primaquine and quinine down-regulated interferon-γ-induced 
GTP-cyclohydrolase 1 mRNA expression in U937 cells by 1.2-, 1.3- and 1.7-fold, respectively. 
The remaining drugs had relatively insignificant effects on GTP-cyclohydrolase 1 mRNA 
expression. β-haematin up-regulated the mRNA expression by 1.2-fold, whereas P. falciparum-
infected red blood cell lysate down-regulated the interferon-γ-induced GTP-cyclohydrolase 1 
mRNA expression by 1.6-fold. This suggests that artemisinin, primaquine, quinine and parasite 
lysate reduce the responsiveness of the macrophage to interferon-γ. It would have been 
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preferable to measure neopterin levels secreted by the U937 cells for a comparison to the 
effects observed on GTP-cyclohydrolase 1 mRNA expression. 
 
3.1 Introduction 
Neopterin is biosynthetically derived from guanosine triphosphate (GTP) (Murr et al., 2002) by 
GTP-cyclohydrolase 1, which catalyzes the cleavage of the purine to produce 7,8-
dihydronoepterin triphosphate (Werner et al., 1990). In most cells, like fibroblasts and 
endothelial cells, 7,8-dihydroneopterin is used to synthesize 5,6,7,8-tetrahydrobiopterin which is 
an essential cofactor for mono-oxygenases and inducible nitric oxide synthases (Gorren and 
Mayer, 2002). However, due to the lower levels of 6-pyruvoyltetrahydropterin synthase in 
primate and human monocytes and macrophages, activation of GTP-cyclohydrolase 1 results in 
an accumulation of 7,8-dihydroneopterin triphosphate which is converted by intracellular 
phosphatases into 7,8-dihydroneopterin (Schoedon et al., 1987). 7,8-Dihydroneopterin diffuses 
out of the activated macrophage into the intracellular spaces and finally into the plasma. The 
main reaction generating neopterin from 7,8-dihydroneopterin is oxidation by hypochlorous acid 
(HOCl) (Widner et al., 2000) which is released from neutrophils and macrophages during 
inflammation (Chisolm et al., 1999; Schraufstatter et al., 1990). The neopterin:7,8-
dihydroneopterin ratio of 1:2 is nearly constant in urine, serum or cerebrospinal fluid, whereas 
higher neopterin:7,8-dihydroneopterin ratios are found in arterial blood in comparison to venous 
blood (Weiss et al., 1992b).        
 
Neopterin derivatives are produced by human monocyte-derived macrophages (Huber et al., 
1984) and dendritic cells (Wirleitner et al., 2002) when stimulated with the cytokine, interferon-
gamma (IFN-γ), that is released from activated T helper (Th) cells subtype 1 (Romagnani, 
1991). As these cells promote an immune response mediated by cytotoxic T cells, increased 
production of neopterin in body fluids can be used to monitor cell-mediated immunity (Wachter 
et al., 1989). Neopterin can be easily measured in plasma, urine and cerebrospinal fluid by high 
performance liquid chromatography because of its high fluorescence (Rippin, 1992; Werner et 
al., 1987a; Werner et al., 1987b). However, many clinical laboratories also use immuno-based 
methods such as enzyme-linked immunosorbent assay (ELISA) to measure neopterin 
(Westermann et al., 2000). The levels of neopterin in body fluids are elevated in infections such 
as malaria (Awandare et al., 2006a; Reibnegger et al., 1984), human immunodeficiency virus 
infection (Baier-Bitterlich et al., 1996b; Fuchs et al., 1988) and tuberculosis (Fuchs et al., 
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1984b; Yuksekol et al., 2003), malignancies (Fuchs et al., 1984a; Reibnegger et al., 1991), 
autoimmune diseases (Leohirun et al., 1991; Reibnegger et al., 1986; Schroecksnadel et al., 
2003), allograft rejection (Margreiter et al., 1983; Reibnegger et al., 1991), cardiac and renal 
failure (Roccatello et al., 1992), coronary artery disease (Schumacher et al., 1992; Tatzber et 
al., 1991) and myocardial infarction (Schumacher et al., 1997). Neopterin measurements not 
only provide insight into the cell mediated immune response but also allow monitoring and 
prognosis of disease progression.  
 
The role of 7,8-dihydroneopterin and neopterin during the inflammatory process remains poorly 
understood and controversial. Neopterin acts as a pro-oxidant, enhancing oxidant damage 
(Murr et al., 1994; Wede et al., 1999; Weiss et al., 1993) and triggering apoptosis in a number 
of different cell types (Baier-Bitterlich et al., 1995; Hoffmann et al., 1998; Schobersberger et al., 
1996). In contrast, 7,8-dihydroneopterin acts as an antioxidant at low concentrations. It reacts 
with and neutralizes a range of reactive oxygen species including hypochlorite, nitric oxide and 
peroxyl radicals, thus protecting lipoproteins and various cell types including macrophages and 
red blood cells (Baird et al., 2005; Firth et al., 2008; Gieseg and Cato, 2003; Gieseg et al., 
2001a; Gieseg et al., 1995; Gieseg et al., 2001b). 7,8-Dihydroneopterin inhibited direct 
oxidation of plasma membranes of U937 cells by ferrous ions (Gieseg et al., 2001b). Thus, it 
has been suggested that IFN-γ-stimulated macrophages synthesize 7,8-dihydroneopterin to 
protect these antigen presenting cells from the oxidants encountered within an inflammatory 
site (Duggan et al., 2002; Gieseg et al., 1995; Kojima et al., 1992). However, there are 
instances where high concentrations of 7,8-dihydroneopterin have pro-oxidant properties  
(Baier-Bitterlich et al., 1996a; Baier-Bitterlich et al., 1995; Enzinger et al., 2002b; Speth et al., 
2000; Spottl et al., 2000; Wirleitner et al., 1998; Wirleitner et al., 2001).  
 
Neopterin and its derivatives have also been reported to play a role in cell signalling. Neopterin 
and 7,8-dihydroneopterin were found to increase intracellular calcium concentrations (Hoffmann 
et al., 2002; Woll et al., 1993), activate redox-sensitive transcription factor nuclear factor-κB 
(Baier-Bitterlich et al., 1997), inhibit hypoxia-induced erythropoietin gene expression (Pagel et 
al., 1999; Schobersberger et al., 1995b), stimulate nitric oxide synthase gene expression 
(Schobersberger et al., 1995a), and together with cyclic-GMP, induce redox-sensitive proto-
oncogene c-fos (Uberall et al., 1994).  
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Elevated levels of neopterin have been detected in urine (Reibnegger et al., 1984) and plasma 
(Kremsner et al., 1989; Ringwald et al., 1991) of malaria patients infected with Plasmodium 
falciparum. When 71 Thai patients with acute, uncomplicated falciparum malaria were treated 
with quinine and tetracycline for 7 days, the neopterin levels in urine peaked on days 3-5 
following the start of treatment before decreasing towards the normal range on days 6-8 (Brown 
et al., 1990). Similar trends were observed in other studies (Kremsner et al., 1996; Ringwald et 
al., 1991). Higher concentrations of neopterin as well as IFN-γ were found more frequently in 
patients infected with malaria for the first time than experienced patients (Brown et al., 1990; 
Ringwald et al., 1991) which suggested that repeated malaria infection and antigen exposure 
results in a progressive suppression of the T-cell-macrophage interaction mediated by IFN-γ. 
During seven days of quinine antimalarial therapy, serum neopterin levels remained elevated in 
children who were still found to have persisting anaemia one month after completing treatment; 
but the neopterin levels declined significantly in the children who had normal haemoglobin 
levels a month after completing treatment (Biemba et al., 1998). The elevated neopterin levels 
suggested the persistence of the Th-1 mediated immune response and associated macrophage 
activation may be involved in the pathogenesis of the lingering anaemia after the treatment of 
malaria. Children with severe P. falciparum malaria with respiratory distress, which is a 
symptom of underlying acidosis, had significantly higher levels of neopterin than those malaria- 
infected children without respiratory distress (Awandare et al., 2006a). These observations 
show that monitoring the neopterin levels of a patient during treatment of malaria with 
antimalarial drugs cannot be used to give an indication if the antimalarial drugs themselves 
have any effect on macrophage activation and neopterin production. 
 
Lysates of P. falciparum-infected erythrocytes were found to stimulate neopterin secretion from 
U937 cells after 48 hours co-incubation (Facer, 1995) and this secretion was enhanced by IFN-
γ. Several P. falciparum antigens also activated U937 cells to secrete neopterin and produced a 
similar response when cultured with peripheral blood mononuclear cells for 7 days (Facer, 
1995). The malarial pigment, haemozoin, has been shown to have both stimulatory and 
inhibitory effects on the functions of monocytes and macrophages (Schwarzer et al., 2008), 
however, the effect of β-haematin, the synthetic equivalent of haemozoin, on neopterin 
secretion is unknown. In this study, the effects of seven antimalarial drugs (amodiaquine, 
artemisinin, chloroquine, doxycycline, primaquine, pyrimethamine and quinine), β-haematin, 
latex beads, non-infected- and P. falciparum-infected-red blood cell lysates on the IFN-γ-
induced expression of GTP-cyclohydrolase 1 mRNA were investigated in the human monocytic 
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cell line, U937. Antibodies were raised against neopterin in chickens and used in the 
development of a competitive ELISA to detect neopterin in the supernatants of treated U937 
cells. Total RNA was isolated from the treated U937 cells and the expression of GTP-
cyclohydrolase 1 mRNA was analysed using quantitative RT-PCR and the TC∆∆−2 method.        
 
3.2 Materials and Methods 
3.2.1 Materials 
Common chemicals and buffers were purchased from Saarchem (South Africa) and Sigma-
Aldrich (Germany). Neopterin, rabbit albumin, ovalbumin, sodium borohydride, Freund’s 
complete and incomplete adjuvants, RPMI-1640, Hank’s Balanced Salt Solution (HBSS), 
penicillin-streptomycin, L-glutamine, phorbol-12-myristate-13-acetate, chloroquine diphosphate, 
quinine hydrochloride, pyrimethamine, primaquine diphosphate, artemisinin, doxycycline 
hydrochloride, amodiaquine dihydrochloride dihydrate, latex beads (10% w/v, 0.8 µm), 
interferon-γ, guanidine isothiocyanate, N-lauroylsarcosine, 2-mercaptoethanol were purchased 
from Sigma-Aldrich (Germany). Glutaraldehyde (25% v/v) and sodium cyanoborohydride was 
obtained from Fluka (Germany). Polyethylene glycol (6000), Tween 20, propan-2-ol, absolute 
ethanol, chloroform, phenol, isoamylalcohol were purchased from Merck (Germany). Rabbit 
anti-chicken IgY was obtained from Jackson Immunoresearch Laboratories Inc. (U.S.A.). 
Bovine serum albumin and 2,2’-azino-di-(3-ethylbenzthiozoline-6-sulfonic acid) (ABTS) were 
purchased from Roche Diagnostics (Germany). Formamide was purchased from Calbiochem 
(U.S.A.). Sodium citrate dehydrate was purchased from SAFC (U.S.A.). Foetal calf serum was 
obtained from Gibco, Invitrogen (U.S.A.). AminoLink® Coupling Gel was obtained from Pierce 
Biotechnology (U.S.A.). Polyprep columns were purchased from Bio-RAD (U.S.A.). Nunc-
Immuno™ Maxisorp ELISA plates were obtained from Nunc (Denmark). RNase-free filter tips 
and microcentrifuge tubes were obtained from Quality Scientific Plastics (U.S.A.). Nunc 
(Denmark) T-flasks (75 cm2 and 25 cm2), Delta (Spain) 15 ml, 50 ml tubes and Falcon (U.S.A.) 
35 x 10 mm Petri-dishes were used. VacuCap PF Bottle-top Filter devices were obtained from 
PALL Life Sciences (U.S.A.). Distilled water (dH2O) was produced by a Milli-Q Plus ultra pure 
water system (Millipore, U.S.A.). 
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3.2.2 Coupling of neopterin to albumin carriers   
Neopterin is light sensitive; hence all reactions with neopterin were performed in the dark. 
Neopterin contains a primary amine group, thus glutaraldehyde was used for coupling neopterin  
to protein carriers according to the method of Hermanson, (1996). Neopterin was coupled to 
rabbit albumin at a molar ratio of 40:1 for immunisation of chickens. The neopterin-carrier 
conjugate was aliquoted and stored at -20ºC. Neopterin was coupled to ovalbumin with 
glutaraldehyde at molar ratios of 40:1 or 200:1 for preparing affinity matrices to purify antibodies 
and to coat wells of microtitre plates for ELISAs. The conjugates were dialyzed against three 
changes of PBS, pH 7.2 and stored at -20ºC (Hermanson, 1996).  
  
3.2.3 Preparation of immunogen and immunisation of chickens 
Prior to immunisation, the neopterin-rabbit albumin conjugate was made up to 1 ml with PBS 
pH 7.2, and triturated with an equal volume of Freund’s complete adjuvant.  Two laying hens 
(Gallus gallus - Hi-line Browns) were immunised with 500 µg neopterin intramuscularly at two 
sites (Polson et al., 1980a; Schwarzkopf et al., 2001). Booster injection immunogen were 
emulsified in Freund’s incomplete adjuvant and given at weeks 2, 4, 6. Eggs were collected 
throughout the immunisation schedule until week 12 and stored at 4ºC. 
 
3.2.4 Isolation of Immunoglobulin Y (IgY) from egg yolks 
Chicken antibodies, IgY, were isolated from egg yolks using polyethylene glycol (PEG) 
precipitation, according to Polson’s method (Polson et al., 1985; Polson et al., 1980a). The 
concentration of IgY was determined by measuring the absorbance of a 1:50 dilution and using 
the extinction co-efficient of IgY, 1.25 (mg/ml)-1(Goldring and Coetzer, 2003).  
  
3.2.5 Monitoring the titre of antibody production i n chickens with an ELISA   
Wells of a Nunc-Immuno™ microtitre plate were coated with 150 µl of 1 µg/ml rabbit albumin in 
50 mM NaHCO3, pH 6, or 150 µl of 6.25 µg/ml neopterin of a 40:1 neopterin-ovalbumin 
conjugate in PBS, pH 7.2, and incubated overnight at 4ºC. The wells were blocked with 200 µl 
0.5% (w/v) bovine serum albumin in PBS, pH 7.2, (BSA-PBS) for 1 h at 37ºC and then washed 
thee times with 0.1% (v/v) Tween 20  in PBS, pH 7.2 (Tween-PBS). Crude IgY dilutions, 100, 
10, 1 and 0.1 µg/ml in 0.5% BSA-PBS, were incubated in the wells (100 µl) for 2 h at 37ºC. 
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Wells were washed three times with 0.1% Tween-PBS. Secondary antibody, rabbit anti-chicken 
IgY-horseradish peroxidase, diluted 1:10 000 in 0.5% BSA-PBS, was added (120 µl) and 
incubated for 1 h at 37ºC. The wells were washed three times in 0.1% Tween-PBS. Substrate 
solution containing 0.05% (w/v) 2,2’-azino-di-(3-ethylbenzthiozoline-6-sulfonic acid) (ABTS) and 
0.0015% (v/v) H2O2 in 0.15 M citrate phosphate buffer, pH 5.0, was added (150 µl) and the 
colour was allowed to develop for 30 min in the dark at RT. The A405 of each well was measured 
with a Versamax microplate reader using SOFTmax® software from Molecular Devices 
(U.S.A.).                     
 
3.2.6 Preparation of affinity matrices  
Affinity matrices were prepared with neopterin alone or with neopterin conjugated to ovalbumin 
at a molar ratio of 40:1 or 200:1 using the protocol for the AminoLink® Coupling Gel from Pierce 
Biotechnology (U.S.A.). The resin was stored in 100 mM sodium phosphate buffer, pH 7.6, 
0.1% NaN3 at 4ºC.      
 
3.2.7 Affinity purification of IgY 
IgY isolated from weeks 4-7 eggs from chicken 1 were pooled and filtered (Whatman no.1). The 
affinity matrices (Section 3.2.6) were equilibrated with 100 mM sodium phosphate buffer, pH 
7.6, 0.1% NaN3, and the IgY pool cycled over the affinity matrix overnight in the reverse 
direction. The column was washed with 12 column volumes of phosphate buffer and eluted with 
100 mM glycine, 0.02% (w/v) NaN3, pH 2.8. Fractions (900 µl) were collected in microcentrifuge 
tubes containing 100 µl of neutralisation buffer (1 M NaH2PO4, 0.02% NaN3, pH 8.5) and the 
elution monitored by measuring the absorbance of each fraction at 280 nm. The fractions with 
absorbance readings > 0.1 were pooled, NaN3 was added to a final concentration of 0.1% (w/v) 
and the antibodies were stored at 4ºC. The affinity columns were washed with 12 volumes of 
100 mM sodium phosphate buffer, pH 7.6, 0.1% NaN3 prior to storage at 4ºC. 
 
3.2.8 Development of a competitive ELISA to detect neopterin secretion in the 
supernatants of U937 cells  
(A) Neopterin-ovalbumin conjugates coupled at ratios of 40:1 and 200:1 were compared as 
well-coatings in an indirect ELISA. Wells of a Nunc-Immuno™ ELISA plate were coated with 
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150 µl of either neat neopterin-ovalbumin conjugate coupled at a ratio of 40:1 or conjugate 
coupled at a ratio of 200:1, and incubated overnight at 4ºC. The ELISA was performed as 
described in section 3.2.5 using crude IgY (100 µg/ml) from week 0 (non-immune) and week 8 
(immune), and affinity purified IgY (25 µg/ml). 
 
(B) An indirect ELISA was performed to determine the optimal coating concentration of the 
neopterin-ovalbumin conjugate coupled at a molar ratio of 200:1. Wells were coated with 150 µl 
of doubling dilutions (1048 to 8.2 ng/ml neopterin) of the neopterin-ovalbumin conjugate (200:1) 
in PBS, pH 7.2 and incubated overnight at 4ºC. The ELISA then proceeded as described in 
section 3.2.5 using crude IgY (100 µg/ml) from week 0 (non-immune) and week 8 (immune) 
from chicken 1 and chicken 2.  
 
(C) Several parameters were varied in a competitive ELISA in an attempt to detect anti-
neopterin IgY. Wells were coated with 150 µl of 1:2 dilution of the neopterin-ovalbumin 
conjugate (200:1) (equivalent to 524.5 ng/ml neopterin) in 50 mM NaHCO3, pH 6, or PBS (pH 
7.2) overnight at 4ºC. Varying concentrations of free neopterin in solution (37.5 µg/ml to 21 
pg/ml) were incubated with varying concentrations of affinity purified anti-neopterin IgY (0.1, 1 
or 10 µg/ml) diluted in 0.5% BSA-PBS, in microcentrifuge tubes for 1 hour at RT in the dark. 
During this incubation, the wells of the Nunc-Immuno™ ELISA plate were blocked as described 
in section 3.2.5. After the wells were washed, 100 µl of the neopterin-IgY solutions were added 
and incubated for 1 h at 37ºC. The wells were washed and the bound IgY was detected as 
described in 3.2.5. Variations in the coating concentrations of the neopterin-ovalbumin 
conjugate (doubling-dilutions from 524 to 16.375 ng/ml) were also investigated in a competitive 
ELISA with two concentrations of crude immune IgY (100 and 10 µg/ml). 
 
 (D) In order to determine the cross-reactivity of the anti-neopterin antibodies with rabbit 
albumin, ovalbumin, bovine ovalbumin and neopterin in an indirect ELISA, wells were coated 
with 150 µl of 1 µg/ml rabbit albumin, ovalbumin or bovine albumin, or 50 µg/ml neopterin in 
PBS, pH 7.2. Gelatin (0.1%, w/v) melted in PBS, pH 7.2 (gelatin-PBS), was used to replace 
0.5% (w/v) BSA-PBS to block the wells coated with bovine albumin and dilute the antibodies 
added to these wells. Non-immune (week 0) and immune (week 8) crude IgY (100 µg/ml) were 
used as primary antibodies in the ELISA as described in section 3.2.5.  
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(E) An alternative method of coating the wells was explored where the wells were activated with 
150 µl 0.2% (v/v) glutaraldehyde for 2 h at 4ºC and coated with 150 µl of 3-fold dilutions of 
neopterin (50, 16.7, 5.55, 1.85 and 0.617 µg/ml) in PBS, pH 7.2, overnight at 4ºC to determine 
the optimal coating concentration of neopterin in an indirect ELISA. The wells were blocked with 
0.1% gelatin-PBS. Various concentrations of week 8 crude IgY (100, 50, 25, 10, 5, 2.5 µg/ml) 
and the affinity purified antibodies (1 and 0.5 µg/ml) prepared in 0.1% gelatin-PBS were added 
(100 µl) and incubated for 2 h at 37ºC. The bound primary antibody was detected as described 
(section 3.2.5). 
          
(F) In the competitive ELISA, after activation with 0.2% glutaraldehyde for 2 h at 4ºC, the wells 
were coated with 150 µl of 16.7 µg/ml neopterin in PBS, pH 7.2, overnight at 4ºC. The 
competitive ELISA proceeded as described above in (C) except various concentrations of crude 
IgY only (100, 50, 25 µg/ml) in 0.1% gelatin-PBS were incubated with 10-fold dilutions of free 
neopterin (28.11, 9.37, 3.12, 1.04, 0.35, 0.12 ng/ml) for 1 h in glass tubes at RT prior to their 
addition to the glutaraldehyde-activated wells coated with neopterin.         
 
3.2.9 Culturing of the U937 cell line 
The human monocyte-like U937 cell line (Fischer et al., 1980; Koren et al., 1979; Ralph et al., 
1976; Sundstrom and Nilsson, 1976) was obtained from the European Collection of Cell 
Cultures (ECACC, Salisbury, U.K.). It was cultured in complete RPMI-1640 medium 
supplemented with 10% FCS (NOT heat-inactivated), 4 mM L-glutamine, 100 units/ml of 
penicillin and 100 µg/ml of streptomycin. This cell line was grown at 37ºC in a humidified 5% 
CO2 atmosphere and subcultured every 2-3 days. 
 
3.2.10 Synthesis and analysis of β-haematin 
β-haematin was prepared according to Egan et al., (1994). Briefly, haemin chloride (30 mg) was 
dissolved in 6.0 ml of 0.1 M NaOH and equilibrated at 60ºC. To this solution, 0.6 ml of 1.0 M 
HCl and 3.7 ml of 12.9 M sodium acetate (pH 5) pre-incubated at 60ºC were added and the 
mixture was stirred at 60ºC for 1 h. The crystals were filtered (8 µm cellulose acetate/nitrate 




The β-haematin crystals were mounted onto stubs covered with carbon tape and viewed under 
a Philips environmental scanning electron microscope (ESEM) with a large field detector and a 
gaseous secondary electron detector. X-Ray microanalysis of the crystals was performed on 
the ESEM at 2000x magnification, an accelerating voltage of 15 kV and a spot size of 4.5 for 
150 s under low vacuum.  
 
3.2.11 Treatment of U937 cells with interferon- γ (IFN-γ) and antimalarial drugs, β-
haematin, latex beads, P. falciparum-infected or non-infected red blood cell 
lysate  
U937 cells (3.5 x 105 cells/ml, 15ml) were differentiated by incubation with 10 ng/ml phorbol-12-
myristate-13-acetate (PMA) for 48 h (Goldring et al., 1992). The non-adherent cells and spent 
media were aspirated. Complete culture medium (15ml) containing 200 U/ml human 
recombinant interferon-gamma (IFN-γ) (Facer, 1995) and one of the following: (a) physiological 
therapeutic concentrations of seven antimalarial drugs separately, (b) β-haematin to a final 
concentration of 25 µg/ml, (c) latex beads to a final concentration of 0.1% (w/v),  (d) non-
infected red blood cell lysate, or (e) P. falciparum-infected red blood cell lysate (10% 
parasitaemia, kindly supplied by Professor Peter Smith from University of Cape Town) to final 
protein concentrations of 10 or 20 µg/ml, was added to the adherent cells and incubated for 18 
h at 37ºC in a humidified 5% CO2 atmosphere. The concentration of the antimalarial drugs 
were: amodiaquine, 75.6 ng/ml (White et al., 1987; Winstanley et al., 1987; Winstanley et al., 
1990); artemisinin, 400 ng/ml (Wernsdorfer, 1997); chloroquine, 200 ng/ml (Desjardins et al., 
1988); doxycycline, 3 µg/ml (Wernsdorfer, 1997); primaquine, 153 ng/ml (Desjardins et al., 
1988); pyrimethamine, 234 ng/ml; and quinine, 15 µg/ml (Wernsdorfer, 1997). The following 
controls were set up: cells treated with (a) PMA, IFN-γ and the concentrations of solvents used 
to solubilise the antimalarial drugs; (b) PMA, but not IFN-γ; and (c) neither PMA nor IFN-γ. 
Following treatment for 18 h, the supernatants were collected and stored at -70ºC for analysis 
of neopterin secretion by competitive ELISA. The cells were harvested by trypsin treatment 
(trypsin was diluted 10-fold in HBSS) for 5 min, pelleted, washed with HBSS and used for RNA 
isolation.      
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3.2.12 Isolation of Total RNA from U937 cells 
Total RNA was extracted from the U937 cells by the guanidinium isothiocyanate method 
(Chomczynski and Sacchi, 1987) according to Voss (2002).  Briefly, 1 ml of RNA extraction 
buffer containing 4 M guanidine isothiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% (w/v) N-
lauroylsarcosine and 0.1 M 2-mercaptoethanol, was added to the cell pellet and the cells were 
rapidly homogenized by pipetting to inactivate endogenous RNases. Sodium acetate (2 M, pH 
4.0, 1/10 volume) was added and mixed by inversion. Water-saturated phenol (1 volume) was 
added, mixed by inversion and a 1/3 volume of chloroform:isoamylalcohol (49:1) was added, 
mixed by inversion and  placed on ice for 5 min. The sample was centrifuged at 3 500 g for 30 
min at 4ºC. The aqueous supernatant was transferred to a RNase-free microcentrifuge tube 
containing 7/8 volume isopropanol and the RNA was left at -20ºC for 1 h. The RNA was 
pelleted at 15 000 g for 20 min at 4ºC, the supernatant was discarded and the RNA pellet air 
dried for 5 min (RT). The pellet was resuspended in 450 µl RNA extraction buffer, 1/10 volume 
of sodium acetate was added and mixed, followed by 1 volume of water-saturated phenol, 
mixing, 1/3 volume of chloroform:isoamylalcohol (49:1) and mixing. The sample was 
centrifuged at 15 000 g for 10 min at 4ºC. The aqueous supernatant was transferred to a 
RNase-free microcentrifuge tube and the RNA incubated with 7/8 volume of ice-cold 
isopropanol for 1 h at -20ºC. The RNA was pelleted by centrifugation at 15 000 g (20 min, 4ºC), 
washed once with 70% (v/v) ethanol and centrifuged again at 15 000 g (5 min, 4ºC). The 
ethanol wash was discarded and the RNA pellet was air dried for 5 min (RT) prior to dissolution 
in 30 µl of diethyl pyrocarbonate (DEPC)-treated ddH2O. 
  
The concentration of the RNA was determined from the absorbance at 260 nm. The integrity of 
the RNA was evaluated using a 25% Tris-EDTA, 75% formamide gel loading buffer (Voss, 
2002) at a ratio of 1:4 on a 1.2% (w/v) agarose gel for 1 h at 80 V in the presence of ethidium 
bromide.  
 
3.2.13 Analysis of the relative expression of GTP-c yclohydrolase 1 mRNA 
transcripts using quantitative RT-PCR  
Two sets of specific exon-spanning primers were designed for human GTP cyclohydrolase 1 
(GTP-CH1) (accession number NM_000161) using Primer 3 software (Rozen and Skaletsky, 
2000). Refer to Table 3.1. These primers and primers for β-actin and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were synthesized at the MCB Synthetic DNA unit, 
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University of Cape Town, South Africa. The β-actin and GAPDH house-keeping genes were 
used as the endogenous control genes. 
  
Table 3.1. Primers used for analysing relative expr ession of GTP-cyclohydrolase 1 using 
quantitative RT-PCR 
Primer Name Direction Sequence 
Target 
Size (bp) Source 
GTP-CH1A Forward 5’-AGCAAACTTGCGAGGATTGT-3’b 207 Primer 3a 
GTP-CH1A Reverse 5’-GAACACACCCAACATTGTGC-3’c  Primer 3a 
GTP-CH1B Forward 5’-TCTTCACCAAGGGCTACCAG-3’d 247 Primer 3a 
GTP-CH1B Reverse 5’-GTAAGGCGCTCCTGAACTTG-3’e  Primer 3a 
β-actin  Forward 5’-GCGGGAAATCGTGCGTGACATT-3’f 232 
Epicentre Biotechnologies 
(U.S.A.)  
β-actin Reverse 5’-GATGGAGTTGAAGGTAGTTTCGTG-3’g  
Epicentre Biotechnologies 
(U.S.A.) 
GAPDH Forward 5’-GGTATCGTGGAAGGACTCATGAC-3’h 188 Wang et al. (2008) 
GAPDH Reverse 5’-ATGCCAGTGAGCTTCCCGTTCAGC-3’i  Wang et al. (2008) 
a) Primer 3 software was designed by Rozen and Skaletsky (2000) 
b) Primer spans exon 3 and 4 
c) Exon 6 
d) Exon 1 
e) Primer spans exon 4 and 5  
f) Exon 4 
g) Exon 5 
h) Exon 7 
i) Exon 8 
 
 
RNA treated with DNase (as per protocol from Fermentas, U.S.A.) was compared to untreated 
RNA as a template in the reverse-transcriptase reaction followed by quantitative PCR. The 
quantitative PCR was optimised by comparing the two primer sets designed for GTP-
cyclohydrolase 1 (GTP-CH1A and B) using β-actin as the endogenous control, and annealing 
temperatures of 55ºC and 60ºC. 
 
RNA (1 µg) was reverse transcribed to generate cDNA using 5 µM of random hexamers and 
the SensiMix™ Two-Step Kit (Quantace Ltd., U.K.) in a 20 µl reaction. One fiftieth of the 
resulting cDNA was used as a template for SYBR® Green I (Molecular Probes®, U.S.A.) 
quantitative PCR with the SensiMix™ Two-Step kit in the RotorGene 6000 Series real-time 
PCR cycler (Corbett Life Science Research, Australia). Each PCR reaction (10 µl) was set up in 
triplicate and contained cDNA template (1 µl of a 2.5 x dilution of the cDNA), 200 nM of the 
reverse and forward primers for one of the genes, 5 µl of SensiMix dT (reaction buffer, heat-
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inactivated Taq DNA polymerase, dNTPs and 6 mM MgCl2) and 0.2 µl of 50 x SYBR
® Green I 
solution. No-template controls were also set up. Quantitative PCR was carried out using the 
following thermal cycling parameters: 95ºC for 10 min to activate the enzyme, followed by 40 
cycles of three-step PCR (95ºC for 10 s, 60ºC for 15 s, 72ºC for 15 s). The fluorescence signal 
was acquired at the end of each elongation step.  
 
Data from the quantitative PCR were compared using the ∆∆CT method (Livak and Schmittgen, 
2001) where the cycle threshold (CT) value of the endogenous control gene (β-actin or 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)) was subtracted from the CT of the 
experimental gene (GTP-cyclohydrolase 1 (GTP-CH1)) for each sample. The change in CT 
(∆CT) for each experimental sample was then subtracted from the ∆CT of the unstimulated 
control sample. Change (n-fold) was expressed as TC∆∆−2 relative to results from unstimulated 
conditions (Livak and Schmittgen, 2001).  
 
For the TC∆∆−2 calculation to be valid, the amplification efficiencies of the target (GTP-CH1) and 
the reference genes (β-actin or GAPDH) must be approximately equal. To determine if the 
target and reference amplifications have the same PCR efficiencies, variation in ∆CT (CT, target - 
CT, reference) with template dilution is monitored. Dilutions of the cDNA (1, 2.5, 6.25, 10, 25, 62.5 
and 100 x) were used as templates in quantitative PCR set up in triplicate with the primers for 
the GTP-CH1, β-actin and GAPDH in separate tubes. The average CT values generated from 
the equivalent cDNA inputs (target versus reference) were used in the ∆CT calculation (CT, GTP-
CH1 - CT, β-actin OR GAPDH). The ∆CT values calculated for each cDNA dilution were plotted against 
the logarithm of the cDNA input and the dynamic range of the assay was ascertained by 
removing outlying dilutions (usually the highest and/or lowest dilution). Once the dilution points 
within the dynamic range were plotted and the data fitted using least-squares  linear regression 
analysis, absolute values of the resulting slope < 0.1 indicated that the TC∆∆−2  method could be 
used for relative quantification (Livak and Schmittgen, 2001).    
  
3.2.14 Statistical analysis 
Statistically significant differences were determined by the Mann-Whitney U (Wilcoxon Rank-
Sum) test using the GenStat Program, 9th Edition. Values of p<0.05 were considered 
statistically significant. All data are presented as the mean ± SD.     
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3.3 Results 
Chickens were immunised with neopterin conjugated to rabbit albumin (40:1) and boosted 
every second week on three occasions. Eggs were collected each week and IgY was isolated 
from the egg yolks (Polson et al., 1985; Polson et al., 1980b). The titre of the IgY production 
was measured by ELISA detecting anti-neopterin as well as anti-rabbit albumin antibodies in 
the crude IgY preparations. The crude IgY isolated from weeks 4 to 7 eggs from chicken no. 1 
were pooled and affinity purified. Using the crude and affinity purified IgY, several attempts 
were made to develop a competitive ELISA with microtitre plates coated with neopterin-
ovalbumin conjugates or neopterin added to glutaraldehyde-activated wells. U937 cells 
differentiated with phorbol-12-myristate-13-acetate were treated with interferon-γ and one of the 
following for 18 h: antimalarial drugs, β-haematin, latex beads, non-infected red blood cell 
lysate or P. falciparum-infected red blood cell lysate. The supernatants were collected for 
measuring neopterin secretion by competitive ELISA, and the cells were harvested for total 
RNA isolation to determine the relative expression of GTP-cyclohydrolase I mRNA transcripts 
by quantitative RT-PCR. GTP-cyclohydrolase I is an enzyme that catalyses the conversion of 
guanosine triphosphate to 7,8-dihydroneopterin triphosphate, which is then transformed to 
neopterin by phosphatases and oxidation (Hoffmann et al., 2003).  
 
3.3.1 Evaluation of chicken anti-rabbit albumin ant ibody and anti-neopterin 
antibody titres using ELISA 
Two chickens were injected with neopterin conjugated to rabbit albumin at a ratio of 40:1. The 
titres for antibodies against the rabbit albumin started to increase from week 4 and started to 
decrease at about week 10 (Figure 3.1A). The titres for the anti-neopterin antibodies increased 
from week 3 and started decreasing after week 9 (Figure 3.1B). The titre of the anti-carrier 
peaked at similar periods to that of anti-neopterin in both chickens, weeks 5-7 in chicken 1 and 































































Figure 3.1. Progress of anti-rabbit albumin and ant i-neopterin antibody production in 
chickens immunised with neopterin conjugated to rab bit albumin measured by ELISA.  
Two chickens were immunised with neopterin conjugated to rabbit albumin. Wells were coated 
with (A) rabbit albumin (B) neopterin-ovalbumin conjugate (40:1). Crude chicken IgY antibodies 
(100 µg/ml) isolated from the eggs of each week were incubated in the wells. Binding was 
visualised with horse-radish peroxidase (HRPO)-linked rabbit anti-chicken IgY and the 
ABTS/H2O2 detection system.  Each point is the mean absorbance at 405 nm of duplicate 
samples.    
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Figure 3.2. Elution profile of anti-neopterin antib odies from the neopterin-ovalbumin 
(40:1) affinity matrix.  Neopterin-ovalbumin conjugate (40:1) was coupled to the AminoLink® 
Coupling Gel. The isolated chicken antibodies (weeks 4-7, chicken 1) were circulated over the 
neopterin-ovalbumin affinity matrix overnight. The unbound antibodies were washed off the 
column and the bound antibodies were eluted using a low pH buffer (100 mM glycine, pH 2.8) 
applied at ↓. The absorbance of the eluted fractions was measured at 280 nm. The fractions 
with A280 values greater than 0.1 were stored at 4ºC.     
 
 
The anti-neopterin antibodies from weeks 4 to 7 of chicken 1 were pooled. When the pool was 
passed over the neopterin affinity matrix, no antibodies eluted from the column. When the pool 
was passed over the neopterin-ovalbumin conjugate (40:1) affinity matrix, anti-neopterin 
antibodies eluted from the affinity column with a total yield of 254.4 µg/ml (Figure 3.2). An 
ELISA (section 3.2.5) of the pooled crude IgY after it had passed through the affinity matrix 
showed that there were still anti-neopterin antibodies present in the crude IgY pool (data not 
shown). Hence, the pool was passed over the column another three times, producing yields of 
309, 256 and 187 µg anti-neopterin IgY, respectively. In each instance, an ELISA indicated that 
the week 4-7 pool of crude IgY still contained anti-neopterin antibodies after being passed over 
the matrix. This suggested that the capacity of the affinity matrix coupled to the neopterin-
ovalbumin conjugate (40:1) to bind anti-neopterin antibodies was limited. In an attempt to 
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increase the capacity of the affinity matrix, a neopterin-ovalbumin conjugate with a 200:1 molar 
ratio was coupled to the AminoLink® coupling gel, but when the pool of week 4-7 crude IgY of 
chicken 1 was passed over this matrix, no antibodies eluted from the column. 
 
3.3.3 Development of a competitive ELISA to measure  the neopterin secreted 
into the supernatants of the U937 cells 
Neopterin-ovalbumin conjugates were prepared at molar ratios of 40:1 and 200:1. To compare 
the conjugates prepared at different molar ratios, wells of a microtitre plate were coated with the 
neopterin-ovalbumin conjugates for an indirect ELISA using both crude and affinity purified IgY 
as described in section 3.2.5. Ratios of the immune (week 8) A405 values over the non-immune 
(week 0) A405 values in Figure 3.3A shows that the 200:1 conjugate distinguished the immune 
IgY from the non-immune IgY to a greater degree than the 40:1 conjugate (Ratios of 4.1 and 
3.3, respectively). Figure 3.3B demonstrates that the 200:1 neopterin-ovalbumin conjugate 
resulted in a better detection of the affinity purified antibodies.  
 
An indirect ELISA was performed to ascertain the optimal coating concentration of the 
neopterin-ovalbumin conjugate (200:1) to detect anti-neopterin IgY. The immune IgY (Week 8) 
resulted in A405 values 2 to 3-fold higher than the non-immune IgY A405 values, up to a 16-fold 
dilution of the neopterin-ovalbumin conjugate (200:1), although the immune IgY from chicken 2 
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Figure 3.3. Comparison of neopterin-ovalbumin conju gates coupled at molar ratios of 
40:1 and 200:1 as coatings in an indirect ELISA to detect anti-neopterin IgY. Wells were 
coated with neat neopterin-ovalbumin conjugates prepared at ratios of 200:1 and 40:1. (A) Non-
immune (Week 0) and immune (Week 8) crude IgY and (B) affinity purified antibodies were 
incubated in the wells and bound antibody was detected by rabbit anti-chicken IgY HRPO-
linked secondary antibody followed by the addition of the substrate ABTS/H2O2. Absorbances 
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Figure 3.4. ELISA to determine the appropriate coat ing concentration of the neopterin-
ovalbumin conjugate (200:1) to detect anti-neopteri n IgY.  Wells were coated with doubling 
dilutions of the neopterin-ovalbumin conjugate. Crude IgY antibodies isolated from week 0 
(non-immune) and week 8 (immune) were incubated in the wells and bound antibody was 
detected by rabbit anti-chicken IgY HRPO-linked secondary antibody and the substrate 
ABTS/H2O2. Absorbances at 405 nm were the mean of duplicate experiments. 
 
 
A competitive ELISA was used to set up a neopterin standard curve to measure the neopterin 
in the supernatants of U937 cells. Various concentrations of affinity purified antibody were 
incubated with 5-fold dilutions of free neopterin for 1 h in microcentrifuge tubes prior to their 
addition to wells coated with the neopterin-ovalbumin conjugate (200:1). Figure 3.5 is a 
representation of one of the ELISAs performed with the free neopterin concentration range of 
37500-60 ng/ml; lower free neopterin concentrations were investigated in competitive ELISAs, 
but results similar to those in Figure 3.5 were obtained. For each antibody concentration, 
almost constant A405 values (~0.55, ~0.45 or ~0.23) were obtained at all the free neopterin 
concentrations investigated. The only difference was a reduction in the constant A405 value with 
a decrease in the concentration of the affinity purified antibodies incubated with the free 
neopterin. This suggests that the affinity purified anti-neopterin antibodies were not binding to 
the free neopterin prior to being incubated in the wells coated with the neopterin-ovalbumin 
conjugate. The buffer used to dilute the neopterin-ovalbumin conjugate to coat the wells was 
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changed from a carbonate buffer (50 mM NaHCO3, pH 6) to PBS, pH 7.2, but PBS, pH 7.2 
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Figure 3.5. Competitive ELISA: Standard curve for n eopterin using neopterin-
ovalbumin conjugate (200:1) coated wells and varyin g concentrations of affinity purified 
anti-neopterin IgY.  Wells were coated with a 1:2 dilution of the neopterin-ovalbumin conjugate.  
Dilutions of the affinity purified antibodies (10, 1, 0.1 µg/ml) were incubated with 5-fold dilutions 
of free neopterin for 1 h in microcentrifuge tubes. The neopterin-antibody combinations were 
then incubated in the wells for 1 h and antibody that bound to the well was detected using 
HRPO-linked rabbit anti-chicken IgY and ABTS/H2O2 as a substrate. Each point is the mean 
absorbance at 405 nm of duplicate experiments.   
 
 
Variations in the coating concentrations of the 200:1 neopterin-ovalbumin conjugate from 524 to 
16.375 ng/ml neopterin were investigated in the competitive ELISA. Two concentrations (100 
and 10 µg/ml) of crude anti-neopterin IgY (chicken 1, week 8) were incubated with 10-fold 
dilutions of free neopterin (37.5 µg/ml to 37.5 ng/ml) in microcentrifuge tubes for 1 h prior to 
their addition to the neopterin-ovalbumin coated wells. However, no increase in the A405 values 
with decreasing free neopterin concentrations were observed at any of coating concentrations 
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Figure 3.6. Competitive ELISA: Standard curve for n eopterin using varying 
concentrations of neopterin-ovalbumin conjugate (20 0:1) to coat the wells and crude 
anti-neopterin IgY (week 8).  Wells were coated with 2-fold dilutions (524 to 16.375 ng/ml) of 
the neopterin-ovalbumin conjugate. Dilutions of free neopterin (10-fold) were incubated with (A) 
10 µg/ml, and (B) 100 µg/ml crude anti-neopterin IgY for 1 h in microcentrifuge tubes. The 
neopterin-antibody combinations were then incubated in the wells for 1 h and antibody that 
bound to the well was detected using HRPO-linked rabbit anti-chicken IgY and ABTS/H2O2 as a 
substrate. Each point is the mean absorbance at 405 nm of duplicate experiments.  
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To investigate why the affinity purified and crude IgY did not bind to the free neopterin in 
solution in the competitive ELISA, but bound to the coated neopterin-ovalbumin conjugate with 
constant absorbance values, an indirect ELISA was performed to ascertain the anti-neopterin 
IgY’s cross reactivity with (a) ovalbumin, which is used as the carrier in the conjugates used to 
coat the wells, (b) bovine albumin, which is used to block the wells and dilute the antibodies in 
the ELISA, and (c) rabbit albumin, which is used as the carrier in the conjugates to immunise 
the chickens. In the same ELISA, an attempt was made to coat the wells with neopterin on its 
own.  
 
Figure 3.7 indicated that the immune anti-neopterin IgY (Week 8) recognised rabbit albumin 
which was expected as the rabbit albumin was used as the carrier to immunise the chickens. 
Furthermore, the immune IgY showed cross-reactivity with bovine albumin, but very little 
reactivity with the ovalbumin- and the neopterin-coated wells. It is uncertain if neopterin did coat 
the wells without a protein carrier, hence it is difficult to speculate whether or not the anti-
neopterin IgY is recognising neopterin. As the crude IgY cross-reacted with bovine albumin, 
BSA-PBS (0.5 %, w/v) was replaced with 0.1% (w/v) gelatin in PBS, pH 7.2, to block the wells 
and as a diluent for the antibodies. 
 
An alternative method of coating the wells of the Nunc-Immuno™ ELISA plate was 
investigated. The wells were activated with 0.2% (w/v) glutaraldehyde for 2 h prior to adding 
neopterin to coat the wells overnight. Initially, various concentrations of neopterin were 
investigated with various dilutions of both crude IgY (week 8) and affinity purified IgY in an 
indirect ELISA to determine the most appropriate antibody and coating concentrations for the 
competitive ELISA. Figure 3.8 demonstrates that antibody concentrations of crude IgY from 100 
to 25 µg/ml bound to the neopterin coating maximally at a concentration of 16.7 µg/ml neopterin 
with 100 µg/ml crude IgY resulting in the highest A405. The affinity purified antibodies did not 
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Figure 3.7. ELISA to determine reactivity of anti-n eopterin IgY with rabbit albumin, 
ovalbumin, bovine albumin and neopterin.  Wells were coated with rabbit albumin, ovalbumin, 
bovine albumin and neopterin. Crude IgY from week 8 (Immune) and week 0 (non-immune) were 
incubated in the wells and bound antibody was detected with HRPO-linked rabbit anti-chicken IgY and 
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Figure 3.8. ELISA to assay the most appropriate ant ibody concentration and coating 
concentration of neopterin in glutaraldehyde-activa ted wells to detect anti-neopterin IgY. 
Wells of a Nunc-Immuno™ ELISA plate were activated with 0.2% (v/v) glutaraldehyde and coated with 
three-fold dilutions of neopterin. Various concentrations of week 8 crude IgY (100 – 2.5 µg/ml) and 
affinity purified IgY (Aff 1.0 and 0.5 µg/ml) were incubated in the wells. Bound antibody was detected by 
HRPO-linked rabbit anti-chicken IgY and the substrate ABTS/H2O2. Absorbance values at 405 nm were 
the mean of duplicate experiments. 
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An attempt was made to set up a neopterin standard curve in a competitive ELISA using 
neopterin to coat glutaraldehyde-activated wells. Only crude IgY was used in this competitive 
ELISA as affinity purified antibodies did not bind to the glutaraldehyde-activated wells coated 
with neopterin that were blocked with 0.1% (w/v) gelatin-PBS (Figure 3.8). Once again, there 
was no decrease in the A405 values with an increase in the concentration of free neopterin 
(Figure 3.9). However, the A405 values were lower (0.21 to 0.26) than those observed in the 
competitive ELISA using the neopterin-ovalbumin conjugate to coat the wells in Figure 3.5 (0.55 
to 0.23). This could be due to the alternate method of blocking with 0.1% (w/v) gelatin-PBS in 
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Figure 3.9. Competitive ELISA: Standard curve for n eopterin using glutaraldehyde-
activated wells coated with neopterin. Dilutions of the crude IgY antibodies (100, 50, 25 
µg/ml) were incubated with three-fold dilutions of free neopterin for 1 h in glass tubes. Wells 
were activated with glutaraldehyde and coated with neopterin. The neopterin-antibody 
combinations were incubated in the wells for 1 h and antibody that bound to the well was 
detected using HRPO-linked rabbit anti-chicken IgY and ABTS/H2O2 as a substrate. Each point 




In summary, the anti-neopterin IgY produced in chickens immunised with a neopterin-rabbit 
albumin conjugate recognized neopterin-ovalbumin conjugates and neopterin added to 
glutaraldehyde-activated wells when they were used as coatings in an indirect ELISA. However, 
the antibodies did not titrate in a competitive ELISA.  
 
 3.3.4 Analysis of the relative expression of GTP-c yclohydrolase 1 mRNA 
transcripts using quantitative RT-PCR and the TC∆∆−2  method  
Quantitative PCR was optimised by comparing DNase-treated total RNA isolated from U937 
cells to untreated RNA, two primer sets (A and B) designed for GTP-cyclohydrolase 1 (GTP-
CH1), and annealing temperatures of 55ºC and 60ºC in the amplification of the cDNA. The PCR 
products obtained from the quantitative PCR performed at an annealing temperature of 55ºC 
were run on an agarose gel (Figure 3.10). Single bands were obtained for both GTP-
cyclohydrolase primer set A (lanes 12-15) and B (lanes 8-11). The sizes of the products of 
Primer set A and B were calculated to be 209 bp and 259 bp, respectively, which are 
comparable to the predicted sizes of 207 bp (Primer set A) and 247 bp (Primer set B). There 
appears to be a very light band above the main product of ~250 bp for the β-actin primers 
(lanes 4-7) but only one peak was observed in the melting profile of these quantitative PCR 
products. The size of the product for the β-actin primers was calculated to be 242 bp which is 
similar to the predicted size of 232 bp. There appears to be no difference between the RT-PCR 
products obtained from the DNase-treated or untreated RNA (Figure 3.10), hence untreated 
total RNA was used in the reverse transcription reactions. The quantification and melt profiles 
of the PCR products from the quantitative data indicate no significant difference between the 
annealing temperatures of 55ºC or 60 ºC (data not shown). Thus, the quantitative PCR were 
performed with annealing temperatures of 60ºC as a precautionary measure to prevent the 
formation of primer-dimers or non-specific binding of the primers to the template, which are 
more likely at lower annealing temperatures. Primer set A for GTP-cyclohydrolase 1 was used 








               
       
Figure 3.10. Agarose gel (1% w/v) of quantitative P CR products amplified from cDNA 
generated from U937 RNA, using primers for β-actin and GTP-cyclohydrolase 1 (Primer 
set A and B).  Using reverse transcriptase, cDNA was synthesized from total RNA isolated from 
U937 cells. RNA was either treated with DNase (Lanes 4, 5, 8, 9, 12 and 13) or not (Lanes 6, 7, 
10, 11, 14 and 15). cDNA was amplified using SYBR® Green quantitative PCR, an annealing 
temperature of 55ºC and primers for β-actin (Lanes 4, 5, 6 and 7), GTP-cyclohydrolase 1 primer 
set B (Lanes 8, 9, 10 and 11) and GTP-cyclohydrolase 1 primer set A (Lanes 12, 13, 14 and 
15). The quantitative PCR products were run on a 1% (w/v) agarose gel in the presence of 
ethidium bromide. Lane 1: Fermentas MassRuler™ DNA Ladder Mix (U.S.A.), Lane 2, no-
template control for GTP-cyclohydrolase 1 primer set B, lane 3: no-template control for β-actin. 
 
 
For the TC∆∆−2 method to be valid, the amplification efficiencies of the target (GTP 
cyclohydrolase 1 (GTP-CH1) and reference (β-actin or glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)) must be comparable. To determine if the efficiencies are equal, 
variation in ∆CT (CT, target - CT, reference) with template dilution was monitored. The ∆CT values were 
plotted versus the logarithm of the cDNA input, the dynamic range of the assay was 
ascertained and the data were fit using least-squares linear regression analysis. The absolute 
values of both slopes were less than 0.1 (Figure 3.11), indicating that the amplification 
efficiencies of the target, GTP-CH1, and references, β-actin or GAPDH, were similar, and the 









































Figure 3.11. Validation of the TC∆∆−2  method used to determine the relative expression 
of the target gene mRNA (GTP-cyclohydrolase 1) to t he expression of the internal control 
gene mRNA ( β-actin OR glyceraldehyde-3-phosphate dehydrogenase) . Using reverse 
transcriptase, cDNA was synthesized from total RNA isolated from U937 cells. Serial dilutions 
of the cDNA were amplified by SYBR® Green quantitative PCR using primers specific for GTP-
cyclohydrolase 1 and (A) β-actin or (B) glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
The ∆CT (CT,GTP-CH1 – CT,β-actin OR GAPDH) was calculated for each cDNA dilution and plotted 
against the logarithm of the cDNA input. The data were fit using least-squares linear regression 
analysis and the slope of the trendline was determined. Results are expressed as the mean of 
three amplifications ± SD. 
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3.3.4.1 Effect of phorbol-12-myristate-13-acetate a nd interferon- γ on the expression of 
GTP-cyclohydrolase 1 mRNA 
Figure 3.12 demonstrates that treatment of the suspended U937 cells (Control) with phorbol-
12-myristate-13-acetate (PMA) for 48 hours produced a 2-fold increase in the expression of 
GTP-cyclohydrolase 1 (GTP-CH1) mRNA (p<0.05), and the addition of interferon-γ (IFN-γ) for 
18 hours promoted ~15-fold increase in GTP-CH1 mRNA expression (p<0.05), both relative to 
the expression of β-actin mRNA and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA. There was no significant difference (p>0.05) between the fold-change observed in the 
GTP-CH1 mRNA expression between the two house-keeping reference genes, β-actin and 


































































Figure 3.12. Effect of phorbol-12-myristate-13-acet ate (PMA) alone and PMA with 
interferon- γ (IFN-γ) on the expression of GTP-cyclohydrolase 1 mRNA in  U937 cells. U937 
cells in suspension were used as a control. U937 cells were differentiated with 10 ng/ml 
phorbol-12-myristate-13-acetate (PMA) for 48 hours. The cells were then treated or not with 
interferon-γ (IFN-γ, 250 U/ml) for 18 hours. Total RNA was isolated and quantitative RT-PCR 
was performed to establish the expression of GTP-cyclohydrolase 1 mRNA relative to the 
expression of β-actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA using 
the TC∆∆−2  method. Results are the representation of one of two experiments performed in 
triplicate in quantitative PCR ± SD. 
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3.3.4.2 Effect of antimalarial drugs on the express ion of GTP-cyclohydrolase 1 mRNA  
The effects of 18 hours treatment with antimalarial drugs in addition to phorbol-12-myristate-13-
acetate (PMA) and interferon-γ (IFN-γ) on the relative expression of GTP-cyclohydrolase 1 
(GTP-CH1) mRNA in U937 cells were investigated. When compared to U937 cells treated with 
PMA and IFN-γ without drugs (control), quinine, primaquine and artemisinin significantly down-
regulated the relative expression of the GTP-CH1 mRNA by 1.7-, 1.4- and 1.3-fold, respectively 
(p<0.05). Doxycycline also down-regulated the expression of GTP-CH1 mRNA by 1.1-fold, and 
amodiaquine up-regulated the mRNA expression by 1.1 fold, but both effects were insignificant 














































Figure 3.13. Effect of antimalarial drugs on GTP-cy clohydrolase 1 mRNA expression in 
U937 cells. U937 cells were differentiated with 10 ng/ml phorbol-12-myristate-13-acetate 
(PMA) for 48 hours. The cells were treated with IFN-γ (250 U/ml) and therapeutic 
concentrations of seven antimalarial drugs for 18 hours. Total RNA was isolated from the cells 
and quantitative RT-PCR was performed to establish the expression of GTP-cyclohydrolase 1 
mRNA relative to the expression of β-actin mRNA using the TC∆∆−2  method. Results are the 
representation of one of two experiments performed in triplicate in quantitative PCR ± SD. 
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3.3.4.3 Effects of β-haematin, latex beads, non-infected and P. falciparum-infected red 
blood cell lysates on GTP-cyclohydrolase 1 mRNA exp ression      
The effects of β-haematin, latex beads, non-infected and P. falciparum-infected red blood cell 
lysate on the expression of GTP-cyclohydrolase 1 (GTP-CH1) mRNA expression were 
compared to the GTP-CH1 mRNA expression in U937 cells treated with PMA and IFN-γ only 
(control). β-haematin significantly up-regulated the relative expression of GTP-CH1 mRNA by 
1.2-fold (p<0.05) and 20 µg/ml protein of P. falciparum-infected red blood cell lysate (10% 
parasitaemia) significantly down-regulated the GTP-CH1 mRNA expression by 1.5-fold 
(p<0.05). Latex beads, non-infected red blood cell lysate (20 and 10 µg/ml) and P. falciparum-
infected red blood cell lysate (10 µg/ml) had no significant effects on the expression of GTP-
CH1 mRNA (p>0.05).  
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Figure 3.14. Effect of β-haematin, latex beads, non-infected and P. falciparum-infected 
red blood cell lysates on GTP-cyclohydrolase 1 mRNA  expression in U937 cells.  U937 
cells were differentiated with 10 ng/ml phorbol-12-myristate-13-acetate (PMA) for 48 hours. The 
cells were then treated with interferon-γ (IFN-γ) (250 U/ml) and β-haematin or latex beads or 
non-infected red blood cell lysate (RBC lysate) or P. falciparum-infected red blood cell lysate 
(Pf RBC lysate) for 18 hours. Total RNA was isolated from the cells and quantitative RT-PCR 
was performed to establish the expression of GTP-cyclohydrolase 1 mRNA relative to the 
expression of β-actin mRNA using the TC∆∆−2  method. Results are the representation of one of 
two experiments performed in triplicate in quantitative PCR ± SD. 
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In summary, GTP cyclohydrolase 1 (GTP-CH1) mRNA expression in U937 cells was up-
regulated 15-fold by interferon-γ (IFN-γ) treatment. Quinine, primaquine and artemisinin down-
regulated this increase in GTP-CH1 mRNA expression by 1.7- , 1.4- and 1.3-fold, respectively. 
Amodiaquine, chloroquine, doxycycline and pyrimethamine had no significant effects on the 
GTP-CH1 mRNA expression. β-haematin up-regulated the IFN-γ-induced GTP-CH1 mRNA 
expression by 1.2 fold, whereas 20 µg/ml P. falciparum-infected red blood cell lysate down-
regulated this induced expression by 1.5-fold. Non-infected red blood cell lysate had no 
significant effects on the IFN-γ-induced GTP-CH1 mRNA expression.   
 
3.4 Discussion 
Neopterin is secreted by monocytes, macrophages and dendritic cells when they are activated 
in patients with malignant diseases, infectious diseases such as AIDS, tuberculosis or malaria, 
autoimmune diseases, allograft rejection, renal or cardiac failure, coronary artery disease and 
myocardial infarction (Berdowska and Zwirska-Korczala, 2001; Wachter et al., 1989). Neopterin 
levels are often monitored during diseases or following an organ transplant to give an indication 
of the development of organ rejection (Berdowska and Zwirska-Korczala, 2001; Wachter et al., 
1989). In this study, the effects of antimalarial drugs, β-haematin, latex beads, non-infected- or 
P. falciparum-infected red blood cell lysates on interferon-γ-induced neopterin production in 
human monocytic U937 cells were investigated. An attempt was made to measure the 
neopterin levels in the U937 supernatants using a competitive ELISA, and the expression of the 
mRNA of GTP-cyclohydrolase 1 was analysed using quantitative RT-PCR. GTP-cyclohydrolase 
1 is an enzyme involved in the conversion of guanosine triphosphate to 7,8-dihydroneopterin 
triphosphate, which is then dephosphorylated by phosphatases, and oxidised to form neopterin 
(Hoffmann et al., 2003).   
 
3.4.1 Production of anti-neopterin IgY in chickens  
To detect neopterin in the supernatants of U937 cells, antibodies were raised against neopterin 
in chickens. Neopterin has only been found in primates and humans (Duch et al., 1984) and 
birds are phylogenetically different from mammals (Erhard and Schade, 2001), hence chickens 
would recognize neopterin as a foreign molecule. Furthermore, isolation of IgY from the egg 
yolks provides a convenient easily accessible acquisition of abundant amounts of antibodies 
without venepuncture of the animal, as in the case of rabbits (Jensenius and Koch, 1997). In 
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one week a chicken can supply as much antibody as it takes a rabbit to produce in three 
months (Jensenius and Koch, 1997). Neopterin is a small organic molecule with a Mr of 
253.215, and as a hapten, it will not elicit an immune response unless it is bound to a carrier 
molecule (Hermanson, 1996; Schwarzkopf et al., 2001). Neopterin was conjugated to rabbit 
albumin as a carrier, and used to immunize two chickens. Eggs were collected and IgY was 
isolated from the eggs. The titre of both the anti-rabbit albumin and anti-neopterin antibodies 
(Figure 3.1) were highest around week 6 in chicken 1 and week 8-9 in chicken 2. The antibody 
production in chicken 1 was similar to a previous investigation where antibody titres against 
antimalarial drugs and the carrier were both highest 6 weeks after immunisation (Goldring et al., 
2005).    
 
Low yields (~250 µg IgY) of affinity purified antibodies were obtained with each cycle of pooled 
crude IgY over the affinity matrix. Detection of anti-neopterin IgY in the crude IgY pool by ELISA 
following each cycle over the affinity matrix indicated that the anti-neopterin-binding capacity of 
this matrix was low. This may be due to poor coupling of the neopterin-ovalbumin conjugate to 
the matrix. Furthermore, neopterin is light sensitive and easily degraded, and although all the 
reactions with neopterin were performed in the dark, degradation of the neopterin cannot be 
eliminated (Laich et al., 2002)      
 
To improve the yields, matrices were prepared with neopterin alone or a 200:1 neopterin-
ovalbumin conjugate, but no antibodies were isolated using either approach. This suggested 
that either the neopterin or the conjugate had not bound to the matrix, or the neopterin had 
degraded during the coupling reaction to the gel, or very few antibodies were generated against 
neopterin in the immunised chicken. Neopterin also has a very low solubility in water and 
buffers: 1 mg in 20 ml of water/PBS. Due to poor yields, both the crude and affinity purified IgY 
were used in the development of a competitive ELISA to detect neopterin in supernatants from 
U937 cells.  
 
3.4.2 Development of a competitive ELISA 
A competitive ELISA makes it possible to obtain an estimate of an amount of a particular 
antibody or antigen (in this case neopterin), especially when these components cannot be 
isolated from the medium in which they are found. The competitive assays are less precise than 
the direct or indirect ELISA as more than one component is present in limiting concentrations 
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(Kemeny, 1997). In this case, the sample antigen (free neopterin in standard curve solutions or 
neopterin in U937 supernatants) and solid phase antigen (neopterin-ovalbumin conjugates 
coating the wells or neopterin added to glutaraldehyde-activated wells) competed for binding to 
a fixed amount of unlabelled antibody (crude or affinity purified IgY), and its presence was 
detected with a second labelled antibody in an ELISA (Kemeny, 1997).   
 
3.4.2.1 Competitive ELISA using the neopterin-ovalb umin conjugate to coat the wells 
Indirect ELISAs indicated that the 200:1 neopterin-ovalbumin conjugate was more sensitive 
than the 40:1 conjugate in distinguishing non-immune IgY from immune IgY (Figure 3.3), and 
16-fold dilutions of the 200:1 conjugate still distinguish immune IgY from non-immune IgY 
(Figure 3.4). Competitive ELISAs, using the 200:1 neopterin-ovalbumin conjugate to coat the 
wells, failed to show a decrease in absorbance at 405 nm with an increase in neopterin 
concentration (Figure 3.5). Alterations in the competitive ELISA such as varying the 
concentrations of the (i) affinity purified antibodies or crude IgY, (ii) free neopterin and (iii) 
coating neopterin-ovalbumin conjugate (Figure 3.6), were all unsuccessful. It appeared that 
neither the affinity purified antibodies nor the crude IgY were binding to the free neopterin in this 
format.  
 
An neopterin-ovalbumin conjugate was used to affinity purify the crude IgY and coat the wells 
for indirect and competitive ELISAs. In addition, bovine serum albumin was used to block the 
wells in the ELISAs and rabbit albumin was the carrier in the conjugate used to immunize the 
chickens. Thus, the cross reactivities of these antibodies with ovalbumin, bovine serum albumin 
and rabbit albumin were investigated to determine if the cross reactivities were responsible for 
the failure of the competitive ELISA (Figure 3.7). As expected, the antibodies recognised rabbit 
albumin. No cross reactivity was observed with ovalbumin, but cross-reactivity was detected 
with bovine serum albumin (Figure 3.7). Although this cross-reactivity with the bovine serum 
albumin could render all the ELISA results in Figures 3.1-3.6 invalid, the concentration of 
bovine serum albumin used in all the wells of the ELISA was constant. Therefore, in Figures 3.3 
and 3.4, if the antibodies were only recognising the bovine serum albumin present at constant 
concentrations in all the wells, there would have been no difference between the absorbance 
values of the non-immune (Week 0) and immune (Week 8) antibodies in the indirect ELISAs. 
However, this was not the case indicating that although there might be cross reactivity with 
bovine serum albumin, the immune antibodies still recognised and bound to the neopterin-
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ovalbumin conjugate in the indirect ELISAs. Furthermore, had the antibodies recognised and 
bound the varying concentrations of free neopterin in the competitive ELISAs, there should still 
have been a decrease in absorbance with increasing free neopterin concentration even if the 
remaining antibodies bound to the bovine serum albumin in the wells (Fig. 3.5 and 3.6). Yet, 
this was not observed. In order to avoid maligning the results with the cross reactivity with 
bovine serum albumin, 0.1% (w/v) gelatin-PBS was used to block the wells and dilute the 
antibodies in the experiments that followed. Unfortunately, the use of 0.1% (w/v) gelatin-PBS 
with the neopterin-ovalbumin conjugate as a coating was overlooked.  Wells were coated with 
neopterin alone and although a minimal distinction was detected between the non-immune and 
immune IgY, it is difficult to ascertain if the neopterin was bound to the wells of the ELISA plate.  
 
A competitive ELISA using solid phase bound conjugates of neopterin-carrier (bound to the 
wells) has been used successfully to detect neopterin in serum or cell culture supernatants 
(Barak et al., 1989). Differences to the methods employed in this study include the use of the 
carbodiimide method to couple neopterin to high molecular weight carriers such as bovine 
serum albumin, keyhole limpet haemocyanin or thyroglobulin. These neopterin-carrier 
conjugates were used for immunisation of rabbits to generate antiserum for the competitive 
ELISA, in addition to coating the wells for the competitive ELISA. In this study, glutaraldehyde 
was used to couple neopterin to rabbit albumin for immunisation of chickens, and to couple 
neopterin to ovalbumin for coating the wells in the competitive ELISA. IgY isolated from eggs of 
the immunised chickens was used in the ELISA presented here. Furthermore, Barak et al. 
(1989) used low fat milk to block the wells in comparison to the bovine serum albumin or gelatin 
used in the ELISA presented here. Barak et al. (1989) obtained a dose response curve for 
inhibition of anti-neopterin antiserum binding by known concentrations of standard solutions. 
The best binding efficiency was exhibited by antiserum from rabbits immunised with neopterin 
conjugated to keyhole limpet haemocyanin using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride, and wells coated with bovine serum albumin-neopterin conjugates 
coupled with 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluene sulphonate. 
However in the ELISA presented here, a dose-response curve was not obtained when the 
same standard neopterin concentrations were investigated. Barak et al. (1989) added the 
neopterin standards or samples and the antibody simultaneously to each neopterin-conjugate 
coated well and incubated for 2 hours at 37ºC. In the ELISA presented here, the neopterin 
standards and the antibody were incubated together for 1 hour at room temperature prior to 
adding to the neopterin-conjugate coated wells for 1 hour at 37ºC. Barak et al. (1989) checked 
 116 
the validity of their assay by comparing the results of their ELISA for neopterin production in 
supernatants of peripheral blood mononuclear cells stimulated with IFN-γ with those obtained 
with the “Neopterin RIAcid kit” from Henning Berlin GmbH, West Berlin, F.R.G. A co-efficient of 
correlation of 0.974 was obtained between the two methods. The detection limit of their ELISA 
was 1.6 nmol/l compared with 1 nmol/l for the RIA and HPLC determinations. Thus, the use of 
neopterin-carrier conjugates as a coating for wells used in a competitive ELISA was successful 
in detecting neopterin in tissue supernatants. 
      
3.4.2.2 Competitive ELISA using microtitre plates c oated with neopterin added to 
glutaraldehyde-activated wells  
An alternative method for coating the wells was explored by activating the wells with 
glutaraldehyde prior to adding neopterin to coat the wells. In an indirect ELISA used to 
determine the optimal coating concentration and anti-neopterin antibody concentration (Figure 
3.8), the affinity purified antibodies did not bind to the neopterin coated to glutaraldehyde- 
activated wells at any of the coating concentrations of neopterin investigated. This suggests 
that neopterin might not have bound to the wells, and non-specific binding is occurring with the 
crude IgY. But this does not explain the decrease in A405 values of the crude IgY binding 
observed with a decrease in the neopterin coating concentration.  
 
A competitive ELISA using crude IgY and microtitre plates coated with neopterin added to 
glutaraldehyde-activated wells failed to display a decrease in the absorbance at 405 nm with an 
increase in the concentration of free neopterin (Figure 3.9). The absorbance values were much 
lower than those obtained with the neopterin-ovalbumin coated wells, indicating that minimal 
antibody had bound to the neopterin-coated glutaraldehyde activated wells. This could be as a 
result of most of the anti-neopterin antibodies binding to the free neopterin in the glass tubes, 
leaving minimal free antibodies in solution to bind to the neopterin coating the well. However, 
when much lower concentrations of free neopterin were investigated, there was still no 
difference in the absorbance values.  
 
Antibodies have been successfully generated against chemical molecules for use in competitive 
ELISAs (Danger et al., 2006; Tanaka et al., 2007; Zhao et al., 2007). In particular, chicken IgY 
has been raised against antimalarial drugs and used in a competitive ELISA (Goldring et al., 
2005). Expensive ELISA commercial kits (GenWay Biotech Inc., U.S.A., Immuno-Biological 
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Laboratories, U.S.A., Alpco Diagnostics, U.S.A.) are available to detect neopterin in serum and 
urine using a competitive ELISA (Mayersbach et al., 1994; Ogiwara et al., 1992). In these 
competitive ELISAs, polyclonal anti-neopterin serum from rabbits or sheep or monoclonal 
antibodies were used to detect neopterin in the samples. In this study, although the anti-
neopterin IgY appears to recognise the neopterin-ovalbumin conjugates or the neopterin in 
glutaraldehyde-activated wells in indirect ELISAs, it does not appear to recognise the free 
neopterin in solution in the format of the competitive ELISA. Antibodies show specificity, which 
can be an advantage, but it can also cause problems with some immunochemical procedures 
as antibodies can discriminate between molecular species which differ very slightly from each 
other in conformation (Thorpe et al., 1997). Thus, if a hapten is conjugated to a carrier protein, 
and the conformation of the hapten is altered slightly during the coupling reaction, the 
antibodies generated against the hapten-carrier conjugate may not recognise the hapten on its 
own. It is possible that the conformation of the neopterin molecule may have been altered by 
the glutaraldehyde during the coupling reaction.  
 
Future work on the development of the competitive ELISA could include raising polyclonal 
antibodies against neopterin in mammals that do not produce neopterin, such as rabbits or 
sheep, which are phylogenetically closer to primates and humans than chickens. An alternate 
conjugation method, for example, the carbodiimide method, could be used to couple the 
neopterin to carriers (Barak et al., 1989; Hermanson, 1996). The successful production and 
correct specificity of the resultant antibodies depends on the coupling chemistry used to 
prepare the immunogen from a hapten and a carrier. There is the potential for antibody 
recognition and cross-reactivity toward the cross-linking reagent used to effect the conjugation 
(Hermanson, 1996). The desired antibody response against the hapten may be diluted by 
antibodies generated against the cross-linker bridge. This problem can be eliminated by the use 
of a zero-length cross-linking procedure mediated by the water-soluble carbodiimide EDC (1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) as no bridging molecule is 
introduced between the hapten and the carrier. In addition, alternate carriers, such as keyhole 
limpet haemocyanin or thyroglobulin (Hermanson, 1996), which have been successfully used 
by Barak et al. (1989), could be used to prepare conjugates to immunise the animal and coat 
the wells of the microtitre plates.  In addition, formation of a neopterin-equivalent of a multiple 
antigenic peptide could be investigated to immunise the chickens (Schwarzkopf et al., 2001). 
This immunogenic matrix could be formed by coupling neopterin to trifunctional amino acids, 
such as lysine (Tam, 1988). The lysine residues themselves are relatively non-immunogenic, 
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and the greater the number of lysine residues in the core matrix, the greater the number of 
coupled haptens.  
 
Alternate adjuvants such as Adjuvant 65, Specol, TiterMax, ABM-system, Gerbu, Lipopeptide 
PCSL, which have all been previously investigated in chickens (Schwarzkopf et al., 2001), 
could substitute the Freund’s complete and incomplete adjuvants in the immunisation and 
boosting of the chickens. Specol has been demonstrated to produce antibody titres and 
antibody avidities in chickens similar to that obtained with Freund’s complete adjuvant. In 
addition, Specol does not have the noticeable side effects of Freund’s complete adjuvant on the 
chickens (Schwarzkopf et al., 2001). Lipopeptide PCSL has been shown to produce high 
antibody titres with certain antigens (Erhard et al., 2000) and seems to be successful when its 
concentration is kept within certain limits (250 µg/injection, subcutaneous). Lipopeptide PCSL 
also has minimal side effects on the chicken (Schwarzkopf et al., 2001). TiterMax, when used 
as an adjuvant in chickens, results in lower antibody titres than Freund’s complete adjuvant but 
does have fewer side effects (Bollen and Hau, 1999; McClimon et al., 1994; Svendsen Bollen et 
al., 1996).         
 
3.4.3 Analysis of relative expression of GTP-cycloh ydrolase 1 mRNA transcripts 
in U937 cells using quantitative RT-PCR 
Total RNA was isolated from U937 cells that were treated with interferon-γ and either one of 
seven antimalarial drugs, β-haematin, latex beads, non-infected or P. falciparum-infected red 
blood cell lysates. RNA was reverse transcribed to generate cDNA, which was used as a 
template in quantitative PCR with primers for the target, GTP-cyclohydrolase 1 gene (GTP-
CH1), and references, β-actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes. 
The relative expression of the GTP-CH1 mRNA was determined using the TC∆∆−2 method (Livak 
and Schmittgen, 2001), which was validated by assessing how ∆CT  (CT,target - CT,reference) varies 
with template dilution. Two different reference genes were investigated because ∆CT values 
between GTP-CH1 and β-actin CT values were fairly large (~17), hence GAPDH was also 
investigated as a reference gene. The ∆CT values between GTP-CH1 and GAPDH CT values 
were smaller (~8). However, both reference genes gave rise to regression lines with slopes of 
<0.1 in the plot of ∆CT versus log cDNA input (Figure 3.12A and B) demonstrating that the 
amplification efficiency of the target gene, GTP-cyclohydrolase 1, was approximately equal to 
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that of both reference genes, β-actin and GAPDH (Livak and Schmittgen, 2001). Thus, the 
TC∆∆−2  method could be used to measure the relative expression of GTP-cyclohydrolase 1 
mRNA with either of the reference genes. 
 
3.4.3.1 Effect of phorbol-12-myristate-13-acetate a nd interferon- γ on the expression of 
GTP-cyclohydrolase 1 mRNA in U937 cells  
Differentiation of U937 cells with phorbol-12-myristate-13-acetate (PMA) up-regulates the 
expression of GTP-cyclohydrolase 1 mRNA in U937 cells 2-fold, whereas treatment of the 
U937 cells with PMA together with interferon-γ (IFN-γ) up-regulates the expression of GTP-
cyclohydrolase 1 by almost 15-fold (Figure 3.13). Up-regulation in GTP-cyclohydrolase 1 mRNA 
expression was observed with both the β-actin and the GAPDH reference genes. INF-γ has 
been reported to increase the expression of GTP-cyclohydrolase 1 mRNA in human umbilical 
vein endothelial cells (Gesierich et al., 2003; Katusic et al., 1998). When peripheral blood 
derived macrophages and THP-1 myelomonocytic cells were treated with IFN-γ, GTP-
cyclohydrolase 1 activity in these cells increased 40-fold (Werner et al., 1990). GTP-
cyclohydrolase 1 catalyzes the conversion of guanosine triphosphate to 7,8-dihydroneopterin 
triphosphate, which is dephosphorylated and oxidised to produce neopterin (Hoffmann et al., 
2003). INF-γ released from activated T-cells, is the central stimulus that induces neopterin 
release from monocytes/macrophages (Huber et al., 1984). Other potent inducers of 
macrophage activity, including phorbol ester, do not induce the release of significant amounts 
of neopterin (Murr et al., 2002), which correlates with the minor stimulation of PMA on GTP-
cyclohydrolase 1 mRNA expression observed in U937 cells.  
     
3.4.3.2 Effect of antimalarial drugs on the express ion of GTP-cyclohydrolase 1 mRNA 
in U937 cells 
Interferon-γ (IFN-γ)-induced GTP-cyclohydrolase 1 mRNA expression in U937 cells was 
significantly inhibited by quinine, primaquine and artemisinin. Amodiaquine, chloroquine, 
doxycycline and pyrimethamine had insignificant effects on the expression of GTP-
cyclohydrolase 1 (Figure 3.14). As neopterin is one of the downstream products of the enzyme 
GTP-cyclohydrolase 1, and a marker of monocyte activation, the down-regulation observed in 
the GTP-cyclohydrolase 1 mRNA expression could be indicative of quinine, primaquine and 
artemisinin down-regulating the activation of the monocyte induced by IFN-γ. In terms of 
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defence against a malaria infection, activation of macrophages increases the capacity for 
antigen presentation through induction of class II HLA antigens in addition to increasing anti-
microbial effector mechanisms, such as phagocytosis of infected red blood cells, followed by 
the destruction of the phagocytosed protozoa by oxygen and oxygen-independent mechanisms 
(Auger and Ross, 1992).  
 
Several investigations monitored neopterin levels in patients infected with P. falciparum that 
were being treated with quinine alone (Kremsner et al., 1996; Ringwald et al., 1991), quinine 
and tetracycline (Brown et al., 1990), or halofantrine (Ringwald et al., 1991). Neopterin levels 
peaked 2-3 days after the start of the treatment and decreased to normal levels by days 6-8. 
However, in patients with severe anaemia, the neopterin levels were still elevated even after 7 
days of treatment with quinine (Biemba et al., 1998). The neopterin levels were found to 
associate significantly with peak temperatures, fever clearance times and parasite clearance 
times (Brown et al., 1990), as well as severe malarial anaemia (Biemba et al., 2000) and 
respiratory distress in life-threatening malaria (Awandare et al., 2006a). Hence, it would be 
difficult to correlate the neopterin levels observed in malaria patients with the effect of the 
antimalarial drug treatment on GTP-cyclohydrolase 1 in the monocytes of these patients. The 
decrease in neopterin levels observed in malaria patients by day 6-8 after initiation of treatment 
are more likely due to the eradication of the P. falciparum parasites by quinine which would 
lead to a decrease in the activation of the macrophage and hence, a decrease in neopterin 
secretions. The quinine-induced down-regulation of the GTP-cyclohydrolase 1 mRNA 
expression observed in U937 cells might contribute to the overall decrease in neopterin levels, 
if it contributes at all.         
 
Other chemical compounds that have been found to affect neopterin production include the 
drugs aspirin (Schroecksnadel et al., 2005), a general cyclooxygenase inhibitor with anti-
inflammatory, analgesic and anti pyretic effects, and resveratrol (Wirleitner et al., 2005) with 
antioxidant, antitumour and anti-inflammatory effects. Both drugs down-regulate the production 
of neopterin by suppressing the production of interferon-γ. Short-term administration of estradiol 
benzoate led to an increase in the GTP-cyclohydrolase 1 mRNA levels in dopaminergic and 
noradrenergic cell bodies (Serova et al., 2004). Ascorbic acid, vitamin C, did not alter either the 
mRNA expression or the activity of GTP-cyclohydrolase 1 in human umbilical vein endothelial 
cells (Heller et al., 2001) and vitamin C supplementation was also found to have no effects on 
circulating neopterin levels in smokers or non-smokers (Scott et al., 2005). Food antioxidant 
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preservatives, sodium sulphite and sorbic acid, both suppressed GTP-cyclohydrolase 1 in 
human peripheral blood mononuclear cells (Winkler et al., 2006).  2,4-Diamino-6-hydroxy-
pyrimidine is a known selective inhibitor of GTP-cyclohydrolase 1 (Kasai et al., 1997). Thus 
quinine, primaquine and artemisinin appear to induce similar suppressive effects as aspirin, 
resveratrol, sodium sulphite and sorbic acid on GTP-cyclohydrolase 1 mRNA expression, 
although aspirin, resveratrol and sodium sulphite suppress neopterin secretion  to a greater 
degree (2-5 fold), whereas sorbic acid results in a similar reduction (1.5-fold). Although these 
changes may not be significant in a healthy individual in vivo, in a diseased patient, these small 
changes may be potentially therapeutic. Chloroquine, doxycycline, pyrimethamine and 
amodiaquine are similar to ascorbic acid which has no significant effects on GTP-
cyclohydrolase 1 mRNA expression.  
 
3.4.3.3 Effect of β-haematin, latex beads, non-infected and P. falciparum-infected red 
blood cell lysates on GTP-cyclohydrolase 1 mRNA exp ression in U937 cells          
When U937 cells were treated with physiological concentrations of β-haematin for 18 hours, the 
GTP-cyclohydrolase 1 mRNA expression was up-regulated ~1.2-fold. However, treatment of 
U937 cells with 20 µg/ml protein of P. falciparum-infected red blood cell lysate (10% 
parasitaemia) down-regulated the expression of GTP-cyclohydrolase 1 mRNA by ~1.6 fold 
(Figure 3.15). The latex beads, non-infected red blood cell lysates and 10 µg/ml protein of P. 
falciparum-infected red blood cell lysate (10% parasitaemia) had no significant effects on the 
GTP-cyclohydrolase 1 mRNA expression.  
 
Low concentrations of free and transferrin-bound iron have been shown to reduce the efficiency 
of the IFN-γ signal in the myelomonocytic cell line THP-1 as observed by the decreased 
production of neopterin (Weiss et al., 1992a). Later studies demonstrated that iron significantly 
reduced the mRNA expression and activity of GTP-cyclohydrolase 1 in THP-1 cells. The GTP-
cyclohydrolase 1 mRNA expression was found to be regulated post-transcriptionally by iron 
perturbations (Oexle et al., 2003). The observed effects of β-haematin on GTP-cyclohydrolase 
1 mRNA expression were opposite to that of iron, with a 1.2-fold up regulation of mRNA 
expression. This could be due to the fact that the iron in β-haematin is co-ordinated into 
porphyrin dimers assembled into insoluble crystal lattices that remain, apparently unchanged in 
monocytes/macrophages for several months (Schwarzer et al., 1998). Thus, the iron in β-
haematin is not “biologically” available. Once β-haematin has been phagocytosed by the 
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monocyte, it generates large amounts of lipoperoxidation products by non-enzymatic catalysis 
(Schwarzer et al., 2003). These lipoperoxidation products might be responsible for the up 
regulation of GTP-cyclohydrolase 1 mRNA expression caused by β-haematin.  
 
The red blood cell lysates had no significant effects on the mRNA expression of GTP-
cyclohydrolase 1 (Figure 3.15). Hence, the down regulation in the GTP-cyclohydrolase mRNA 
expression observed with 20 µg/ml protein of P. falciparum-infected red blood cell lysate (10% 
parasitaemia) is probably due to P. falciparum material in the lysate. There was no significant 
effect with 10 µg/ml protein of P. falciparum-infected red blood cell lysate (10% parasitaemia), 
indicating that the parasites were too diluted at this concentration of protein to have an effect on 
the mRNA expression. These findings are in contrast to a previous study with P. falciparum-
infected red blood cell lysate which stimulated U937 cells to secrete neopterin and this 
secretion was enhanced by the addition of human IFN-γ (Facer, 1995). However, Facer (1995) 
did not indicate the protein concentration of the P. falciparum-infected red blood cell lysate that 
was added to the U937 cells or the parasitaemia of the lysate used in the studies. A significant 
difference with this investigation was the time period of incubating the U937 cells with the P. 
falciparum-infected red blood cell lysate: Facer (1985) incubated the U937 cells with the lysate 
for 48 hours whereas in this study the U937 cells were exposed to the lysates for only 18 hours. 
Huber et al. (1984) reported that the release of neopterin from activated macrophages started 
after 24 hours post-stimulation and the neopterin concentration was maximal after 2-3 days. 
Another difference is that Facer (1985) was monitoring the levels of neopterin in the 
supernatant, whereas in this study the relative expression of the mRNA of GTP-cyclohydrolase 
1 in the U937 cell was measured. Thus, an up-regulation of GTP-cyclohydrolase 1 mRNA 
expression might have been observed after 48 hours incubation with the P. falciparum-infected 
red blood cell lysate. Alternatively, GTP-cyclohydrolase 1 mRNA expression and the production 
of neopterin may be controlled by different mechanisms or conditions. In hind site, higher 
protein concentrations of P. falciparum-infected red blood cell lysates and lysates with higher 
parasitaemia should also have been investigated.   
 
It is intriguing that β-haematin up regulated the relative expression of GTP-cyclohydrolase 1 
mRNA, whereas the P. falciparum-infected red blood cell lysate down regulated the relative 
GTP-cyclohydrolase 1 mRNA levels in the U937 cells, as the P. falciparum-infected red blood 
cell lysate also contains native haemozoin. However, the concentration of haemozoin present in 
the parasite lysate (10% parasitaemia) added to the U937 cells was approximately 500 times 
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lower than the concentration of β-haematin added to the cells. Furthermore, the β-haematin 
was free of any parasite proteins, lipids or nucleic acids, whereas unpurified haemozoin is often 
associated with proteins, lipids and nucleic acids of both host and parasitic origin (Goldie et al., 
1990). Thus, future work could determine if β-haematin and native haemozoin induce similar 
effects on the relative expression levels of GTP-cyclohydrolase 1 mRNA.         
 
7,8-Dihydroneopterin reacts very rapidly with hypochlorous acid to produce neopterin (Widner 
et al., 2000). At least a third of the 7,8-dihydroneopterin produced is oxidised to neopterin 
(Gieseg et al., 2001a). Reports are contradictory as to whether the oxidation of 7,8-
dihydroneopterin to neopterin takes place inside (Murr et al., 2002) or outside the 
monocyte/macrophage (Gieseg et al., 2008) or both. There are no reports of 7,8-
dihydroneopterin being synthesized concomitantly with hypochlorous acid release in the 
monocyte (Sugiyama et al., 2004) and being converted into neopterin immediately, or of 7,8-
dihydroneopterin accumulating in the macrophage and being oxidized to neopterin later when 
hypochlorous acid production is activated in the monocyte or when the monocyte enters an 
inflammation site. In most studies, 7,8-dihydroneopterin is oxidised to neopterin using iodine, 
and the total pterin is measured as only neopterin is fluorescent and can be measured by a 
fluorescent detector (Wachter et al., 1989). Hence, there is no distinction between 7,8-
dihydroneopterin and neopterin concentrations (Gieseg and Cato, 2003; Schoedon et al., 1987; 
Werner-Felmayer et al., 1990; Werner et al., 1990). Furthermore, if the neopterin is synthesized 
inside the monocyte/macrophage, reports do not intimate if the neopterin is retained in the cell 
before secretion or if it is secreted upon formation and whether or not the triggering of the 
neopterin release is independent of the synthesis of 7,8-dihydroneopterin. Therefore it is 
difficult to establish if the mRNA expression of GTP-cyclohydrolase 1 is directly related to the 
neopterin concentration in the supernatants of stimulated monocytes/ macrophages or not.  
 
Further work would entail determining neopterin concentrations in the supernatants of the 
treated U937 cells by commercial competitive ELISA kits (Westermann et al., 2000) and HPLC 
(Werner et al., 1987a; Werner et al., 1987b) to determine how GTP-cyclohydrolase 1 mRNA 
expression correlates with secreted neopterin levels. The effects of longer incubation periods of 
U937 cells with antimalarial drugs, β-haematin, latex beads, P. falciparum-infected and non-
infected red blood cell lysates on GTP-cyclohydrolase 1 mRNA expression and neopterin levels 
in the supernatants could also be investigated. The GTP-cyclohydrolase mRNA expression 
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could also be monitored in peripheral blood mononuclear cells isolated from blood samples 









Malaria is an infectious disease infecting approximately 250 million people each year resulting 
in about 900 000 deaths annually mainly in children below the age of 5 and pregnant women 
(WHO, 2008). The disease reduces GDP by up to 1.3% in poor countries. This is due to an 
increasing resistance of the parasite to antimalarial drugs (Pearce et al., 2009; 
Pongtavornpinyo et al., 2008) and of the vectors, Anopheles gambiae and A. funestus in Africa, 
to insecticides (Casimiro et al., 2006; Santolamazza et al., 2008; Wondji et al., 2009). Although 
there is a large number of potential antigen targets for malaria vaccine development, the 
immune evasion strategies of the parasite continue to confound vaccine development (Pierce 
and Miller, 2009).  
 
The parasite results in an immune response that is not appropriate, suppressed and contributes 
to the pathophysiology of malaria (Artavanis-Tsakonas et al., 2003; Riley, 1999). 
Immunodepression in malaria is often associated with parasite haemozoin (Millington et al., 
2006; Schwarzer et al., 1998; Scorza et al., 1999), an insoluble crystal pigment that is formed 
by the parasite from haeme released during parasite haemoglobin digestion in infected red 
blood cells (Egan, 2008a). Monocytes phagocytose haemozoin-containing trophozoites and 
schizonts in addition to haemozoin that is released into the blood stream when the red blood 
cell bursts to release merozoites (Arese and Schwarzer, 1997; Schwarzer et al., 2001). 
Phagocytosed haemozoin modifies a number of monocyte functions including reducing 
monocyte antigen presentation and stimulation of T-cells, inhibiting differentiation and 
maturation to dendritic cells, inhibiting erythropoiesis and thrombopoiesis, stimulating the 
production of proinflammatory cytokines and activating metalloproteinase 9 (Schwarzer et al., 
2008).  
 
Antimalarial drugs have also been found to have immunomodulatory effects on monocytes. 
Antimalarial drugs have been reported to: inhibit phagocytosis (Osorio et al., 1992; Prasad et 
al., 1986; Prasad et al., 1984; Shalmiev et al., 1996); reduce the expression of cytoadherance 
receptors on the surface of the monocytes (Goldring and Nemaorani, 1999); inhibit the 
production of pro-inflammatory cytokines (Ballal et al., 2009; Jang et al., 2006; Maruyama et al., 
1994; van den Borne et al., 1997); inhibit production of reactive nitrogen intermediates 
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(Kremsner et al., 1993a), or stimulate production of reactive oxygen intermediates (Prada et al., 
1996b). However, the effects of antimalarial drugs on β-haematin phagocytosis by monocytes 
are unknown.  
              
In the first part of the study, the effects of antimalarial drugs on the phagocytosis of β-haematin 
(synthetic haemozoin) by two monocytic cell lines, mouse J774A.1 and human U937 cells, and 
peripheral blood mononuclear cells (PBMC) were investigated using direct observation and 
spectrophotometry. None of the changes observed, inhibition or activation, exceeded 25%. On 
comparing the effects of the antimalarial drugs on the phagocytosis of latex beads or β-
haematin by the J774A.1 cells, which were determined by counting, four of the 7 drugs inhibited 
latex bead phagocytosis whereas four drugs activated β-haematin phagocytosis (Table 4.1). 
Most of the reported effects of antimalarial drugs on monocyte phagocytosis involve inhibition 
(Osorio et al., 1992; Prasad et al., 1986; Prasad et al., 1984; Shalmiev et al., 1996), which 
aligns with the inhibition observed with the phagocytosis of the latex beads by the J774A.1 
cells.  
  
In U937 cells and PBMC, similar activation effects were observed with β-haematin 
phagocytosis, measured with a novel spectrophotometric assay adapted from the method used 
by Sullivan et al. (1996c). The exceptions to this activation in both U937 cells and PBMC were 
chloroquine and amodiaquine (Table 4.1), which inhibited the phagocytosis of β-haematin. This 
could be because chloroquine and amodiaquine are both 4-aminoquinolines (Wernsdorfer, 
1997). There were some instances where the antimalarial drugs had no effect on the 
phagocytosis of β-haematin, for example, the effects of doxycycline and primaquine on U937 
phagocytosis. Kharazmi et al., (1986) also reported that chloroquine, quinine, pyrimethamine 
and tetracycline had no effects on the phagocytosis of S. aureus by human peripheral blood 
leucocytes. Different patterns of inhibition observed with different monocytic cell types could be 
due to different stages of differentiation in the cell types and the mixed population of cells in 
PBMC. PMA-differentiated U937 cells appear to be more mature than the J774A.1 cells as 
peroxidase activity was detected in both J774A.1 and PBMC, but not in PMA-differentiated 
U937 cells, and granule peroxidases decrease as monocytes mature into macrophages 
(Nakagawara et al., 1981; Papadimitriou and Ashman, 1989). PBMC contain a mixed 
population of cells at different stages of differentiation that are isolated using Histopaque®-1077 






Table 4.1 Effects of antimalarial drugs on phagocyt osis, GTP-cyclohydrolase 1 mRNA expression and cyto adherance 



















Phagocytosis of P. 
falciparum 
infected red blood 






Amodiaquine 0 - 2- - 0 2- ND 
Artemisinin - 2+ 2+ 0 - - - 
Chloroquine - 0 2- - 0 - - 
Doxycycline 0 2+ - 0 0 ND ND 
Primaquine - + 2+ 0 - ND - 
Pyrimethamine 0 2+ 2+ 2+ 0 ND 3- 
Quinine 2- 0 2+ + - 2- 3- 
- : Inhibition 
+ : Activation 
0 : No effect 




Goldring and Nemaorani (1999) reported that antimalarial drugs decreased the expression of 
cytoadherance receptors on the surface of the monocyte by 40% or more (Refer to Table 4.1).  
Prasad et al., (1986) proposed that the inhibition of monocyte phagocytosis observed with 
chloroquine may be due to the prevention of receptor cycling by the drug and neutralisation of 
the low pH of the endosome. The antimalarial drugs inhibiting latex bead phagocytosis, also 
decreased the expression of cytoadherance receptors. The greatest inhibition of phagocytosis 
of latex beads was observed with quinine (Table 4.1), which was also the most effective drug in 
reducing the expression of cytoadherance receptors (Goldring and Nemaorani, 1999).  
   
These results could be confirmed using flow cytometry with fluorescently labelled latex beads 
and a flow cytometer that can detect depolarized side scatter. An example is the Cell-Dyn 
automated blood cell analyzer (Grobusch et al., 2003; Padial et al., 2005; Scott et al., 2003), 
which detects the depolarized side scatter of monocytes containing β-haematin owing to the 
birefringent optical properties of the crystal, that is, its ability to depolarize light (Hempelmann 
and Marques, 1994; Lawrence and Olson, 1986). Fluorescently labelled antibodies against Fc 
and complement receptors and cytoadherance receptors could be used simultaneously in the 
flow cytometry to determine which receptors are being down-regulated by the antimalarial 
drugs. As only a few β-haematin crystals were observed in the transmission electron 
micrographs of the monocytes after 30 minutes of exposure to β-haematin (Figure 2.10), the 
period of incubation with the β-haematin could be increased. It might also be of interest to 
examine drug combinations that are currently being used to treat malaria, especially 
artemisinin-based combination therapy, to ascertain their immunomodulatory effects on 
phagocytosis by monocytes and whether they contribute to or antagonise the 
immunosuppression observed in malaria infections.  
 
Neopterin is the oxidation product of 7,8-dihydroneopterin produced by monocyte-derived 
macrophages and dendritic cells upon stimulation with interferon during inflammation, and is 
used as a marker of the cell-mediated T helper cell subtype 1 immune response (Murr et al., 
2002). Neopterin levels are elevated in the serum and urine of malaria-infected patients (Brown 
et al., 1991; Brown et al., 1990; Picot et al., 1993; Reibnegger et al., 1984). Neopterin was also 
secreted by monocytic U937 cells when they were treated with malarial antigens and P. 
falciparum-infected red blood cell lysate in vitro (Facer, 1995). However, the effects of β-
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haematin and antimalarial drugs on the secretion of neopterin by monocytes aside from a 
malaria infection are not known and were investigated.  
  
In order to assay the neopterin secreted by U937 cells treated with antimalarial drugs, β-
haematin and P. falciparum-infected red blood cell lysate, an attempt was made to develop a 
competitive ELISA using antibodies raised against a neopterin-rabbit albumin conjugate in 
chickens. Competitive ELISAs have previously been developed to detect neopterin in serum, 
urine and tissue culture supernatants (Barak et al., 1989; Ogiwara et al., 1992) using polyclonal 
rabbit antibodies. In addition, chicken antibodies have been raised successfully against 
antimalarial drugs, that are haptens with molecular masses similar to neopterin (Goldring et al., 
2005).  Although the chicken antibodies raised against neopterin appeared to recognize the 
neopterin-ovalbumin conjugate coating the wells and the neopterin added to glutaraldehyde-
activated wells in indirect ELISAs, they failed to recognise the free neopterin in the competitive 
ELISAs. The reaction with glutaraldehyde used to generate the conjugates containing neopterin 
may have altered the conformation of the neopterin molecule. Future work would entail using a 
carbodiimide method to couple the neopterin to a high molecular weight carrier (Hermanson, 
1996) as well as generating the antibodies in a mammal that does not produce neopterin, such 
as a rabbit or a mouse. 
       
The main reaction in the formation of neopterin in the monocyte/macrophage is the conversion 
of guanosine triphosphate to 7,8-dihydroneopterin triphosphate which is catalysed by GTP-
cyclohydrolase 1. 7,8-Dihydroneopterin triphosphate is then dephosphorylated by non-specific 
phosphatases to form 7,8-dihydroneopterin which is oxidised to neopterin by hypochlorous acid 
(Hoffmann et al., 2003; Murr et al., 2002). Thus, the effects of antimalarial drugs on the IFN-γ-
induced expression of GTP-cyclohydrolase 1 mRNA were monitored using quantitative RT-
PCR. Only artemisinin, primaquine and quinine significantly inhibited the expression of IFN-γ-
induced GTP-cyclohydrolase 1 mRNA (Table 4.1). Antimalarial drugs have also been shown to 
inhibit the activities of other enzymes. For example, quinidine, the dextrorotatory stereoisomer 
of quinine, has been shown to inhibit naphthol AS-D chloroacetate esterase in 
polymorphonuclear neutrophils and alpha-naphthyl acetate esterase and alpha-naphthyl 
butyrate esterase in monocytes (Markovic et al., 1988). Chloroquine, primaquine and quinine 
which also contain quinoline rings, also inhibit naphthol AS-D chloroacetate esterase but to a 
lesser degree (Markovic et al., 1988). In contrast, amodiaquine, chloroquine, doxycycline and 
pyrimethamine had no effect on GTP-cyclohydrolase 1 mRNA expression (Table 4.1). Likewise, 
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chloroquine, primaquine, quinidine and quinine have been reported to have no effect on 
alkaline phosphatase activity (Markovic et al., 1988). The results observed with GTP-
cyclohydrolase 1 mRNA expression were very similar to those obtained with the phagocytosis 
of latex beads by the J774A.1 cells, with the exception of chloroquine which inhibited latex bead 
phagocytosis but had no effect on the expression of GTP-cyclohydrolase 1 mRNA (Table 4.1).  
 
 
Table 4.2 Effect of latex beads, β-haematin, P. falciparum-infected and non-infected red 
blood cell lysates on expression of GTP-cyclohydrol ase 1 mRNA 




Latex Beads 0 
β-haematin + 
RBC lysate (10 µg/ml) 0 
RBC lysate (20 µg/ml) 0 
Pf-RBC lysate (10 µg/ml) 0 
Pf-RBC lysate (20 µg/ml) - 
+ : Activation 
 - : Inhibition 
0 : No effect 
RBC : Red blood cell 
Pf-RBC : P. falciparum-infected red blood cell 
 GTP-CH1: GTP-cyclohydrolase 1  
 
 
β-haematin was found to increase the expression of GTP-cyclohydrolase 1 mRNA and 20 µg/ml 
protein of P. falciparum-infected red blood cell lysate (10% parasitaemia) was found to 
decrease the expression (Table 4.2). This is in contrast to reports, where iron was found to 
inhibit GTP-cyclohydrolase 1 mRNA expression (Oexle et al., 2003) and P. falciparum-infected 
red blood cell lysate was found to stimulate neopterin secretion in monocytes (Facer, 1995). 
However, iron in β-haematin is assembled into an insoluble crystal lattice and is unavailable. 
Furthermore, the stimulatory effects of the parasite lysates on neopterin secretion were 
observed after 48 hours in Facer’s study, whereas the parasite lysates were incubated with the 
monocytes for only 18 hours in this study, because this time period was compatible to other 
studies investigating the effect of antimalarial drugs on expression of monocyte receptors and 
TNF secretion (Goldring and Nemaorani, 1999; Kwiatkowski and Bate, 1995). The stimulatory 
effects may have been observed after longer incubation periods or using higher protein 
concentrations of the P. falciparum-infected red blood cell lysate with parasitaemias greater 
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than 10% as the amount of parasite lysate and parasitaemia were not stipulated in Facer’s 
study. Another enzyme in human monocytes that has been shown to be up-regulated by the 
phagocytosis of β-haematin is metalloproteinase 9 (Facer, 1995; Prato et al., 2008; Prato et al., 
2005). The increase in GTP-cyclohydrolase 1 mRNA expression induced by β-haematin aligns 
with the observed activation of phagocytosis of β-haematin in comparison to latex bead 
phagocytosis (Table 4.1). When β-haematin is phagocytosed by monocytes, a large amount of 
lipoperoxidation products are generated by non-enzymatic haeme catalysis (Schwarzer et al., 
2003) and these products appear to be responsible for most of the reported effects of 
haemozoin on monocytes (Skorokhod et al., 2005). Thus, these lipoperoxidation products could 
be responsible for the up-regulation of IFN-γ-induced GTP-cyclohydrolase 1 mRNA expression 
as well as the increase in the number of monocytes phagocytosing β-haematin observed with 
some antimalarial drugs.      
 
There are expensive commercial ELISA kits available to detect neopterin in serum, urine and 
supernatants from cells (Mayersbach et al., 1994). Future work could include using these kits to 
determine the neopterin in the supernatants of the monocytes after treatment with antimalarial 
drugs in order to determine the relationship between the IFN-γ-induced GTP-cyclohydrolase 1 
mRNA expression within the monocyte and the secretion of neopterin from the monocytes. The 
effects of β-haematin in combination with antimalarial drugs on GTP-cyclohydrolase 1 mRNA 
expression could also be investigated to determine if there are any correlations to the effects of 
the antimalarial drugs on β-haematin phagocytosis. Furthermore, the effects of drug 
combinations, such as artemisinin-based combination therapies used today to treat acute 
malaria in most parts of the world (WHO, 2008), on the neopterin secretion and the GTP-
cyclohydrolase 1 mRNA expression could also be investigated to demonstrate if the 
macrophage’s response to IFN-γ is activated or inhibited by these drugs.    
 
Inhibition of latex bead phagocytosis by artemisinin, chloroquine, primaquine and quinine 
indicates that these drugs could contribute to the immunosuppression observed in malaria 
infections by decreasing the phagocytosis of P. falciparum ring-infected red blood cells or any 
other concomitant bacteria or infectious agent which may infect the malaria patient (Hartgers 
and Yazdanbakhsh, 2006; Skinner-Adams et al., 2008; Wiwanitkit, 2006). However, 
phagocytosis of non-infected red blood cells will also be decreased, which may benefit the 
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patient by slowing down the progress of anaemia often associated with malaria (Goka et al., 
2001).  
 
The effects of the antimalarial drugs on peripheral blood mononuclear cells (PBMC), rather than 
the J774A.1 and U937 cells, more closely reflects what occurs in a malaria patient during 
treatment. The activation of β-haematin phagocytosis by artemisinin, primaquine, 
pyrimethamine and quinine observed in PBMC could indicate that these drugs activate 
monocyte phagocytosis of P. falciparum-infected red blood cells, thereby promoting clearance 
of the blood forms of the parasite from circulation. However, activation of β-haematin 
phagocytosis could also contribute to immunosuppression associated with malaria as this 
activation would result in more circulating monocytes that contain haemozoin, which modifies a 
number of monocyte functions. Alternatively, amodiaquine, chloroquine and doxycycline inhibit 
β-haematin phagocytosis and would thus reduce the number of haemozoin-laden monocytes in 
circulation and the associated immunosuppression.  
 
One of the monocyte enzymes modulated by haemozoin is metalloproteinase 9. 
Metalloproteinase 9 activity and protein/mRNA expression is increased in haemozoin-fed 
monocytes (Prato et al., 2005). Metalloproteinase 9 proteolytically sheds pro-forms of cytokines 
such as TNF-α and IL-1β in the blood and it also disrupts the sub-endothelial matrix and 
enhances extravasation of blood cells (Prato et al., 2008). Thus, metalloproteinase 9 increases 
the formation of TNF-α, which in vivo, has been associated with parasite clearance and 
resolution of headaches in the early response to malaria infection (Kremsner et al., 1995), but 
in excess, TNF-α has been linked to disease severity (Grau et al., 1989; Shaffer et al., 1991) 
and complications such as cerebral malaria (Kwiatkowski et al., 1990), suggesting that excess 
TNF-α might play a role in the pathogenesis of malaria. Moreover, monocytes/macrophages 
are impaired by phagocytosed β-haematin in terms of their inability to initiate oxidative bursts, 
to kill and repeat phagocytosis, to express MHC Class II, ICAM-1 and integrin-CD11c on the 
surface of the monocytes in response to interferon-γ (IFN-γ), and to differentiate into functional 
antigen-presenting dendritic cells (Schwarzer et al., 2008). Dendritic cells are a link between 
the innate and adaptive immune response (Steinman, 2006; Steinman and Hemmi, 2006), thus 
inhibition of dendritic cell formation will suppress an appropriate adaptive immune response to  
malaria infection. Abrogation of the MHC Class II expression on the monocyte surface leads to 
disruptions in antigen presentation to T cells, and the reduction in the up regulation of ICAM-1 
on the cell surface prevents the monocyte from adhering to and stimulating T-cell proliferation 
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(Schwarzer et al., 1998; Scorza et al., 1999). Hence, haemozoin-laden monocytes may be 
responsible for the defective T-cell response in malaria, which will be aggravated by certain 
antimalarial drugs that promote β-haematin phagocytosis. However, ICAM-1 on the surface of 
the monocytes, which has been shown to bind to malaria-infected erythrocytes (Ockenhouse et 
al., 1991), is involved in the sequestration of the infected red blood cells and contributes to the 
pathogenesis of complicated and severe malaria (Chulay and Ockenhouse, 1990). Haemozoin 
reduces the IFN-γ mediated expression of ICAM-1 on the surface of the monocytes (Schwarzer 
et al., 1998). Hence, an increase in the number of haemozoin-laden monocytes potentiated by 
artemisinin, primaquine, pyrimethamine and quinine, would result in decreased ICAM-1 
expression on the monocytes, leading to reduced cytoadherance and sequestration. This would 
increase the number of circulating monocytes available to phagocytose infected red blood cells.    
 
Haemozoin decreased the expression of monocyte MHC Class II and ICAM-1, which are both 
mediated by IFN-γ. This is indicative of haemozoin suppressing the monocyte’s responsiveness 
to IFN-γ.  As GTP-cyclohydrolase 1 production is up-regulated by interferon-γ (Werner et al., 
1990), down-regulation of GTP-cyclohydrolase 1 mRNA expression in U937 cells by quinine, 
artemisinin and primaquine (Table 4.1) suggests that these drugs could reduce the 
monocyte/macrophage’s responsiveness to IFN-γ. IFN-γ is a central cytokine, derived from T 
helper subtype 1 cells, that regulates the antimicrobial effector mechanisms of macrophages. It 
promotes antigen stimulation by stimulating expression of MHC class I and II (Mach et al., 
1996), modulates interactions between leukocytes and endothelium, stimulates the synthesis of 
pro-inflammatory cytokines, such as  IL-1, TNF-α and IL-6, by monocytes, and in synergism 
with IL-6, induces the formation of toxic oxygen radicals and nitric oxide (NO) for the host 
defence (Boehm et al., 1997). Conversely, TNF-α has been associated with severe and 
cerebral malaria (Grau et al., 1989; Kwiatkowski, 1990; Shaffer et al., 1991). Thus, if 
haemozoin in addition to quinine, artemisinin and primaquine reduce the monocyte’s 
responsiveness to IFN-γ, this could lead to a reduced synthesis of proinflammatory cytokines, 
including TNF-α, by monocytes, which could be beneficial in preventing the progression to 
severe malaria.     
 
Overproduction of proinflammatory cytokines is thought to play a prominent role in the 
suppression of erythropoiesis leading to the development of severe malaria anaemia (McDevitt 
et al., 2004; Othoro et al., 1999; Perkins et al., 2000). Macrophage migration inhibitory factor 
(MIF) is a proinflammatory cytokine that plays a pivotal role in regulating the innate immune 
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response to invading pathogens (Calandra and Roger, 2003). MIF has been shown to suppress 
erythroid progenitor development and promote pathogenesis of severe malaria anaemia in 
murine models (Martiney et al., 2000; McDevitt et al., 2006). Elevated plasma levels of MIF 
have been reported in Zambian children with malarial anaemia (McDevitt et al., 2006). In 
contrast, reduced peripheral blood MIF concentrations and peripheral blood mononuclear cell 
MIF mRNA expression were found in Gabonese children with mild to moderate anaemia and 
hyperparasitaemia (Awandare et al., 2006b). This suppression of peripheral blood MIF 
production was found to be associated with the acquisition of haemozoin by monocytes 
(Awandare et al., 2007). Therefore, treatment with artemisinin, primaquine, pyrimethamine or 
quinine which results in increased β-haematin phagocytosis, could result in reduced levels of 
circulating MIF and prevent the MIF-induced suppression of erythropoiesis and resultant 
anaemia.  
 
β-chemokines, macrophage inflammatory protein 1α (MIP-1α) and MIP-1β, were found to be 
significantly elevated in Gabonese children with mild and severe malaria (Ochiel et al., 2005), 
and in adults with severe and complicated falciparum malaria (Burgmann et al., 1995). 
Chemokines are essential for translating an innate-immune response into an acquired immune 
response (Luster, 2002). MIP-1α and MIP-1β are secreted by activated macrophages and are 
crucial for recruiting macrophages, dendritic cells, T cells and B cells to sites of inflammation by 
chemotaxis. They also promote degranulation, phagocytosis and are important in the regulation 
of transendothelial migration of monocytes, dendritic cells, and natural killer cells. MIP-1 can 
also regulate immune responses by modulating Th-differentiation (Maurer and von Stebut, 
2004). Haemozoin has been shown to significantly increase the gene expression and 
production of MIP-1α and MIP-1β in PBMC (Ochiel et al., 2005), thus activation of β-haematin 
phagocytosis by artemisinin, primaquine, pyrimethamine and artemisinin could up-regulate the 
production of MIP-1α and MIP-1β by macrophages and recruit monocytes, dendritic cells, T and 
B cells to sites of inflammation and promote phagocytosis, degranulation and Th differentiation.   
 
GTP-cyclohydrolase 1 is involved in the synthesis of 7,8-dihydroneopteirn which has been 
shown to act as an antioxidant that protects cells from apoptosis and biomolecules from 
oxidation (Gieseg et al., 2000; Gieseg et al., 2001a; Gieseg et al., 2001b). Low density 
lipoproteins are one of the biomolecules that are protected by 7,8-dihydroneopterin (Baird et al., 
2005; Gieseg et al., 1995) which scavenges lipid peroxyl radicals (Gieseg and Cato, 2003; 
Gieseg et al., 2008). Haemozoin or synthetic β-haematin has been shown to release 
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lipoperoxidation products (Schwarzer et al., 2003). Thus, it is possible that the up-regulation 
observed in the IFN-γ-induced expression of the GTP-cyclohydrolase 1 mRNA when U937 cells 
were exposed to β-haematin for 18 hours (Table 4.2), may be in response to β-haematin-
generated lipoperoxidation products. Up-regulation in GTP-cyclohydrolase 1 may result in 
higher levels of 7,8-dihydroneoptrein which could react with the lipid peroxidation products and 
protect the monocyte from cytotoxic oxidised low density lipoproteins (Clare et al., 1995; 
Marchant et al., 1995). In contrast, artemisinin, primaquine and quinine down-regulated the 
expression of GTP-cyclohydrolase 1 mRNA which could lead to reduced production of 7,8-
dihydroneopterin and hence, render the monocytes/macrophages more susceptible to the 
cytotoxic effects of oxidised low density lipoproteins.       
 
In conclusion, some antimalarial drugs appear to have immunomodulatory effects on the in vitro 
phagocytosis of both latex beads and β-haematin and the expression of GTP-cyclohydrolase 1 
mRNA by monocytes. Artemisinin-based combination therapies (artemether-lumefantrine) or 
quinine plus doxycycline are recommended for the treatment of acute malaria in South Africa, 
while intravenous quinine is recommended for the treatment of severe malaria 
[(www.malaria.org.za/Malaria_Risk/Treatment/treatment_malaria08.pdf.) (last accessed 18-06-
09)] This study indicates that artemisinin and quinine both activated β-haematin phagocytosis in 
PBMC, and inhibited IFN-γ-induced GTP-cyclohydrolase 1 mRNA expression in U937 cells. 
Increased β-haematin phagocytosis by monocytes could imply increased phagocytosis of 
infected red blood cells by monocytes thereby enhancing the clearing of the blood stages of the 
parasite. More haemozoin-laden monocytes with a reduced expression of ICAM-1 on their 
surface could reduce sequestration of the monocytes, thus increasing the number of circulating 
monocytes to phagocytose infected red blood cells. Decreased expression of IFN-γ-induced 
GTP-cyclohydrolase 1 mRNA in monocytes suggests a reduced responsiveness of the 
monocyte to IFN-γ, which could decrease the secretion of proinflammatory cytokines, such as 
TNF-α, and possibly prevent the onset of severe malaria. Increased phagocytosis of β-
haematin, although often associated with immunosuppression, can down-regulate the 
monocyte’s production of MIF and thus slow down the progression of anaemia caused by MIF-
induced suppressed erythropoiesis. Furthermore, increased β-haematin phagocytosis by 
monocytes could up-regulate the monocyte’s production of chemokines, MIP-1α and MIP-1β, 
and thereby recruit macrophages, dendritic cells, T and B cells to sites of inflammation and 
promote phagocytosis and degranulation. The relative balance between the pro-inflammatory 
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and anti-inflammatory immune response to malaria appears to be play a role in determining 
mild versus severe malaria (Dodoo et al., 2002; Torre et al., 2002). It is therefore possible that 
the immunomodulatory effects of artemisinin and quinine might contribute to maintaining this 
balance when treating acute malaria and re-establishing this balance when used to treat severe 
malaria. Thus, the immunomodulatory effects of the antimalarial drugs may play a role in 
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